<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Environ Res Public Health</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Environ Res Public Health</journal-id>
<journal-id journal-id-type="publisher-id">ijerph</journal-id>
<journal-title-group>
<journal-title>International Journal of Environmental Research and Public Health</journal-title>
</journal-title-group>
<issn pub-type="ppub">1661-7827</issn>
<issn pub-type="epub">1660-4601</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30857240</article-id>
<article-id pub-id-type="pmc">6427526</article-id>
<article-id pub-id-type="doi">10.3390/ijerph16050856</article-id>
<article-id pub-id-type="publisher-id">ijerph-16-00856</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Contribution of Fluoride to the Pathogenesis of Eye Diseases: Molecular Mechanisms and Implications for Public Health</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Waugh</surname>
<given-names>Declan Timothy</given-names>
</name>
</contrib>
</contrib-group>
<aff id="af1-ijerph-16-00856">EnviroManagement Services, 11 Riverview, Doherty’s Rd, Bandon, P72 YF10 Co. Cork, Ireland; <email>declan@enviro.ie</email>; Tel.: +353-23-884-1933</aff>
<pub-date pub-type="epub">
<day>08</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2019</year>
</pub-date>
<volume>16</volume>
<issue>5</issue>
<elocation-id>856</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>2</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the author.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>This study provides diverse lines of evidence demonstrating that fluoride (F) exposure contributes to degenerative eye diseases by stimulating or inhibiting biological pathways associated with the pathogenesis of cataract, age-related macular degeneration and glaucoma. As elucidated in this study, F exerts this effect by inhibiting enolase, τ-crystallin, Hsp40, Na<sup>+</sup>, K<sup>+</sup>-ATPase, Nrf2, γ -GCS, HO-1 Bcl-2, FoxO1, SOD, PON-1 and glutathione activity, and upregulating NF-κB, IL-6, AGEs, HsP27 and Hsp70 expression. Moreover, F exposure leads to enhanced oxidative stress and impaired antioxidant activity. Based on the evidence presented in this study, it can be concluded that F exposure may be added to the list of identifiable risk factors associated with pathogenesis of degenerative eye diseases. The broader impact of these findings suggests that reducing F intake may lead to an overall reduction in the modifiable risk factors associated with degenerative eye diseases. Further studies are required to examine this association and determine differences in prevalence rates amongst fluoridated and non-fluoridated communities, taking into consideration other dietary sources of F such as tea. Finally, the findings of this study elucidate molecular pathways associated with F exposure that may suggest a possible association between F exposure and other inflammatory diseases. Further studies are also warranted to examine these associations.</p>
</abstract>
<kwd-group>
<kwd>fluoride</kwd>
<kwd>age-related macular degeneration</kwd>
<kwd>cataract</kwd>
<kwd>glaucoma</kwd>
<kwd>molecular mechanisms</kwd>
<kwd>heat shock proteins</kwd>
<kwd>FoxO proteins</kwd>
<kwd>BCL-2</kwd>
<kwd>Na+, K+-ATPase</kwd>
<kwd>NF-kB</kwd>
<kwd>Nrf2</kwd>
<kwd>IL-6</kwd>
<kwd>diabetes</kwd>
<kwd>down syndrome</kwd>
<kwd>schizophrenia</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijerph-16-00856" sec-type="intro">
<title>1. Introduction</title>
<p>Age-related macular degeneration (AMD), cataracts and glaucoma are the leading causes of eye diseases and blindness worldwide. AMD is caused by progressive degeneration of retinal pigment epithelial (RPE) cells and neural retina. AMD is the leading cause for irreversible damage of the vision of people over the age of fifty [<xref ref-type="bibr" rid="B1-ijerph-16-00856">1</xref>]. The pathogenesis of AMD, which covers a complex interaction of genetic and environmental factors, is strongly associated with chronic oxidative stress that ultimately leads to protein damage and degeneration of RPE [<xref ref-type="bibr" rid="B2-ijerph-16-00856">2</xref>]. Among the risk factors for AMD are diet, smoking, obesity, hypertension, cardiovascular disease and diabetes [<xref ref-type="bibr" rid="B3-ijerph-16-00856">3</xref>,<xref ref-type="bibr" rid="B4-ijerph-16-00856">4</xref>,<xref ref-type="bibr" rid="B5-ijerph-16-00856">5</xref>,<xref ref-type="bibr" rid="B6-ijerph-16-00856">6</xref>,<xref ref-type="bibr" rid="B7-ijerph-16-00856">7</xref>,<xref ref-type="bibr" rid="B8-ijerph-16-00856">8</xref>,<xref ref-type="bibr" rid="B9-ijerph-16-00856">9</xref>,<xref ref-type="bibr" rid="B10-ijerph-16-00856">10</xref>]. Cataracts result from the deposition of aggregated proteins in the eye lens and lens fibre cells plasma membrane damage which causes clouding of the lens, light scattering, and obstruction of vision [<xref ref-type="bibr" rid="B11-ijerph-16-00856">11</xref>]. Cataract is a multifactorial disease associated with age, diet, smoking, environmental exposure to UVB radiation and inflammatory degenerative diseases such as diabetes, asthma or chronic bronchitis and cardiovascular disease [<xref ref-type="bibr" rid="B12-ijerph-16-00856">12</xref>,<xref ref-type="bibr" rid="B13-ijerph-16-00856">13</xref>,<xref ref-type="bibr" rid="B14-ijerph-16-00856">14</xref>,<xref ref-type="bibr" rid="B15-ijerph-16-00856">15</xref>]. A recent meta-analysis also found that hypertension increases the risk of cataract [<xref ref-type="bibr" rid="B16-ijerph-16-00856">16</xref>]. It is important to note that a significantly higher prevalence of cataract is found in individuals with Down syndrome [<xref ref-type="bibr" rid="B17-ijerph-16-00856">17</xref>,<xref ref-type="bibr" rid="B18-ijerph-16-00856">18</xref>,<xref ref-type="bibr" rid="B19-ijerph-16-00856">19</xref>,<xref ref-type="bibr" rid="B20-ijerph-16-00856">20</xref>], schizophrenia [<xref ref-type="bibr" rid="B21-ijerph-16-00856">21</xref>] and diabetes [<xref ref-type="bibr" rid="B22-ijerph-16-00856">22</xref>]. Worldwide, cataract remains the predominant cause of blindness and moderate to severe visual impairment (MSVI) and was the second most common cause of blindness in 2010, after macular degeneration, in five world regions (high income Asia Pacific, Australasia, Western Europe, Southern Latin America, and high-income North America). Overall, one in three blind people was blind due to cataract, and one of six visually impaired people was visually impaired due to cataract in 2010 [<xref ref-type="bibr" rid="B23-ijerph-16-00856">23</xref>]. Glaucoma can be viewed as neurodegenerative disease involving a progressive loss of retinal ganglion cells (RGC) and characteristic changes in neuroretinal rim tissue in the optic nerve head (ONH) which are accompanied by visual field loss [<xref ref-type="bibr" rid="B24-ijerph-16-00856">24</xref>]. Hypertension and diabetes are associated with increased risk of glaucoma [<xref ref-type="bibr" rid="B25-ijerph-16-00856">25</xref>].</p>
<p>From a population health perspective, degenerative eye diseases place a significant burden on society and the public health system. In the Republic of Ireland (RoI), it has been estimated that there were nearly 224,832 people with vision impairment and blindness in 2010. The most common causes of blindness were macular degeneration, glaucoma and cataracts. The total economic cost of vision impairment and blindness was estimated to be €2.14 billion in 2010, which is projected to rise to nearly €2.67 billion by 2020 [<xref ref-type="bibr" rid="B26-ijerph-16-00856">26</xref>]. In 2016, some 218,000 cataract surgeries took place in the RoI [<xref ref-type="bibr" rid="B27-ijerph-16-00856">27</xref>], however, due to delays performing surgery and patient waiting lists an increasing number of Irish citizens are travelling abroad for cataract operations A recent study found that the prevalence of AMD in adults over 50 years of age in the RoI was 7.2% [<xref ref-type="bibr" rid="B28-ijerph-16-00856">28</xref>]. Elsewhere, Nolan et al. reported that the prevalence of early AMD was 28% in a randomly selected sample of Irish subjects over 50 years of age [<xref ref-type="bibr" rid="B29-ijerph-16-00856">29</xref>]. </p>
<p>In the EUREYE Study the prevalence of AMD in persons 65 years and older in seven European countries including, Bergen, Norway; Tallinn, Estonia; Belfast, Northern Ireland, U.K.; Paris-Creteil, France; Verona, Italy; Thessaloniki, Greece; and Alicante, Spain was 3.3%, with no significant differences found among the participating countries. The prevalence of AMD in Belfast, Northern Ireland among person over 65 years was 3.77% [<xref ref-type="bibr" rid="B30-ijerph-16-00856">30</xref>]. More recently, Colijn et al. reported in 2017 that the prevalence of early AMD among participants from 10 countries in Europe including Estonia, France, Germany, Greece, Italy, Northern Ireland, Norway, Netherlands, Spain, Portugal, and the U.K. was 3.5% among persons aged 55–59 years [<xref ref-type="bibr" rid="B31-ijerph-16-00856">31</xref>]. Previously, Owen et al. reported that the prevalence of AMD in the U.K. among people aged 50 years or over is 2.4% (from a meta-analysis applied to UK 2007–2009 population data). This increases to 4.8% in people aged 65 years or over, and 12.2% in people aged 80 years or over [<xref ref-type="bibr" rid="B32-ijerph-16-00856">32</xref>]. In Iceland, it has been reported that the prevalence of AMD among subjects 50 years and older is 2.3% [<xref ref-type="bibr" rid="B33-ijerph-16-00856">33</xref>], which is similar to that reported in Norway among subjects 51 years and older (2.9%) [<xref ref-type="bibr" rid="B34-ijerph-16-00856">34</xref>]. In the Netherlands, Klein et al. reported a prevalence of 1.2% for AMD among the population under 85 years of age [<xref ref-type="bibr" rid="B35-ijerph-16-00856">35</xref>]. In the Japanese population, the prevalence of early AMD in the Funagata Study was 3.5% among all participants 35 years and older and 4.3% in those 50 years and over [<xref ref-type="bibr" rid="B36-ijerph-16-00856">36</xref>].</p>
<p>Similar to the RoI, significantly higher prevalence rates of AMD have been reported in the United States (U.S.). For example, Klein et al. reported that the prevalence of AMD among persons over 40 years was 6.5%. Among non-Hispanic whites the prevalence was 7.3% [<xref ref-type="bibr" rid="B37-ijerph-16-00856">37</xref>]. Previous US studies reported that the prevalence of early AMD among non-Hispanic whites was 14.7% among adults aged 60 years and over [<xref ref-type="bibr" rid="B38-ijerph-16-00856">38</xref>]. In addition to AMD, the prevalence of cataracts among individuals over 40 years of age in the US was 17.2% in 2004 [<xref ref-type="bibr" rid="B39-ijerph-16-00856">39</xref>]. Furthermore, by 2020, over 30.1 million people are projected to have cataracts in the U.S. [<xref ref-type="bibr" rid="B39-ijerph-16-00856">39</xref>]. In 2015, some 9000 ophthalmic surgeons were performing 3.6 million cataract surgeries in the U.S. [<xref ref-type="bibr" rid="B40-ijerph-16-00856">40</xref>]. The average cost of cataract surgery in the U.S. has been reported to be US $2525 [<xref ref-type="bibr" rid="B41-ijerph-16-00856">41</xref>]. This suggests that the costs associated with cataract surgery alone in the USA may be in excess of 9 billion dollars annually. Elsewhere it has recently been reported that the economic cost of treating diabetes is over 176 billion dollars a year in the United States, of which over 20% is spent on the ophthalmic complications [<xref ref-type="bibr" rid="B42-ijerph-16-00856">42</xref>]. As previously noted, diabetes is associated with significantly increased risk of cataract, AMD and glaucoma. </p>
<p>A higher prevalence rate of AMD has also been reported in Australia. Recently Keel et al. reported that the weighted prevalence among nonindigenous Australians 50 years and older was 14.8% for early AMD and 10.5% for intermediate AMD. Among indigenous Australians 40 years and older, the weighted prevalence was 13.8% for early AMD and 5.7% for intermediate AMD. Among persons aged 70–79 years the prevalence was 17.4% for early AMD and 14.7% for intermediate AMD [<xref ref-type="bibr" rid="B43-ijerph-16-00856">43</xref>]. In Australia a 2.6-fold increase in the total number of cataract procedures was also documented between 1985 to 1994 [<xref ref-type="bibr" rid="B44-ijerph-16-00856">44</xref>]. Moreover, the rate of cataract surgery per thousand persons aged 65 years or older doubled between the mid-1980s and mid-2000s [<xref ref-type="bibr" rid="B45-ijerph-16-00856">45</xref>]. McCarthy et al. previously reported that the prevalence of cataracts among Australians over 40 years of age was 12.6% [<xref ref-type="bibr" rid="B46-ijerph-16-00856">46</xref>]. Rochtchina et al. reported that by the year 2021 the number of people affected by cataract in Australia will increase by 63%, due to population aging [<xref ref-type="bibr" rid="B47-ijerph-16-00856">47</xref>]. In New Zealand, the prevalence of AMD is uncertain due to a lack of appropriate studies, but it was estimated in 2014 that it affected 10% of people aged 45–85 years, and 38% of people aged over 85 years [<xref ref-type="bibr" rid="B48-ijerph-16-00856">48</xref>]. It was further estimated that AMD accounts for 48% of cases of blindness among adults aged 50 years and older in New Zealand and causes approximately 400–500 new cases of blindness per year [<xref ref-type="bibr" rid="B49-ijerph-16-00856">49</xref>,<xref ref-type="bibr" rid="B50-ijerph-16-00856">50</xref>]. Moreover, it is estimated that 370,000 of the population have cataracts and 30,000 cataract surgeries are performed every year in New Zealand, [<xref ref-type="bibr" rid="B51-ijerph-16-00856">51</xref>]. </p>
<p>As elucidated above, evidence tentatively suggests that the overall prevalence of degenerative eye diseases, particularly AMD, is significantly higher in developed countries with water fluoridation; including, the RoI, U.S., Australia and New Zealand, than in other developed countries without fluoridation of drinking water. Within Europe, the 3-fold differences in prevalence rates for AMD between the RoI the U.K. and mainland Europe are intriguing, especially considering the proximity of the RoI to the U.K. and the shared landmass of the island of Ireland, along with similarities in diet and genetic makeup. It is important to highlight that drinking water is artificially fluoridated in the RoI since 1964, with currently over 80% of households provided with fluoridated water compared to &lt;10% in the U.K. In mainland Europe, drinking water is fluoridated in only one small region, principally the Basque country of Spain since 1988. </p>
<p>Evidence in support of the hypothesis that fluoride (F) intake may be a contributory factor to degenerative eye diseases include several studies documenting that F can accumulate to high concentrations in the eye contributing to retinal toxicity [<xref ref-type="bibr" rid="B52-ijerph-16-00856">52</xref>,<xref ref-type="bibr" rid="B53-ijerph-16-00856">53</xref>,<xref ref-type="bibr" rid="B54-ijerph-16-00856">54</xref>,<xref ref-type="bibr" rid="B55-ijerph-16-00856">55</xref>,<xref ref-type="bibr" rid="B56-ijerph-16-00856">56</xref>,<xref ref-type="bibr" rid="B57-ijerph-16-00856">57</xref>]. An association between chronic F exposure and cataracts has also been reported in human [<xref ref-type="bibr" rid="B58-ijerph-16-00856">58</xref>,<xref ref-type="bibr" rid="B59-ijerph-16-00856">59</xref>,<xref ref-type="bibr" rid="B60-ijerph-16-00856">60</xref>,<xref ref-type="bibr" rid="B61-ijerph-16-00856">61</xref>,<xref ref-type="bibr" rid="B62-ijerph-16-00856">62</xref>,<xref ref-type="bibr" rid="B63-ijerph-16-00856">63</xref>] and animal studies [<xref ref-type="bibr" rid="B64-ijerph-16-00856">64</xref>,<xref ref-type="bibr" rid="B65-ijerph-16-00856">65</xref>]. Furthermore, early in vitro studies by Nordmann et al. using calf lens confirmed that a blockage of the breakdown of sugars by F is followed by cataracts [<xref ref-type="bibr" rid="B66-ijerph-16-00856">66</xref>]. Further in vitro studies examining metabolism of the lens and of retina identified that F is an enzyme inhibitor in ocular tissue [<xref ref-type="bibr" rid="B67-ijerph-16-00856">67</xref>,<xref ref-type="bibr" rid="B68-ijerph-16-00856">68</xref>,<xref ref-type="bibr" rid="B69-ijerph-16-00856">69</xref>]. Consistent with this finding, early research by Dickens and Simer observed that F significantly inhibited glycolysis in the retina [<xref ref-type="bibr" rid="B70-ijerph-16-00856">70</xref>]. Previous human studies have also reported an association between chronic F intake and iridocorneal angle hyperpigmentation and open angle glaucoma [<xref ref-type="bibr" rid="B71-ijerph-16-00856">71</xref>]. However, there is a paucity of qualitative research in epidemiology in western countries to examine the possible association between F intake, water fluoridation and degenerative eye diseases and no study until now has elucidated the molecular mechanisms by which F intake may increase the likelihood of AMD, cataracts or glaucoma. Given the high societal and economic costs of eye diseases in developed countries and globally, a review of modifiable risk factors and the molecular mechanisms by which chronic F exposure may contribute to degenerative eye diseases is therefore warranted. Although much information has become available in recent decades, evidence of a causal relationship requires plausible biological mechanisms by which chronic F exposure may contribute to degenerative eye diseases. Consequently, the purpose of the present study is therefore to elucidate for the first time the key biological mechanisms underlying how F exposure may contribute to degenerative eye diseases including AMD, cataracts and glaucoma. This study therefore provides important insights into the molecular mechanisms by which F intake contributes to degenerative eye diseases and complements the findings of previous human and animal studies making it possible to reach definite conclusions. An understanding of the mechanisms can also elucidate the conditions under which dietary intervention will be most effective and help to identify target populations who may receive optimal benefits.</p>
</sec>
<sec id="sec2-ijerph-16-00856">
<title>2. The Role of Fluoride in Oral Health and Dietary Sources of Fluoride</title>
<p>Today, community water fluoridation and F toothpaste are considered the most common sources of F exposure in the U.S. [<xref ref-type="bibr" rid="B72-ijerph-16-00856">72</xref>]. In countries such as the RoI, U.K., Australia and New Zealand, where habitual tea drinking is commonplace, the major dietary source of F is tea consumption [<xref ref-type="bibr" rid="B73-ijerph-16-00856">73</xref>,<xref ref-type="bibr" rid="B74-ijerph-16-00856">74</xref>,<xref ref-type="bibr" rid="B75-ijerph-16-00856">75</xref>]. In addition to tea, fluoridated water, and toothpaste other sources of F exposure include other beverages produced from fluoridated water (beers, coffee, soft drinks, and fruit juices); pesticide residues in foods, foods processed or cooked in fluoridated water; foods grown in soil containing F or irrigated with fluoridated water; consumption of foods with elevated F levels (i.e., seafood and processed chicken); foods cooked in Teflon cookware; tobacco consumption; use of fluoridated mouthwash; use of medical inhalers containing fluoridated gases, and fluoridated medications, in addition to other environmental or occupational exposures to F [<xref ref-type="bibr" rid="B75-ijerph-16-00856">75</xref>]. </p>
<p>F has no known essential function in human growth and development and no signs of F deficiency have been identified [<xref ref-type="bibr" rid="B76-ijerph-16-00856">76</xref>]. However, F is considered to have played a major role in the reduction of dental caries in the past decades in the industrialized countries. It is added as an anti-caries agent to a variety of vehicles, particularly drinking water and toothpastes. Though F is not essential nutrient, current views of its anti-caries action suggest that it is beneficial in the prevention of dental caries when applied topically on the tooth surface and ingestion is not required [<xref ref-type="bibr" rid="B77-ijerph-16-00856">77</xref>,<xref ref-type="bibr" rid="B78-ijerph-16-00856">78</xref>]. However, caries is not a F deficiency disease [<xref ref-type="bibr" rid="B76-ijerph-16-00856">76</xref>]. </p>
</sec>
<sec id="sec3-ijerph-16-00856">
<title>3. Molecular and Biochemical Markers Relevant to the Pathophysiology of Eye Diseases</title>
<p>Knowledge of type-specific risk factors of degenerative eye diseases is important for the investigation of association between chronic F exposure and eye diseases.</p>
<sec id="sec3dot1-ijerph-16-00856">
<title>3.1. The Role of Oxidative Stress and Antioxidants in Eye Disease</title>
<p>Overproduction of reactive oxygen species (ROS) or dysfunction of anti-oxidative enzymes can result in oxidative stress and lead to cellular damages [<xref ref-type="bibr" rid="B79-ijerph-16-00856">79</xref>,<xref ref-type="bibr" rid="B80-ijerph-16-00856">80</xref>]. When anti-oxidant defence mechanisms are impaired the mechanisms by which increased free radical production and oxidative stress can cause cellular injury increase [<xref ref-type="bibr" rid="B81-ijerph-16-00856">81</xref>]. Excessive oxidative damage due to ROS and oxidative stress is a major factor in the pathogenesis of many vision-impairing diseases such as age-related macular degeneration, glaucomatous neurodegeneration, cataracts and diabetic retinopathy [<xref ref-type="bibr" rid="B82-ijerph-16-00856">82</xref>,<xref ref-type="bibr" rid="B83-ijerph-16-00856">83</xref>,<xref ref-type="bibr" rid="B84-ijerph-16-00856">84</xref>,<xref ref-type="bibr" rid="B85-ijerph-16-00856">85</xref>,<xref ref-type="bibr" rid="B86-ijerph-16-00856">86</xref>,<xref ref-type="bibr" rid="B87-ijerph-16-00856">87</xref>,<xref ref-type="bibr" rid="B88-ijerph-16-00856">88</xref>,<xref ref-type="bibr" rid="B89-ijerph-16-00856">89</xref>,<xref ref-type="bibr" rid="B90-ijerph-16-00856">90</xref>,<xref ref-type="bibr" rid="B91-ijerph-16-00856">91</xref>,<xref ref-type="bibr" rid="B92-ijerph-16-00856">92</xref>,<xref ref-type="bibr" rid="B93-ijerph-16-00856">93</xref>,<xref ref-type="bibr" rid="B94-ijerph-16-00856">94</xref>,<xref ref-type="bibr" rid="B95-ijerph-16-00856">95</xref>].</p>
<p>The lens is able to defend itself against oxidation using antioxidants from either enzymatic or nonenzymatic systems to maintain lens transparency [<xref ref-type="bibr" rid="B82-ijerph-16-00856">82</xref>,<xref ref-type="bibr" rid="B96-ijerph-16-00856">96</xref>]. ROS are degraded through the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) and peroxidases [<xref ref-type="bibr" rid="B97-ijerph-16-00856">97</xref>,<xref ref-type="bibr" rid="B98-ijerph-16-00856">98</xref>,<xref ref-type="bibr" rid="B99-ijerph-16-00856">99</xref>,<xref ref-type="bibr" rid="B100-ijerph-16-00856">100</xref>,<xref ref-type="bibr" rid="B101-ijerph-16-00856">101</xref>]. Elevated oxidative stress and a decrease in antioxidant capacity results in retinal dysfunction and cell loss leading to visual impairment [<xref ref-type="bibr" rid="B102-ijerph-16-00856">102</xref>]. It has also been shown that the antioxidant enzymes such as superoxide dismutase (SOD) in cataractous lenses are decreased, suggesting a role of antioxidant enzymes in the genesis of cataracts [<xref ref-type="bibr" rid="B103-ijerph-16-00856">103</xref>,<xref ref-type="bibr" rid="B104-ijerph-16-00856">104</xref>,<xref ref-type="bibr" rid="B105-ijerph-16-00856">105</xref>,<xref ref-type="bibr" rid="B106-ijerph-16-00856">106</xref>]. In a study conducted in Turkey, it was reported that serum SOD concentrations were significantly lower and lipid peroxidation products significantly higher in patients with AMD than in subjects without AMD [<xref ref-type="bibr" rid="B107-ijerph-16-00856">107</xref>]. However, these findings are inconsistent as studies from China [<xref ref-type="bibr" rid="B108-ijerph-16-00856">108</xref>,<xref ref-type="bibr" rid="B109-ijerph-16-00856">109</xref>] and India [<xref ref-type="bibr" rid="B110-ijerph-16-00856">110</xref>], reported that serum SOD levels were increased in patients with AMD. </p>
<p>What factors account for this discrepancy? Apart from genetic background, one possibility in the observed differences in SOD may be related to differences in diet between the study populations. For example, green tea, which is high in epigallocatechin gallate (EGCG) is consumed in China and curcumin, a bioactive compound in turmeric, is a stable of the Indian diet. EGCG and curcumin stimulate SOD activity [<xref ref-type="bibr" rid="B111-ijerph-16-00856">111</xref>,<xref ref-type="bibr" rid="B112-ijerph-16-00856">112</xref>,<xref ref-type="bibr" rid="B113-ijerph-16-00856">113</xref>,<xref ref-type="bibr" rid="B114-ijerph-16-00856">114</xref>]. A recent cross-sectional study in China reported that the consumption of green tea, but not black tea, reduced the risk of age-related cataracts [<xref ref-type="bibr" rid="B115-ijerph-16-00856">115</xref>]. As I previously elucidated, green tea contains significantly higher antioxidants, including EGCG than black tea [<xref ref-type="bibr" rid="B75-ijerph-16-00856">75</xref>]. Elsewhere, it has been demonstrated that SOD deficiency has been found to be associated with glaucomatous optic neuropathy in human and animal models [<xref ref-type="bibr" rid="B116-ijerph-16-00856">116</xref>]. Oxidative stress has also been proposed to contribute to retinal ganglion cell (RGC) death in glaucoma [<xref ref-type="bibr" rid="B117-ijerph-16-00856">117</xref>,<xref ref-type="bibr" rid="B118-ijerph-16-00856">118</xref>]. Previous studies have also demonstrated that GSH, a tripeptide of glutamate, cysteine, and glycine, has a central role in protecting RGCs against oxidative stress and that glutamate uptake is a rate-limiting step in glial GSH synthesis [<xref ref-type="bibr" rid="B118-ijerph-16-00856">118</xref>,<xref ref-type="bibr" rid="B119-ijerph-16-00856">119</xref>]. Consistent with these findings, a reduction in GSH levels has been reported in the plasma of human primary open-angle glaucoma (POAG) patients [<xref ref-type="bibr" rid="B120-ijerph-16-00856">120</xref>]. Of note, GSH has been found to be decreased in cataractous lenses [<xref ref-type="bibr" rid="B121-ijerph-16-00856">121</xref>].</p>
</sec>
<sec id="sec3dot2-ijerph-16-00856">
<title>3.2. The Role of Na+, K+-ATPase Activity in Degenerative Eye Diseases</title>
<p>Previous studies have shown that inhibition of Na+, K+-ATPase activity has been found to accelerate depletion of adenosine triphosphate (ATP), induce mitochondrial depolarization, suppress reactive oxygen species (ROS) scavenging, and enhance ROS production and oxidative stress [<xref ref-type="bibr" rid="B122-ijerph-16-00856">122</xref>,<xref ref-type="bibr" rid="B123-ijerph-16-00856">123</xref>,<xref ref-type="bibr" rid="B124-ijerph-16-00856">124</xref>]. Loss of Na+, K+-ATPase activity is associated with cataract formation [<xref ref-type="bibr" rid="B125-ijerph-16-00856">125</xref>,<xref ref-type="bibr" rid="B126-ijerph-16-00856">126</xref>,<xref ref-type="bibr" rid="B127-ijerph-16-00856">127</xref>,<xref ref-type="bibr" rid="B128-ijerph-16-00856">128</xref>,<xref ref-type="bibr" rid="B129-ijerph-16-00856">129</xref>] and age-dependent degeneration in photoreceptors [<xref ref-type="bibr" rid="B130-ijerph-16-00856">130</xref>]; suggesting a link between loss of Na+, K+-ATPase and AMD. </p>
</sec>
<sec id="sec3dot3-ijerph-16-00856">
<title>3.3. Nuclear Factor Erythroid-2-Related Factor 2 Nuclear Factor</title>
<p>Nuclear factor erythroid-2-related factor 2 Nuclear factor (Nrf2) is a key nuclear transcription factor for the systemic antioxidant defence system [<xref ref-type="bibr" rid="B131-ijerph-16-00856">131</xref>,<xref ref-type="bibr" rid="B132-ijerph-16-00856">132</xref>]. Inhibition of dysregulation of Nrf2 pathway may contribute to a state of chronic inflammation with a diminished capacity to compensate for conditions of increased oxidative stress [<xref ref-type="bibr" rid="B133-ijerph-16-00856">133</xref>]. Importantly, Nrf2 is considered as one of the main cellular defence mechanisms against oxidative stresses and ocular diseases including cataracts and AMD [<xref ref-type="bibr" rid="B79-ijerph-16-00856">79</xref>,<xref ref-type="bibr" rid="B134-ijerph-16-00856">134</xref>,<xref ref-type="bibr" rid="B135-ijerph-16-00856">135</xref>,<xref ref-type="bibr" rid="B136-ijerph-16-00856">136</xref>,<xref ref-type="bibr" rid="B137-ijerph-16-00856">137</xref>,<xref ref-type="bibr" rid="B138-ijerph-16-00856">138</xref>,<xref ref-type="bibr" rid="B139-ijerph-16-00856">139</xref>]. Consistent with this, an animal model for AMD found that Nrf2-deficient mice developed retinal pathology that has similarities with human AMD including deregulated autophagy, oxidative injury and inflammation [<xref ref-type="bibr" rid="B139-ijerph-16-00856">139</xref>].</p>
</sec>
<sec id="sec3dot4-ijerph-16-00856">
<title>3.4. Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-kB)</title>
<p>NF-kB plays a critical role in the expression of inflammatory cytokines, chemokines, immunoreceptors, and cell adhesion molecules that are implicated in the initiation of immune, acute phase, and inflammatory responses [<xref ref-type="bibr" rid="B140-ijerph-16-00856">140</xref>,<xref ref-type="bibr" rid="B141-ijerph-16-00856">141</xref>,<xref ref-type="bibr" rid="B142-ijerph-16-00856">142</xref>,<xref ref-type="bibr" rid="B143-ijerph-16-00856">143</xref>]. NF-κB is activated in corneal pathologies involving increased plasma levels of LPS and Tumor Necrosis Factor-α (TNF-α), as well as direct UV-B exposure [<xref ref-type="bibr" rid="B144-ijerph-16-00856">144</xref>]. The constitutive activation of NF- κB has been linked with a wide variety of human diseases including AMD, cataractogenesis and glaucoma [<xref ref-type="bibr" rid="B142-ijerph-16-00856">142</xref>,<xref ref-type="bibr" rid="B145-ijerph-16-00856">145</xref>,<xref ref-type="bibr" rid="B146-ijerph-16-00856">146</xref>,<xref ref-type="bibr" rid="B147-ijerph-16-00856">147</xref>,<xref ref-type="bibr" rid="B148-ijerph-16-00856">148</xref>,<xref ref-type="bibr" rid="B149-ijerph-16-00856">149</xref>].</p>
</sec>
<sec id="sec3dot5-ijerph-16-00856">
<title>3.5. B-Cell Lymphoma 2 (BCL-2)</title>
<p>Bc1-2 serves an anti-inflammatory function through inhibiting the transcription factor NF-kB [<xref ref-type="bibr" rid="B150-ijerph-16-00856">150</xref>]. It must be emphasized that reduced Bcl-2 mRNA expression and activity is associated with severe neurodevelopmental disorders such as Down syndrome [<xref ref-type="bibr" rid="B151-ijerph-16-00856">151</xref>,<xref ref-type="bibr" rid="B152-ijerph-16-00856">152</xref>] and schizophrenia [<xref ref-type="bibr" rid="B153-ijerph-16-00856">153</xref>,<xref ref-type="bibr" rid="B154-ijerph-16-00856">154</xref>]. Hence, this elucidates why the highest prevalence of cataracts are found in individuals with Down syndrome and schizophrenia. In diabetic patients, downregulation of Bcl-2 is associated with a proinflammatory status, enhanced expression of KF-kb, nitric oxide synthase (iNOS) and other inflammatory biomarkers [<xref ref-type="bibr" rid="B155-ijerph-16-00856">155</xref>]. Hence, downregulation of Bcl-2 in diabetic patients also elucidates why patients with diabetic retinopathy have a higher risk of progressive disease.</p>
</sec>
<sec id="sec3dot6-ijerph-16-00856">
<title>3.6. Forkhead Box Protein FoxO Proteins</title>
<p>Forkhead box O (FoxO) subfamily of transcription factors regulate expression of target genes involved in DNA damage repair response, apoptosis, metabolism, cellular proliferation, stress tolerance, and longevity [<xref ref-type="bibr" rid="B156-ijerph-16-00856">156</xref>,<xref ref-type="bibr" rid="B157-ijerph-16-00856">157</xref>]. Notably, FoxO proteins regulate the expression of intracellular antioxidant enzymes, manganese-superoxide dismutase (SOD) and catalase (CAT) [<xref ref-type="bibr" rid="B158-ijerph-16-00856">158</xref>,<xref ref-type="bibr" rid="B159-ijerph-16-00856">159</xref>,<xref ref-type="bibr" rid="B160-ijerph-16-00856">160</xref>]. In response to oxidative stress, FoxO activity is regulated primarily through regulation of its protein levels, subcellular localization and post-translational modifications. In the aging lens Fox1 and FoxO3a levels are decreased significantly which suggests that age-related down regulation of FoxO1 and FoxO3a expression may contribute to degenerative eye disorders such as cataract formation [<xref ref-type="bibr" rid="B161-ijerph-16-00856">161</xref>]. </p>
</sec>
<sec id="sec3dot7-ijerph-16-00856">
<title>3.7. Interleukin 6 </title>
<p>Interleukin 6 (IL-6) is a proinflammatory cytokine produced by leukocytes, adipocytes, endothelial cells, fibroblasts, and myocytes. IL-6 induces the production of mediators for the release of cytokines such as TNF and IL-1, which drive the inflammatory reaction [<xref ref-type="bibr" rid="B162-ijerph-16-00856">162</xref>]. IL-6 has been shown to be a key player in chronic low-grade systemic inflammation [<xref ref-type="bibr" rid="B163-ijerph-16-00856">163</xref>], and IL-6 levels are elevated in inflammatory diseases [<xref ref-type="bibr" rid="B164-ijerph-16-00856">164</xref>]. The expressions of IL-6 is significantly correlated with the inflammation index in cataract patients [<xref ref-type="bibr" rid="B165-ijerph-16-00856">165</xref>]. IL-6 levels are increased in schizophrenia [<xref ref-type="bibr" rid="B166-ijerph-16-00856">166</xref>,<xref ref-type="bibr" rid="B167-ijerph-16-00856">167</xref>], obesity [<xref ref-type="bibr" rid="B168-ijerph-16-00856">168</xref>,<xref ref-type="bibr" rid="B169-ijerph-16-00856">169</xref>,<xref ref-type="bibr" rid="B170-ijerph-16-00856">170</xref>] and Type 2 diabetes [<xref ref-type="bibr" rid="B171-ijerph-16-00856">171</xref>,<xref ref-type="bibr" rid="B172-ijerph-16-00856">172</xref>] which, as previously elucidated, are risk factors for cataracts, AMD and glaucoma.</p>
</sec>
<sec id="sec3dot8-ijerph-16-00856">
<title>3.8. Paraoxonase 1</title>
<p>Paraoxonase 1 (PON1) plays an essential role in detoxifying the body and reducing oxidative stress [<xref ref-type="bibr" rid="B173-ijerph-16-00856">173</xref>]. Recently it has been shown that the expression of human PON1 can prevent diabetes development through its antioxidant properties [<xref ref-type="bibr" rid="B174-ijerph-16-00856">174</xref>,<xref ref-type="bibr" rid="B175-ijerph-16-00856">175</xref>]. Several studies have reported an association between low PON1 activity and AMD [<xref ref-type="bibr" rid="B176-ijerph-16-00856">176</xref>,<xref ref-type="bibr" rid="B177-ijerph-16-00856">177</xref>,<xref ref-type="bibr" rid="B178-ijerph-16-00856">178</xref>]. Low PON1 activity has also been found to be associated with the pathogenesis of cataracts [<xref ref-type="bibr" rid="B179-ijerph-16-00856">179</xref>].</p>
</sec>
</sec>
<sec id="sec4-ijerph-16-00856">
<title>4. Molecular Mechanisms Underlying Fluoride Contribution to Eye Diseases</title>
<p>Building on the results of these studies, it is necessary to identify the key molecular mechanisms by which chronic F exposure may contribute to degenerative eye diseases. Herein, I identify and investigate some of the key molecular mechanisms by which F exposure contributes to eye diseases as summarized in <xref ref-type="table" rid="ijerph-16-00856-t001">Table 1</xref>. </p>
<sec id="sec4dot1-ijerph-16-00856">
<title>4.1. Fluoride Inhibition of Carbohydrate Metabolism</title>
<p>Of all the theories advanced to explain the pathogenesis of cataract, the one which seems to have stood the test of time most satisfactorily is that which ascribes the opacification to a defect in the carbohydrate metabolism of the lens [<xref ref-type="bibr" rid="B66-ijerph-16-00856">66</xref>]. As previously noted, early in vitro studies by Nordmann et al. confirmed that a blockage of the breakdown of sugars by F is followed by cataracts [<xref ref-type="bibr" rid="B66-ijerph-16-00856">66</xref>]. Further in vitro studies examining metabolism of the lens and of retina have shown that F is an enzyme inhibitor of ocular tissue [<xref ref-type="bibr" rid="B67-ijerph-16-00856">67</xref>,<xref ref-type="bibr" rid="B68-ijerph-16-00856">68</xref>,<xref ref-type="bibr" rid="B69-ijerph-16-00856">69</xref>] and inhibits glycolysis in the retina [<xref ref-type="bibr" rid="B70-ijerph-16-00856">70</xref>]. Enolase enzymes are known for their role in glucose metabolism [<xref ref-type="bibr" rid="B180-ijerph-16-00856">180</xref>]. It has been known for many decades that enolase is particularly sensitive to F inhibition [<xref ref-type="bibr" rid="B181-ijerph-16-00856">181</xref>,<xref ref-type="bibr" rid="B182-ijerph-16-00856">182</xref>,<xref ref-type="bibr" rid="B183-ijerph-16-00856">183</xref>]. Furthermore, it is known that the inhibition of enolase results in the formation of advanced glycation end products (AGEs) [<xref ref-type="bibr" rid="B184-ijerph-16-00856">184</xref>]. AGEs are a significant factor in the pathogenesis of retinopathy and cataracts [<xref ref-type="bibr" rid="B185-ijerph-16-00856">185</xref>,<xref ref-type="bibr" rid="B186-ijerph-16-00856">186</xref>]. Consistent with this, recent in vivo studies demonstrated that chronic long-term exposure for six months to F at high and low doses via drinking water significantly increased expression of receptors for advanced glycation end products (RAGE), increased RAGE proteins and increased levels of AGEs in cells. A significant increase in the expression NADPH oxidase 2 (NOX2) was also observed among specimens exposed to fluorine for 6 months. Notably these effects were found to occur at concentrations of just 5 mg/L in drinking water, which is the equivalent to approximately 0.5 mg/L in drinking water for humans. Simultaneous in vitro research with SH-SY5Y cells originating from human neuroblastoma confirmed these results [<xref ref-type="bibr" rid="B187-ijerph-16-00856">187</xref>]. It is important to note that the NADPH oxidase system participates in generating ROS in the lens [<xref ref-type="bibr" rid="B90-ijerph-16-00856">90</xref>].</p>
<p>Beyond glucose metabolism, enolase enzymes have been reported to have a number of other non-glycolytic functions, including being a τ-crystallin protein [<xref ref-type="bibr" rid="B188-ijerph-16-00856">188</xref>], a heat-shock protein [<xref ref-type="bibr" rid="B189-ijerph-16-00856">189</xref>], hypoxic-stress protein [<xref ref-type="bibr" rid="B190-ijerph-16-00856">190</xref>], c-Myc binding and transcription protein [<xref ref-type="bibr" rid="B191-ijerph-16-00856">191</xref>] among others. As F is known to inhibit enolase by binding to active sites within the enolase structure, thereby altering its activity [<xref ref-type="bibr" rid="B183-ijerph-16-00856">183</xref>] it is therefore plausible that F may alter the activity of non-glycolytic enolase enzymes involved in lens development, repair and protection. For example, crystallins comprise 80–90% of the water-soluble proteins of the transparent lens [<xref ref-type="bibr" rid="B192-ijerph-16-00856">192</xref>] and are essential determinants of the transparency and refractivity required for lens function [<xref ref-type="bibr" rid="B193-ijerph-16-00856">193</xref>]. Moreover, τ-crystallin has a distinct function as a lens structural protein [<xref ref-type="bibr" rid="B193-ijerph-16-00856">193</xref>]. In addition, heat shock proteins are found throughout the various tissues of the eye where they are thought to confer protection from disease states such as cataract, glaucoma, and cancer [<xref ref-type="bibr" rid="B194-ijerph-16-00856">194</xref>]. Of note, Hsp 40 has also been found to protect the lens from stress induced denaturation [<xref ref-type="bibr" rid="B195-ijerph-16-00856">195</xref>], while Hsp27 expression is thought to play a role in age-related macular degeneration [<xref ref-type="bibr" rid="B196-ijerph-16-00856">196</xref>] and cataractogenesis [<xref ref-type="bibr" rid="B197-ijerph-16-00856">197</xref>]. In addition, variants of Hsp70 have been found to serve as genetic susceptibility factors for susceptibility to cataract and glaucoma in humans [<xref ref-type="bibr" rid="B198-ijerph-16-00856">198</xref>,<xref ref-type="bibr" rid="B199-ijerph-16-00856">199</xref>,<xref ref-type="bibr" rid="B200-ijerph-16-00856">200</xref>]. Moreover, c-Myc binding proteins play an essential role in promoting lens growth and differentiation [<xref ref-type="bibr" rid="B201-ijerph-16-00856">201</xref>,<xref ref-type="bibr" rid="B202-ijerph-16-00856">202</xref>] and inactivation of c-myc results in severe eye and lens growth impairment and anterior chamber malformation [<xref ref-type="bibr" rid="B202-ijerph-16-00856">202</xref>,<xref ref-type="bibr" rid="B203-ijerph-16-00856">203</xref>]. </p>
</sec>
<sec id="sec4dot2-ijerph-16-00856">
<title>4.2. Fluoride and Heat Shock Proteins </title>
<p>In vivo studies using animal models have found that chronic F exposure can modulate the expression of heat shock proteins in cardiac tissue, liver, kidney and testes [<xref ref-type="bibr" rid="B204-ijerph-16-00856">204</xref>,<xref ref-type="bibr" rid="B205-ijerph-16-00856">205</xref>,<xref ref-type="bibr" rid="B206-ijerph-16-00856">206</xref>]. Recently, Panneerselvam et al. demonstrated that F significantly downregulated the expression of heat shock protein 40 (Hsp40) within living mammalian cells in vivo and upregulated HsP27 and Hsp70 [<xref ref-type="bibr" rid="B204-ijerph-16-00856">204</xref>]. Consistent with this, Zhao et al. also found that F upregulated mRNA and proteins levels of Hsf27 [<xref ref-type="bibr" rid="B205-ijerph-16-00856">205</xref>]. Moreover, Chen et al. showed that F exposure significantly increased the expression of Hsp70 in human subjects exposed to F [<xref ref-type="bibr" rid="B207-ijerph-16-00856">207</xref>]. In this study, the urinary F concentrations in subjects with fluorosis was approximately 2.10 mg/L compared to &lt;1.0 mg/L in controls [<xref ref-type="bibr" rid="B207-ijerph-16-00856">207</xref>]. Taken together, this data suggests that F has the potential to alter non-glycolytic enolase enzymes activity and protein expression, particularly heat shock proteins that contribute to degenerative eye diseases including cataracts, AMD and glaucoma.</p>
</sec>
<sec id="sec4dot3-ijerph-16-00856">
<title>4.3. Fluoride Inhibition of Na+, K+-ATPase Activity </title>
<p>The molecular mechanisms by which F inhibits Na+, K+-ATPase enzyme activity have recently been described [<xref ref-type="bibr" rid="B208-ijerph-16-00856">208</xref>]. As previously elucidated loss of Na+, K+-ATPase enzyme activity is associated with impaired ROS scavenging, enhanced ROS production [<xref ref-type="bibr" rid="B122-ijerph-16-00856">122</xref>,<xref ref-type="bibr" rid="B123-ijerph-16-00856">123</xref>,<xref ref-type="bibr" rid="B124-ijerph-16-00856">124</xref>], cataract formation [<xref ref-type="bibr" rid="B125-ijerph-16-00856">125</xref>,<xref ref-type="bibr" rid="B126-ijerph-16-00856">126</xref>,<xref ref-type="bibr" rid="B127-ijerph-16-00856">127</xref>,<xref ref-type="bibr" rid="B128-ijerph-16-00856">128</xref>,<xref ref-type="bibr" rid="B129-ijerph-16-00856">129</xref>] and age-dependent degeneration in photoreceptors [<xref ref-type="bibr" rid="B130-ijerph-16-00856">130</xref>]. It is long known that F is an inhibitor of the Na+, K+-ATPase enzyme activity [<xref ref-type="bibr" rid="B209-ijerph-16-00856">209</xref>,<xref ref-type="bibr" rid="B210-ijerph-16-00856">210</xref>,<xref ref-type="bibr" rid="B211-ijerph-16-00856">211</xref>,<xref ref-type="bibr" rid="B212-ijerph-16-00856">212</xref>,<xref ref-type="bibr" rid="B213-ijerph-16-00856">213</xref>,<xref ref-type="bibr" rid="B214-ijerph-16-00856">214</xref>,<xref ref-type="bibr" rid="B215-ijerph-16-00856">215</xref>,<xref ref-type="bibr" rid="B216-ijerph-16-00856">216</xref>,<xref ref-type="bibr" rid="B217-ijerph-16-00856">217</xref>,<xref ref-type="bibr" rid="B218-ijerph-16-00856">218</xref>,<xref ref-type="bibr" rid="B219-ijerph-16-00856">219</xref>,<xref ref-type="bibr" rid="B220-ijerph-16-00856">220</xref>]. However, of fundamental importance, evidence from epidemiological studies confirm this association and provide a biological gradient by which serum F levels may inhibit Na+, K+-ATPase activity in humans. This effect has been found to occur at serum F levels &lt; 5.0 µM in adults [<xref ref-type="bibr" rid="B221-ijerph-16-00856">221</xref>,<xref ref-type="bibr" rid="B222-ijerph-16-00856">222</xref>]. Furthermore, it is important to note that AGEs have also been shown to inhibit Na+, K+-ATPase enzyme activity [<xref ref-type="bibr" rid="B223-ijerph-16-00856">223</xref>]. As previously described, inhibition of enolase leads to the production of AGEs and AGEs are a significant factor in the pathogenesis of retinopathy and cataracts [<xref ref-type="bibr" rid="B185-ijerph-16-00856">185</xref>,<xref ref-type="bibr" rid="B186-ijerph-16-00856">186</xref>]. Of interest, inhibition of Na+, K+-ATPase is also a causative factor in the pathogenesis of hypertension [<xref ref-type="bibr" rid="B208-ijerph-16-00856">208</xref>]. As previously elucidated, hypertension is an established risk factor for the development of cataracts, AMD and glaucoma. Taken together, these findings suggest that one of the key molecular mechanisms by which chronic F exposure may contribute to degenerative eye diseases is via inhibition Na+, K+-ATPase.</p>
</sec>
<sec id="sec4dot4-ijerph-16-00856">
<title>4.4. Fluoride Inhibition of Nrf2 </title>
<p>Recent in vivo studies have shown that chronic F exposure significantly downregulates mRNA expression of Nrf2 and its downregulatory target genes γ-glutamyl cysteine synthetase (γ-GCS), NAD(P)H quinone dehydrogenase 1 (NQO1) and heme oxygenase 1 (HO-1) [<xref ref-type="bibr" rid="B113-ijerph-16-00856">113</xref>,<xref ref-type="bibr" rid="B224-ijerph-16-00856">224</xref>]. It is important to note that the first and rate limiting step in the synthesis of GSH is catalysed by γ-GCS [<xref ref-type="bibr" rid="B225-ijerph-16-00856">225</xref>] and decreased γ-GCS in turn leads to reduced levels of GSH [<xref ref-type="bibr" rid="B226-ijerph-16-00856">226</xref>]. As F has been found to downregulate γ-GCS expression, this may elucidate in part one of the molecular mechanisms by which F exposure has been found to decreases GSH activity. Further, HO-1 induction plays an important role in cellular protection against oxidant injury. Overexpression of HO-1 provides protection against inflammation-mediated injury, whereas deficiency in its expression is associated with a chronically inflamed state [<xref ref-type="bibr" rid="B227-ijerph-16-00856">227</xref>]. In in vivo studies it has been shown that HO-1 protects against rhabdomyolysis (the breakdown of damaged skeletal muscle) and kidney failure. Conversely, inhibition of HO activity exacerbates kidney dysfunction [<xref ref-type="bibr" rid="B228-ijerph-16-00856">228</xref>,<xref ref-type="bibr" rid="B229-ijerph-16-00856">229</xref>]. Moreover, HO-1 alleviates ocular surface and corneal inflammation while accelerating wound repair after injury. Wound healing in the cornea is unique because of the need to maintain transparency. The same is true for corneal inflammation, which is intimately linked to the reparative effort [<xref ref-type="bibr" rid="B227-ijerph-16-00856">227</xref>]. A recent study showed that a deficiency in HO activity, as in HO-2 null mice, exacerbates ocular surface inflammation; increased cell infiltration, expression of inflammatory genes, and production of proinflammatory lipid mediators and impaired wound healing, allowing an acute inflammation to become chronic with the stigma of chronic corneal inflammation such as neovascularization, ulceration, and perforation [<xref ref-type="bibr" rid="B230-ijerph-16-00856">230</xref>]. </p>
</sec>
<sec id="sec4dot5-ijerph-16-00856">
<title>4.5. Fluoride Activation of NF-Kb Expression</title>
<p>Tiwari et al. demonstrated that F inhibits vitamin D receptor (VDR) mRNA expression [<xref ref-type="bibr" rid="B231-ijerph-16-00856">231</xref>] and low levels of VDR in turn leads to increased levels of NF-kB expression [<xref ref-type="bibr" rid="B232-ijerph-16-00856">232</xref>]. Consistent with this finding, several in vitro and in vivo studies have demonstrated that F upregulates NF-κB gene expression in in monocytes [<xref ref-type="bibr" rid="B233-ijerph-16-00856">233</xref>], peripheral blood mononuclear cells [<xref ref-type="bibr" rid="B234-ijerph-16-00856">234</xref>], macrophages [<xref ref-type="bibr" rid="B235-ijerph-16-00856">235</xref>,<xref ref-type="bibr" rid="B236-ijerph-16-00856">236</xref>], as well as kidney [<xref ref-type="bibr" rid="B224-ijerph-16-00856">224</xref>,<xref ref-type="bibr" rid="B225-ijerph-16-00856">225</xref>,<xref ref-type="bibr" rid="B226-ijerph-16-00856">226</xref>,<xref ref-type="bibr" rid="B227-ijerph-16-00856">227</xref>,<xref ref-type="bibr" rid="B228-ijerph-16-00856">228</xref>,<xref ref-type="bibr" rid="B229-ijerph-16-00856">229</xref>,<xref ref-type="bibr" rid="B230-ijerph-16-00856">230</xref>,<xref ref-type="bibr" rid="B231-ijerph-16-00856">231</xref>,<xref ref-type="bibr" rid="B232-ijerph-16-00856">232</xref>,<xref ref-type="bibr" rid="B233-ijerph-16-00856">233</xref>,<xref ref-type="bibr" rid="B234-ijerph-16-00856">234</xref>,<xref ref-type="bibr" rid="B235-ijerph-16-00856">235</xref>,<xref ref-type="bibr" rid="B236-ijerph-16-00856">236</xref>,<xref ref-type="bibr" rid="B237-ijerph-16-00856">237</xref>], lung [<xref ref-type="bibr" rid="B238-ijerph-16-00856">238</xref>], spleen [<xref ref-type="bibr" rid="B239-ijerph-16-00856">239</xref>] and brain tissue [<xref ref-type="bibr" rid="B240-ijerph-16-00856">240</xref>,<xref ref-type="bibr" rid="B241-ijerph-16-00856">241</xref>]. This stimulatory effect has been observed at F concentrations of 2.5 µM [<xref ref-type="bibr" rid="B233-ijerph-16-00856">233</xref>]. In a study by Misra et al. the authors examined the effect of very low concentrations of beryllium fluorides and found that concentrations as low as 0.002 µM significantly upregulated the activation of NF-κB in macrophages. The effects demonstrated in this study show that beryllium fluorides complexes have much greater cytotoxicity and genotoxicity than other beryllium complexes such as beryllium chloride [<xref ref-type="bibr" rid="B242-ijerph-16-00856">242</xref>].</p>
</sec>
<sec id="sec4dot6-ijerph-16-00856">
<title>4.6. Fluoride Downregulates BCL-2, FoxO1 mRNA and Protein Activity and Upregulates IL-6 mRNA Expression and Activity</title>
<p>In in-vivo animal studies chronic exposure to F has consistently been found to significantly reduce Bcl-2 activity induce NF-kB expression and impair antioxidant activity [<xref ref-type="bibr" rid="B243-ijerph-16-00856">243</xref>,<xref ref-type="bibr" rid="B244-ijerph-16-00856">244</xref>,<xref ref-type="bibr" rid="B245-ijerph-16-00856">245</xref>,<xref ref-type="bibr" rid="B246-ijerph-16-00856">246</xref>,<xref ref-type="bibr" rid="B247-ijerph-16-00856">247</xref>,<xref ref-type="bibr" rid="B248-ijerph-16-00856">248</xref>]. Furthermore, numerous studies have demonstrated that F downregulates FoxO1 gene and protein expression resulting in enamel hypomineralization and dental fluorosis [<xref ref-type="bibr" rid="B249-ijerph-16-00856">249</xref>,<xref ref-type="bibr" rid="B250-ijerph-16-00856">250</xref>,<xref ref-type="bibr" rid="B251-ijerph-16-00856">251</xref>,<xref ref-type="bibr" rid="B252-ijerph-16-00856">252</xref>]. Finally, in regard to IL-6, the seminar research of Liu et al. found that F exposure mediated the expression of over 1000 genes in humans and was found to upregulate specifically the expression of interleukin 6 (IL6) in leucocytes [<xref ref-type="bibr" rid="B253-ijerph-16-00856">253</xref>]. These findings are in agreement with previous in vitro and in-vivo animal studies which also found that F can induce IL-6 mRNA expression and protein levels [<xref ref-type="bibr" rid="B254-ijerph-16-00856">254</xref>,<xref ref-type="bibr" rid="B255-ijerph-16-00856">255</xref>,<xref ref-type="bibr" rid="B256-ijerph-16-00856">256</xref>,<xref ref-type="bibr" rid="B257-ijerph-16-00856">257</xref>,<xref ref-type="bibr" rid="B258-ijerph-16-00856">258</xref>].</p>
</sec>
<sec id="sec4dot7-ijerph-16-00856">
<title>4.7. Fluoride Inhibits Anitoxidant Activity Including SOD and PON1 Activity</title>
<p>As previously elucidated decreased SOD activity has been reported to be associated with the pathogenesis of cataracts and there is some evidence to suggests it may be associated with AMD in certain populations. In addition, loss of PON1 activity is associated with the pathogenesis of both cataracts and AMD. Sufficient evidence has indicted that consumption of drinking water containing 1ppm F administered to experimental animals contributes to ROS, lipid peroxidation and impaired biological activity of major antioxidant enzymes including SOD, catalase (CAT), and glutathione peroxidase (GPx) [<xref ref-type="bibr" rid="B259-ijerph-16-00856">259</xref>,<xref ref-type="bibr" rid="B260-ijerph-16-00856">260</xref>,<xref ref-type="bibr" rid="B261-ijerph-16-00856">261</xref>,<xref ref-type="bibr" rid="B262-ijerph-16-00856">262</xref>]. It has been reported that F inhibits production of SOD as a result of the direct action of F ion binding to the enzyme leading to a diminished catalytic activity [<xref ref-type="bibr" rid="B263-ijerph-16-00856">263</xref>,<xref ref-type="bibr" rid="B264-ijerph-16-00856">264</xref>,<xref ref-type="bibr" rid="B265-ijerph-16-00856">265</xref>]. Consistent with these findings, Varol et al. found that the total antioxidant capacity was significantly lower and oxidative stress index significantly higher in subjects (35 males and 44 females; mean age 44.0 + 11.9 years) with a mean urinary F level of 1.91 mg/L compared to healthy controls with a mean urinary F level of 0.49 mg/L [<xref ref-type="bibr" rid="B266-ijerph-16-00856">266</xref>]. Chen et al. similar found that activity of SOD, CAT and GSH-Px were significantly lower and the concentration of malondialdehyde, a biomarker of oxidative stress and lipid peroxidation, was significantly higher in subjects with fluorosis compared to healthy controls. Notably, the mean SOD level in controls were 86.65 ± 9.20 U/mL compared to 55.56 ± 4.93 U/mL in the high F exposed group. The mean urinary F concentrations in subjects with fluorosis was approximately 2.10 mg/L compared to &lt;1.0 mg/L in controls [<xref ref-type="bibr" rid="B207-ijerph-16-00856">207</xref>]. These results are consistent with Kalyanalakshmi et al. who also observed enhanced oxidative stress and impaired antioxidant activity in adult male subjects (25–40 years of age) with increasing F exposure [<xref ref-type="bibr" rid="B267-ijerph-16-00856">267</xref>]. Several other studies have also reported decreases in the activities of SOD, CAT, glutathione-S-transferase (GST), and GPX in humans with increasing F exposure [<xref ref-type="bibr" rid="B268-ijerph-16-00856">268</xref>,<xref ref-type="bibr" rid="B269-ijerph-16-00856">269</xref>,<xref ref-type="bibr" rid="B270-ijerph-16-00856">270</xref>]. Reddy et al. also showed that the activity of malondialdehyde was significantly higher in subjects with fluorosis with mean urinary F levels of 5.94 mg/L compared to controls without fluorosis with mean urinary F levels of 0.41 mg/L [<xref ref-type="bibr" rid="B271-ijerph-16-00856">271</xref>]. </p>
<p>Of fundamental importance, a recent cross-sectional study conducted in a F endemic region of India, observed significant increases in lipid peroxidation and protein carbonylation in both serum and crystalline lens of patients with cataracts residing in an endemic fluorosis area compared to controls with cataracts residing in a non-F endemic area. In addition, serum F was significantly increased, and antioxidant activities as measured by SOD and GSG were markedly reduced in patients from the endemic fluorosis area compared to controls. The authors concluded that F ingestion may directly influence cataractogenesis by increased oxidative burden [<xref ref-type="bibr" rid="B71-ijerph-16-00856">71</xref>]. Furthermore, a recent in vitro study using goats eye lens found that exposure to excessive F resulted in oxidative stress through induced lipid peroxidation and reduced antioxidant activity via reduced GSH, SOD and CAT. On the basis of the results, the authors concluded that uptake of excess consumption of F may be linked with increased oxidative burden which may lead to lens opacification, progression and the development of cataract [<xref ref-type="bibr" rid="B65-ijerph-16-00856">65</xref>].</p>
<sec id="sec4dot7dot1-ijerph-16-00856">
<title>4.7.1. Fluoride Inhibits PON1 Activity</title>
<p>Previous investigations have also demonstrated that F exposure significantly inhibits PON-1 activity in humans. The activity of Pon1 was found to decline significantly in a dose dependent manner with increasing serum F concentrations [<xref ref-type="bibr" rid="B221-ijerph-16-00856">221</xref>]. At 6.8 µM serum F levels the activity of PON1 was found to decline by approximately 30% compared to controls with a serum F level of 3.6 µM. At serum F levels of 14.75 µM Pon1 activity was found to decline by approximately 60% [<xref ref-type="bibr" rid="B221-ijerph-16-00856">221</xref>]. </p>
</sec>
<sec id="sec4dot7dot2-ijerph-16-00856">
<title>4.7.2. Fluoride Inhibits Glutathione</title>
<p>Previous studies have shown that GSH levels are significantly lower in subjects (19–30 years old) with mild and moderate dental fluorosis compared to healthy controls. Treatment with antioxidant therapy was found to partially restore imbalance of the anti-oxidative defence in patients with fluorosis [<xref ref-type="bibr" rid="B272-ijerph-16-00856">272</xref>].</p>
</sec>
</sec>
</sec>
<sec id="sec5-ijerph-16-00856" sec-type="discussion">
<title>5. Discussion</title>
<p>The previous sections have described some of the key mechanisms by chronic F exposure can contribute to the pathogenesis of degenerative eyes diseases including cataracts, AMD and glaucoma. In summary, evidence is provided to show that F increases the susceptibility to degenerative eye diseases via multiple pathways and biological interactions. F acts to inhibit enolase, τ-crystallin, Hsp40, Na+, K+-ATPase, Nrf2, γ-GCS, HO-1 Bcl-2, FoxO1, SOD, PON-1 and GSH activity, and upregulates NF-κB, IL-6, AGEs, HsP27 and Hsp70 expression. Moreover, F exposure leads to enhanced oxidative stress and impaired antioxidant activity. Evidence is provided to show that each of these biochemical markers play a role in the pathogenesis of degenerative eye diseases. Collectively, these findings support the hypothesises that chronic F exposure has a causative association in the development and progression of degenerative eye diseases. </p>
<p>A crucial observation which has emanated from this study, is the explanation as to why among the general population, the prevalence of degenerative eye diseases is highest among individuals with Down syndrome, schizophrenia and diabetes. It is important to note that the association between chronic F exposure and risk of cataracts in Down syndrome was first reported in the 1950s [<xref ref-type="bibr" rid="B58-ijerph-16-00856">58</xref>,<xref ref-type="bibr" rid="B59-ijerph-16-00856">59</xref>,<xref ref-type="bibr" rid="B60-ijerph-16-00856">60</xref>]. The prevalence of diabetes [<xref ref-type="bibr" rid="B273-ijerph-16-00856">273</xref>,<xref ref-type="bibr" rid="B274-ijerph-16-00856">274</xref>] and psychiatric disorders [<xref ref-type="bibr" rid="B275-ijerph-16-00856">275</xref>,<xref ref-type="bibr" rid="B276-ijerph-16-00856">276</xref>,<xref ref-type="bibr" rid="B277-ijerph-16-00856">277</xref>,<xref ref-type="bibr" rid="B278-ijerph-16-00856">278</xref>,<xref ref-type="bibr" rid="B279-ijerph-16-00856">279</xref>,<xref ref-type="bibr" rid="B280-ijerph-16-00856">280</xref>] are also significantly higher in people with Down syndrome. Furthermore, the association between schizophrenia and diabetes has been recognized for more than a century [<xref ref-type="bibr" rid="B281-ijerph-16-00856">281</xref>]. It is known that the prevalence of diabetes is increased 2- to 3-fold in patients with schizophrenia [<xref ref-type="bibr" rid="B282-ijerph-16-00856">282</xref>,<xref ref-type="bibr" rid="B283-ijerph-16-00856">283</xref>]. However, to the authors knowledge the mechanisms underlying why the physio pathological features of Down syndrome, schizophrenia and diabetes are associated with higher odds of developing degenerative eye diseases have not been reported previously. </p>
<p>In the present study, I have elucidated the role of genetics and environmental exposures in degenerative eye diseases, specifically, how aberrant expression of BCL-2 expression is associated with the pathophysiology of Down syndrome, schizophrenia and diabetes. I have elucidated how BCL-2 serves an anti-inflammatory function through inhibiting the transcription factor NF-kB [<xref ref-type="bibr" rid="B150-ijerph-16-00856">150</xref>] and how activation of NF-kB has been linked to AMD, cataractogenesis and glaucoma. I have further elucidated that F downregulates BCL-2 and induces NF-kB expression. The importance of these observations is self-evident, and in particular elucidates the reason why the burden and prevalence of degenerative eye diseases is significantly higher among individuals with Down syndrome, schizophrenia and diabetes. Taken together, this evidence suggests the possibility that individuals with Down syndrome, schizophrenia and diabetes are genetically predisposed to increased sensitivity to F induced toxicity. However, it is also important to note, that reduced BCL-2 expression is also associated with autism spectrum disorders [<xref ref-type="bibr" rid="B284-ijerph-16-00856">284</xref>,<xref ref-type="bibr" rid="B285-ijerph-16-00856">285</xref>,<xref ref-type="bibr" rid="B286-ijerph-16-00856">286</xref>], which further suggests the possibility that individuals with ASD are a high-risk subgroup for F induced toxicity. </p>
<p>Aside from the ability of F to alter gene expression and protein activity, F has also been shown to accumulate in human cataract lenses and has previously been reported to be a causative factor in the incidence of senile cataract [<xref ref-type="bibr" rid="B61-ijerph-16-00856">61</xref>]. A recent cross-sectional study conducted in a F endemic region of India, observed significant increases in lipid peroxidation and protein carbonylation in both serum and crystalline lens of patients with cataracts residing in an endemic fluorosis area. In addition, serum F was significantly increased, and antioxidant activities as measured by SOD and GSG were markedly reduced in patients from the endemic fluorosis area compared to controls. The authors concluded that F ingestion may directly influence cataractogenesis by increased oxidative burden [<xref ref-type="bibr" rid="B63-ijerph-16-00856">63</xref>]. Macular degeneration and lens opacifying disease have also been observed in workers exposed occupationally to F intoxication [<xref ref-type="bibr" rid="B287-ijerph-16-00856">287</xref>,<xref ref-type="bibr" rid="B288-ijerph-16-00856">288</xref>]. It is also known that individuals with lens opacifying disease have an increased risk for AMD compared to those who had no lens opacities [<xref ref-type="bibr" rid="B289-ijerph-16-00856">289</xref>]. There is also evidence to suggest that chronic F exposure is associated with iridocorneal angle hyperpigmentation and open angle glaucoma [<xref ref-type="bibr" rid="B62-ijerph-16-00856">62</xref>]. The authors suggested that the trabecular endothelium may be exposed to F toxicity and that heavy trabecular hyperpigmentation appearance may be a feature of endemic fluorosis. It was also reported that the changes underlying the augmentation of trabecular hyperpigmentation observed in subjects may play a role in the development of glaucoma. Interestingly, in this study the mean urinary F level in patients with fluorosis was 2.1 ± 0.60 mg/L compared to 0.38 mg/L in controls [<xref ref-type="bibr" rid="B62-ijerph-16-00856">62</xref>]. </p>
<p>Based on these findings, and those mentioned previously demonstrating that F was an inhibitor of enzymes in ocular tissue, further studies examining the possible association between increasing F intake, including water and salt fluoridation and the prevalence of degenerative eye diseases are considered highly desirable. Importantly, the findings of this study, and an understanding of the mechanisms by which F can contribute to degenerative eye diseases, elucidate that certain subgroups of the population may be at increased risk of degenerative eye diseases and suggest that dietary intervention in minimising F intake may reduce the occurrence or severity of AMD, cataracts and glaucoma and related health care burden. </p>
</sec>
<sec id="sec6-ijerph-16-00856">
<title>6. Additional Perspectives</title>
<p>The current study has elucidated the role of NF-κB in inflammatory eye diseases and the activation of NF-κB by F. It is important to note that in addition to inflammatory eye diseases, other inflammatory health diseases associated with NF-κB activation include asthma, COPD, atherosclerosis, rheumatoid arthritis, inflammatory bowel disease, diabetes, osteoporosis and cancer [<xref ref-type="bibr" rid="B143-ijerph-16-00856">143</xref>,<xref ref-type="bibr" rid="B149-ijerph-16-00856">149</xref>,<xref ref-type="bibr" rid="B290-ijerph-16-00856">290</xref>,<xref ref-type="bibr" rid="B291-ijerph-16-00856">291</xref>,<xref ref-type="bibr" rid="B292-ijerph-16-00856">292</xref>,<xref ref-type="bibr" rid="B293-ijerph-16-00856">293</xref>,<xref ref-type="bibr" rid="B294-ijerph-16-00856">294</xref>]. NF-κB activation has also been linked to autism [<xref ref-type="bibr" rid="B295-ijerph-16-00856">295</xref>,<xref ref-type="bibr" rid="B296-ijerph-16-00856">296</xref>,<xref ref-type="bibr" rid="B297-ijerph-16-00856">297</xref>,<xref ref-type="bibr" rid="B298-ijerph-16-00856">298</xref>], Alzheimer’s disease [<xref ref-type="bibr" rid="B299-ijerph-16-00856">299</xref>,<xref ref-type="bibr" rid="B300-ijerph-16-00856">300</xref>,<xref ref-type="bibr" rid="B301-ijerph-16-00856">301</xref>,<xref ref-type="bibr" rid="B302-ijerph-16-00856">302</xref>], Parkinson’s disease [<xref ref-type="bibr" rid="B303-ijerph-16-00856">303</xref>,<xref ref-type="bibr" rid="B304-ijerph-16-00856">304</xref>] and multiple sclerosis [<xref ref-type="bibr" rid="B305-ijerph-16-00856">305</xref>,<xref ref-type="bibr" rid="B306-ijerph-16-00856">306</xref>].</p>
<p>The current study has further elucidated for the first time the role of two heat shock proteins, Hsp27 and Hsp70 in inflammatory eye diseases and the activation by F of their gene expression. In addition to their role in inflammatory eye diseases, activation of Hsp70 gene is implicated in the development of schizophrenia [<xref ref-type="bibr" rid="B307-ijerph-16-00856">307</xref>,<xref ref-type="bibr" rid="B308-ijerph-16-00856">308</xref>], autism spectrum disorders [<xref ref-type="bibr" rid="B309-ijerph-16-00856">309</xref>], asthma [<xref ref-type="bibr" rid="B310-ijerph-16-00856">310</xref>,<xref ref-type="bibr" rid="B311-ijerph-16-00856">311</xref>], autoimmune diseases [<xref ref-type="bibr" rid="B312-ijerph-16-00856">312</xref>,<xref ref-type="bibr" rid="B313-ijerph-16-00856">313</xref>,<xref ref-type="bibr" rid="B314-ijerph-16-00856">314</xref>,<xref ref-type="bibr" rid="B315-ijerph-16-00856">315</xref>], childhood acute lymphoblastic leukaemia [<xref ref-type="bibr" rid="B316-ijerph-16-00856">316</xref>], breast cancer [<xref ref-type="bibr" rid="B317-ijerph-16-00856">317</xref>], colon cancer [<xref ref-type="bibr" rid="B318-ijerph-16-00856">318</xref>], liver cancer [<xref ref-type="bibr" rid="B319-ijerph-16-00856">319</xref>,<xref ref-type="bibr" rid="B320-ijerph-16-00856">320</xref>], prostate cancer [<xref ref-type="bibr" rid="B321-ijerph-16-00856">321</xref>,<xref ref-type="bibr" rid="B322-ijerph-16-00856">322</xref>], oesophageal cancer [<xref ref-type="bibr" rid="B323-ijerph-16-00856">323</xref>] and cervical cancer [<xref ref-type="bibr" rid="B324-ijerph-16-00856">324</xref>]. In addition, recent studies with animal cancer models provided experimental evidence to suggest that Hsp70 is critical for cancer development [<xref ref-type="bibr" rid="B325-ijerph-16-00856">325</xref>]. Human studies have also shown that overexpression of Hsp27 is associated with several types of human cancer including breast [<xref ref-type="bibr" rid="B326-ijerph-16-00856">326</xref>,<xref ref-type="bibr" rid="B327-ijerph-16-00856">327</xref>], ovarian [<xref ref-type="bibr" rid="B328-ijerph-16-00856">328</xref>], gastric [<xref ref-type="bibr" rid="B329-ijerph-16-00856">329</xref>], prostate [<xref ref-type="bibr" rid="B330-ijerph-16-00856">330</xref>], colorectal cancer [<xref ref-type="bibr" rid="B331-ijerph-16-00856">331</xref>,<xref ref-type="bibr" rid="B332-ijerph-16-00856">332</xref>], endometrial [<xref ref-type="bibr" rid="B333-ijerph-16-00856">333</xref>], liver [<xref ref-type="bibr" rid="B319-ijerph-16-00856">319</xref>], bladder [<xref ref-type="bibr" rid="B334-ijerph-16-00856">334</xref>], leukaemia, osteosarcoma and lung cancer [<xref ref-type="bibr" rid="B335-ijerph-16-00856">335</xref>,<xref ref-type="bibr" rid="B336-ijerph-16-00856">336</xref>]. Moreover, overexpression of Hsp27 in breast, ovarian, gastric, and prostate cancer is associated with aggressive growth and resistance to chemotherapy or radiotherapy, and hence with a poor prognosis [<xref ref-type="bibr" rid="B326-ijerph-16-00856">326</xref>,<xref ref-type="bibr" rid="B327-ijerph-16-00856">327</xref>,<xref ref-type="bibr" rid="B328-ijerph-16-00856">328</xref>,<xref ref-type="bibr" rid="B329-ijerph-16-00856">329</xref>,<xref ref-type="bibr" rid="B330-ijerph-16-00856">330</xref>]. There is also considerable evidence indicating that overexpression of Hsp27 enhances tumorigenicity [<xref ref-type="bibr" rid="B335-ijerph-16-00856">335</xref>]. Furthermore, overexpression of Hsp27 and Hsp70 are implicated in brain tumours [<xref ref-type="bibr" rid="B337-ijerph-16-00856">337</xref>]. </p>
<p>Based on these findings, further studies are warranted to examine the association between F intake and the epidemiology of degenerative chronic disorders including neurodegenerative diseases and cancer. </p>
</sec>
<sec id="sec7-ijerph-16-00856" sec-type="conclusions">
<title>7. Conclusions</title>
<p>In conclusion, this study provides diverse lines of evidence demonstrating that F exposure may contribute to degenerative eye diseases by stimulating or inhibiting biological pathways associated with the pathogenesis of cataract, AMD and glaucoma. As elucidated in this study, F exerts this effect by inhibiting enolase, τ-crystallin, Hsp40, Na+, K+-ATPase, Nrf2, γ-GCS, HO-1 Bcl-2, FoxO1, SOD, PON-1 and GSH activity, and upregulating NF-κB, IL-6, AGEs, HsP27 and Hsp70 expression. Moreover, F exposure leads to enhanced oxidative stress and impaired antioxidant activity. This observation offers another potential relationship to consider when examining the global burden of inflammatory eye diseases including AMD, cataracts and glaucoma worldwide. Based on the evidence presented in this study, it can be concluded that F exposure may be added to the list of identifiable risk factors associated with pathogenesis of degenerative eye diseases. The broader impact of these findings suggests that modifying or reducing F intake may lead to an overall reduction in the modifiable risk factors associated with degenerative eye diseases particularly among persons with Down syndrome, schizophrenia and diabetes. Further studies are required to examine this association and determine differences in prevalence rates amongst fluoridated and non-fluoridated communities, taking into consideration other dietary sources of F such as tea. Finally, the findings of this study elucidate molecular pathways sensitive to F exposure that may suggest a possible association between F exposure and other inflammatory diseases including, pulmonary diseases, neurodegenerative diseases, neurodevelopmental disorders and cancer. Further studies are also warranted to examine these associations. </p>
</sec>
</body>
<back>
<notes>
<title>Author Contributions</title>
<p>D.T.W. is solely responsible for the intellectual content, literature review and drafting of the manuscript. The author reviewed and approved the final manuscript.</p>
</notes>
<notes>
<title>Funding</title>
<p>The author did not receive payment or benefit for this work. This work was undertaken without funding for the benefit of public health and the advancement of scientific education in the fields of health promotion and disease prevention.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>D.T.W. works freelance in the field of environmental science, due diligence and risk assessment. The author declares no conflict of interest. </p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-ijerph-16-00856">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>X.L.</given-names>
</name>
</person-group>
<article-title>Tissue factor with age-related macular degeneration</article-title>
<source/>Int. J. Ophthalmol.
          <year>2012</year>
<volume>5</volume>
<fpage>609</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="pmid">23166874</pub-id>
</element-citation>
</ref>
<ref id="B2-ijerph-16-00856">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.J.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Acetylcholinesterase function in apoptotic retina pigment epithelial cells induced by H<sub>2</sub>O<sub>2</sub></article-title>
<source/>Int. J. Ophthalmol.
          <year>2013</year>
<volume>6</volume>
<fpage>772</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="pmid">24392323</pub-id>
</element-citation>
</ref>
<ref id="B3-ijerph-16-00856">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiu</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gensler</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schleicher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The relationship of major American dietary patterns to age-related macular degeneration</article-title>
<source/>Am. J. Ophthalmol.
          <year>2014</year>
<volume>158</volume>
<fpage>118</fpage>
<lpage>127.e1</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajo.2014.04.016</pub-id>
<pub-id pub-id-type="pmid">24792100</pub-id>
</element-citation>
</ref>
<ref id="B4-ijerph-16-00856">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q.Y.</given-names>
</name>
<name>
<surname>Tie</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Overweight, Obesity, and Risk of Age-Related Macular Degeneration</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2016</year>
<volume>57</volume>
<fpage>1276</fpage>
<lpage>1283</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.15-18637</pub-id>
<pub-id pub-id-type="pmid">26990164</pub-id>
</element-citation>
</ref>
<ref id="B5-ijerph-16-00856">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schachat</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Leske</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group</article-title>
<source/>Arch. Ophthalmol.
          <year>2000</year>
<volume>118</volume>
<fpage>351</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1001/archopht.118.3.351</pub-id>
<pub-id pub-id-type="pmid">10721957</pub-id>
</element-citation>
</ref>
<ref id="B6-ijerph-16-00856">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: The Blue Mountains Eye Study</article-title>
<source/>Ophthalmology
          <year>2007</year>
<volume>114</volume>
<fpage>1143</fpage>
<lpage>1150</lpage>
<pub-id pub-id-type="doi">10.1016/j.ophtha.2006.09.033</pub-id>
<pub-id pub-id-type="pmid">17275090</pub-id>
</element-citation>
</ref>
<ref id="B7-ijerph-16-00856">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomany</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Van Leeuwen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vingerling</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>De Jong</surname>
<given-names>P.T.</given-names>
</name>
</person-group>
<article-title>Risk factors for incident age-related macular degeneration: Pooled findings from 3 continents</article-title>
<source/>Ophthalmology
          <year>2004</year>
<volume>111</volume>
<fpage>1280</fpage>
<lpage>1287</lpage>
<pub-id pub-id-type="doi">10.1016/j.ophtha.2003.11.010</pub-id>
<pub-id pub-id-type="pmid">15234127</pub-id>
</element-citation>
</ref>
<ref id="B8-ijerph-16-00856">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>F.Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>P.O.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Brelén</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>C.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diabetes mellitus and risk of age-related macular degeneration: A systematic review and meta-analysis</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e108196</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0108196</pub-id>
<pub-id pub-id-type="pmid">25238063</pub-id>
</element-citation>
</ref>
<ref id="B9-ijerph-16-00856">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H.Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.C.</given-names>
</name>
</person-group>
<article-title>The Association Between Diabetes and Age-Related Macular Degeneration Among the Elderly in Taiwan</article-title>
<source/>Diabetes Care
          <year>2018</year>
<volume>41</volume>
<fpage>2202</fpage>
<lpage>2211</lpage>
<pub-id pub-id-type="doi">10.2337/dc18-0707</pub-id>
<pub-id pub-id-type="pmid">30061321</pub-id>
</element-citation>
</ref>
<ref id="B10-ijerph-16-00856">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Risk factors for age-related macular degeneration</article-title>
<source/>Prog. Retin. Eye Res.
          <year>2001</year>
<volume>20</volume>
<fpage>227</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="doi">10.1016/S1350-9462(00)00023-9</pub-id>
<pub-id pub-id-type="pmid">11173253</pub-id>
</element-citation>
</ref>
<ref id="B11-ijerph-16-00856">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babizhayev</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Yegorov</surname>
<given-names>Y.E.</given-names>
</name>
</person-group>
<article-title>Reactive Oxygen Species and the Aging Eye: Specific Role of Metabolically Active Mitochondria in Maintaining Lens Function and in the Initiation of the Oxidation-Induced Maturity Onset Cataract—A Novel Platform of Mitochondria-Targeted Antioxidants with Broad Therapeutic Potential for Redox Regulation and Detoxification of Oxidants in Eye Diseases</article-title>
<source/>Am. J. Ther.
          <year>2016</year>
<volume>23</volume>
<fpage>e98</fpage>
<lpage>e117</lpage>
<pub-id pub-id-type="pmid">21048433</pub-id>
</element-citation>
</ref>
<ref id="B12-ijerph-16-00856">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prokofyeva</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wegener</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zrenner</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Cataract prevalence and prevention in Europe: A literature review</article-title>
<source/>Acta Ophthalmol.
          <year>2013</year>
<volume>91</volume>
<fpage>395</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="doi">10.1111/j.1755-3768.2012.02444.x</pub-id>
<pub-id pub-id-type="pmid">22715900</pub-id>
</element-citation>
</ref>
<ref id="B13-ijerph-16-00856">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Negri</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>La Vecchia</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Food and nutrient intake and risk of cataract</article-title>
<source/>Ann. Epidemiol.
          <year>1996</year>
<volume>6</volume>
<fpage>41</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1016/1047-2797(95)00099-2</pub-id>
<pub-id pub-id-type="pmid">8680624</pub-id>
</element-citation>
</ref>
<ref id="B14-ijerph-16-00856">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abraham</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Condon</surname>
<given-names>N.G.</given-names>
</name>
<name>
<surname>West Gower</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>The new epidemiology of cataract</article-title>
<source/>Ophthalmol. Clin. N. Am.
          <year>2006</year>
<volume>19</volume>
<fpage>415</fpage>
<lpage>425</lpage>
</element-citation>
</ref>
<ref id="B15-ijerph-16-00856">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trautner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Haastert</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Giani</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Incidence of Blindness in Southern Germany Due to Glaucoma and Degenerative Conditions</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2003</year>
<volume>44</volume>
<fpage>1031</fpage>
<lpage>1034</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.02-0304</pub-id>
<pub-id pub-id-type="pmid">12601025</pub-id>
</element-citation>
</ref>
<ref id="B16-ijerph-16-00856">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lyu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Hypertension and risk of cataract: A meta-analysis</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e114012</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0114012</pub-id>
<pub-id pub-id-type="pmid">25474403</pub-id>
</element-citation>
</ref>
<ref id="B17-ijerph-16-00856">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gnad</surname>
<given-names>H.D.</given-names>
</name>
<name>
<surname>Rett</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Ophthalmologische symptome beim Down syndrom</article-title>
<source/>Wien. Klin. Wochenschr.
          <year>1979</year>
<volume>91</volume>
<fpage>735</fpage>
<lpage>737</lpage>
<pub-id pub-id-type="pmid">160141</pub-id>
</element-citation>
</ref>
<ref id="B18-ijerph-16-00856">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rochels</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nover</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Ophthalmologische symptome beim Mongolismussyndrom</article-title>
<source/>Albrecht Von Graefes. Arch. Klin. Exp. Ophthalmol.
          <year>1977</year>
<volume>205</volume>
<fpage>9</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1007/BF00413458</pub-id>
<pub-id pub-id-type="pmid">146440</pub-id>
</element-citation>
</ref>
<ref id="B19-ijerph-16-00856">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Da Cunha</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>J.B.</given-names>
</name>
</person-group>
<article-title>Ocular findings in Down’s syndrome</article-title>
<source/>Am. J. Ophthalmol.
          <year>1996</year>
<volume>122</volume>
<fpage>236</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1016/S0002-9394(14)72015-X</pub-id>
<pub-id pub-id-type="pmid">8694092</pub-id>
</element-citation>
</ref>
<ref id="B20-ijerph-16-00856">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puri</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Prevalence of cataract in adult Down’s syndrome patients aged 28 to 83 years</article-title>
<source/>Clin. Pract. Epidemiol. Ment. Health
          <year>2007</year>
<volume>3</volume>
<fpage>26</fpage>
<pub-id pub-id-type="doi">10.1186/1745-0179-3-26</pub-id>
<pub-id pub-id-type="pmid">18034878</pub-id>
</element-citation>
</ref>
<ref id="B21-ijerph-16-00856">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruigomez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garcia Rodriguez</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Dev</surname>
<given-names>V.J.</given-names>
</name>
<name>
<surname>Arellano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Raniwala</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Are schizophrenia or antipsychotic drugs a risk factor for cataracts?</article-title>
<source/>Epidemiology
          <year>2000</year>
<volume>11</volume>
<fpage>620</fpage>
<lpage>623</lpage>
<pub-id pub-id-type="doi">10.1097/00001648-200011000-00002</pub-id>
<pub-id pub-id-type="pmid">11055620</pub-id>
</element-citation>
</ref>
<ref id="B22-ijerph-16-00856">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>X.H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G.H.</given-names>
</name>
</person-group>
<article-title>Meta-analysis of the risk of cataract in type 2 diabetes</article-title>
<source/>BMC Ophthalmol.
          <year>2014</year>
<volume>14</volume>
<elocation-id>94</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2415-14-94</pub-id>
<pub-id pub-id-type="pmid">25060855</pub-id>
</element-citation>
</ref>
<ref id="B23-ijerph-16-00856">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khairallah</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kahloun</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bourne</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Limburg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Flaxman</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Jonas</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Keeffe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Leasher</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Naidoo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pesudovs</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Number of People Blind or Visually Impaired by Cataract Worldwide and in World Regions, 1990 to 2010</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2015</year>
<volume>56</volume>
<fpage>6762</fpage>
<lpage>6769</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.15-17201</pub-id>
<pub-id pub-id-type="pmid">26567788</pub-id>
</element-citation>
</ref>
<ref id="B24-ijerph-16-00856">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMonnies</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Glaucoma history and risk factors</article-title>
<source/>J. Optom.
          <year>2016</year>
<volume>10</volume>
<fpage>71</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/j.optom.2016.02.003</pub-id>
<pub-id pub-id-type="pmid">27025415</pub-id>
</element-citation>
</ref>
<ref id="B25-ijerph-16-00856">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirooka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shiraga</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma</article-title>
<source/>Clin. Ophthalmol.
          <year>2007</year>
<volume>1</volume>
<fpage>217</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="pmid">19668475</pub-id>
</element-citation>
</ref>
<ref id="B26-ijerph-16-00856">
<label>26.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>Deloitte Access Economics</collab>
</person-group>
<article-title>The Economic Impact of Vision Impairment and Blindness in the Republic of Ireland NCBI (National Council for the Blind of Ireland) May 2011</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.eyedoctors.ie/documents/Cost_of_Sight_Loss_Full_Repor.pdf">http://www.eyedoctors.ie/documents/Cost_of_Sight_Loss_Full_Repor.pdf</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-01-09">(accessed on 9 January 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B27-ijerph-16-00856">
<label>27.</label>
<element-citation publication-type="web">
<article-title>Eurostat</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/eurostat/statistics-explained/index.php?title=File:Surgical_operations_and_procedures_performed_in_hospitals_%E2%80%94_top_10_procedures_group_1,_2015_or_2016_(per_100_000_inhabitants)_HLTH18.png">https://ec.europa.eu/eurostat/statistics-explained/index.php?title=File:Surgical_operations_and_procedures_performed_in_hospitals_%E2%80%94_top_10_procedures_group_1,_2015_or_2016_(per_100_000_inhabitants)_HLTH18.png</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-01-09">(accessed on 9 January 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B28-ijerph-16-00856">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akuffo</surname>
<given-names>K.O.</given-names>
</name>
<name>
<surname>Nolan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stack</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Feeney</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kenny</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Peto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dooley</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>O’Halloran</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Cronin</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of age-related macular degeneration in the Republic of Ireland</article-title>
<source/>Br. J. Ophthalmol.
          <year>2015</year>
<volume>99</volume>
<fpage>1037</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1136/bjophthalmol-2014-305768</pub-id>
<pub-id pub-id-type="pmid">25712825</pub-id>
</element-citation>
</ref>
<ref id="B29-ijerph-16-00856">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nolan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kenny</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>O’Regan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cronin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Loughman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Conolly</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kearney</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Beatty</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Macular Pigment Optical Density in an Aging Irish Population: The Irish Longitudinal Study on Ageing</article-title>
<source/>Ophthalm. Res.
          <year>2010</year>
<volume>44</volume>
<fpage>131</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1159/000315531</pub-id>
</element-citation>
</ref>
<ref id="B30-ijerph-16-00856">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Augood</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Vingerling</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>de Jong</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Chakravarthy</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Seland</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Soubrane</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tomazzoli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Topouzis</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bentham</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rahu</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of age-related maculopathy in older Europeans: The European Eye Study (EUREYE)</article-title>
<source/>Arch. Ophthalmol.
          <year>2006</year>
<volume>124</volume>
<fpage>529</fpage>
<lpage>535</lpage>
<pub-id pub-id-type="doi">10.1001/archopht.124.4.529</pub-id>
<pub-id pub-id-type="pmid">16606879</pub-id>
</element-citation>
</ref>
<ref id="B31-ijerph-16-00856">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colijn</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Buitendijk</surname>
<given-names>G.H.S.</given-names>
</name>
<name>
<surname>Prokofyeva</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cachulo</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Khawaja</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Cougnard-Gregoire</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Merle</surname>
<given-names>B.M.J.</given-names>
</name>
<name>
<surname>Korb</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Erke</surname>
<given-names>M.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future</article-title>
<source/>Ophthalmology
          <year>2017</year>
<volume>124</volume>
<fpage>1753</fpage>
<lpage>1763</lpage>
<pub-id pub-id-type="doi">10.1016/j.ophtha.2017.05.035</pub-id>
<pub-id pub-id-type="pmid">28712657</pub-id>
</element-citation>
</ref>
<ref id="B32-ijerph-16-00856">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owen</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Jarrar</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wormald</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Rudnicka</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>The estimated prevalence and incidence of late stage age related macular degeneration in the UK</article-title>
<source/>Br. J. Ophthalmol.
          <year>2012</year>
<volume>96</volume>
<fpage>752</fpage>
<lpage>756</lpage>
<pub-id pub-id-type="doi">10.1136/bjophthalmol-2011-301109</pub-id>
<pub-id pub-id-type="pmid">22329913</pub-id>
</element-citation>
</ref>
<ref id="B33-ijerph-16-00856">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jonasson</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Arnarsson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>The prevalence of age-related maculopathy in iceland: Reykjavik eye study</article-title>
<source/>Arch. Ophthalmol.
          <year>2003</year>
<volume>121</volume>
<fpage>379</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.1001/archopht.121.3.379</pub-id>
<pub-id pub-id-type="pmid">12617709</pub-id>
</element-citation>
</ref>
<ref id="B34-ijerph-16-00856">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Björnsson</surname>
<given-names>O.M.</given-names>
</name>
<name>
<surname>Syrdalen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Peto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kinge</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: The Oslo Macular study</article-title>
<source/>Acta Ophthalmol. Scand.
          <year>2006</year>
<volume>84</volume>
<fpage>636</fpage>
<lpage>641</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0420.2006.00696.x</pub-id>
<pub-id pub-id-type="pmid">16965494</pub-id>
</element-citation>
</ref>
<ref id="B35-ijerph-16-00856">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>B.E.K.</given-names>
</name>
<name>
<surname>Cruickshanks</surname>
<given-names>K.J.</given-names>
</name>
</person-group>
<article-title>The prevalence of age-related maculopathy by geographic region and ethnicity</article-title>
<source/>Prog. Retin. Eye Res.
          <year>1999</year>
<volume>18</volume>
<fpage>371</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="doi">10.1016/S1350-9462(98)00025-1</pub-id>
<pub-id pub-id-type="pmid">10192518</pub-id>
</element-citation>
</ref>
<ref id="B36-ijerph-16-00856">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawasaki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Oizumi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Daimon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawata</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kayama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tano</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence and risk factors for agerelated macular degeneration in an adult Japanese population: The Funagata study</article-title>
<source/>Ophthalmology
          <year>2008</year>
<volume>115</volume>
<fpage>1376</fpage>
<lpage>1381</lpage>
<pub-id pub-id-type="doi">10.1016/j.ophtha.2007.11.015</pub-id>
<pub-id pub-id-type="pmid">18222000</pub-id>
</element-citation>
</ref>
<ref id="B37-ijerph-16-00856">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Meuer</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Saaddine</surname>
<given-names>J.B.</given-names>
</name>
</person-group>
<article-title>Prevalence of age-related macular degeneration in the US population</article-title>
<source/>Arch. Ophthalmol.
          <year>2011</year>
<volume>129</volume>
<fpage>75</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1001/archophthalmol.2010.318</pub-id>
<pub-id pub-id-type="pmid">21220632</pub-id>
</element-citation>
</ref>
<ref id="B38-ijerph-16-00856">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rowland</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>M.I.</given-names>
</name>
</person-group>
<article-title>Racial/ethnic differences in age-related maculopathy: Third National Health and Nutrition Survey</article-title>
<source/>Ophthalmology
          <year>1995</year>
<volume>102</volume>
<fpage>371</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="doi">10.1016/S0161-6420(95)31012-3</pub-id>
<pub-id pub-id-type="pmid">7891973</pub-id>
</element-citation>
</ref>
<ref id="B39-ijerph-16-00856">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Congdon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Vingerling</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>West</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Kempen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>O’Colmain</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>H.R.</given-names>
</name>
<collab>Eye Diseases Prevalence Research Group</collab>
</person-group>
<article-title>Prevalence of Cataract and Pseudophakia/Aphakia Among Adults in the United States</article-title>
<source/>Arch. Ophthalmol.
          <year>2004</year>
<volume>122</volume>
<fpage>487</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="pmid">15078665</pub-id>
</element-citation>
</ref>
<ref id="B40-ijerph-16-00856">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindstrom</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Thoughts on cataract surgery</article-title>
<source/>Rev. Ophthalmol.
          <year>2015</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.reviewofophthalmology.com/article/thoughts-on--cataract-surgery-2015">https://www.reviewofophthalmology.com/article/thoughts-on--cataract-surgery-2015</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-01-10">(accessed on 10 January 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B41-ijerph-16-00856">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busbee</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Incremental cost-effectiveness of initial cataract surgery</article-title>
<source/>Ophthalmology
          <year>2002</year>
<volume>109</volume>
<fpage>606</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="doi">10.1016/S0161-6420(01)00971-X</pub-id>
<pub-id pub-id-type="pmid">11874769</pub-id>
</element-citation>
</ref>
<ref id="B42-ijerph-16-00856">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>American Diabetes Association</collab>
</person-group>
<article-title>Economic costs of diabetes in the U.S. in 2012</article-title>
<source/>Diabetes Care
          <year>2013</year>
<volume>36</volume>
<fpage>1033</fpage>
<lpage>1046</lpage>
<pub-id pub-id-type="doi">10.2337/dc12-2625</pub-id>
<pub-id pub-id-type="pmid">23468086</pub-id>
</element-citation>
</ref>
<ref id="B43-ijerph-16-00856">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Foreman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van Wijngaarden</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Dirani</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Prevalence of Age-Related Macular Degeneration in Australia: The Australian National Eye Health Survey</article-title>
<source/>JAMA Ophthalmol.
          <year>2017</year>
<volume>135</volume>
<fpage>1242</fpage>
<lpage>1249</lpage>
<pub-id pub-id-type="doi">10.1001/jamaophthalmol.2017.4182</pub-id>
<pub-id pub-id-type="pmid">29049463</pub-id>
</element-citation>
</ref>
<ref id="B44-ijerph-16-00856">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keeffe</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>H.R.</given-names>
</name>
</person-group>
<article-title>Cataract surgery in Australia 1985–1994</article-title>
<source/>Aust. N. Z. J. Ophthalmol.
          <year>1996</year>
<volume>24</volume>
<fpage>313</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1111/j.1442-9071.1996.tb01601.x</pub-id>
<pub-id pub-id-type="pmid">8985542</pub-id>
</element-citation>
</ref>
<ref id="B45-ijerph-16-00856">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Rochtchina</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Comparison of age-specific cataract prevalence in two population-based surveys 6 years apart</article-title>
<source/>BMC Ophthalmol.
          <year>2006</year>
<volume>6</volume>
<elocation-id>17</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2415-6-17</pub-id>
<pub-id pub-id-type="pmid">16623958</pub-id>
</element-citation>
</ref>
<ref id="B46-ijerph-16-00856">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCarty</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Mukesh</surname>
<given-names>B.N.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>H.R.</given-names>
</name>
</person-group>
<article-title>The epidemiology of cataract in Australia</article-title>
<source/>Am. J. Ophthalmol.
          <year>1999</year>
<volume>128</volume>
<fpage>446</fpage>
<lpage>465</lpage>
<pub-id pub-id-type="doi">10.1016/S0002-9394(99)00218-4</pub-id>
<pub-id pub-id-type="pmid">10577586</pub-id>
</element-citation>
</ref>
<ref id="B47-ijerph-16-00856">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rochtchina</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mukesh</surname>
<given-names>B.N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>McCarty</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Projected prevalence of age-related cataract and cataract surgery in Australia for the years 2001 and 2021: Pooled data from two population-based surveys</article-title>
<source/>Clin. Exp. Ophthalmol.
          <year>2003</year>
<volume>31</volume>
<fpage>233</fpage>
<lpage>236</lpage>
<pub-id pub-id-type="doi">10.1046/j.1442-9071.2003.00635.x</pub-id>
<pub-id pub-id-type="pmid">12786774</pub-id>
</element-citation>
</ref>
<ref id="B48-ijerph-16-00856">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Worsley</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Worsley</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Prevalence predictions for age-related macular degeneration in New Zealand have implications for provision of healthcare services</article-title>
<source/>N. Z. Med. J.
          <year>2015</year>
<volume>128</volume>
<fpage>44</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="pmid">25721961</pub-id>
</element-citation>
</ref>
<ref id="B49-ijerph-16-00856">
<label>49.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Access Economics</collab>
</person-group>
<source/>Clear focus—The Economic Impact of Vision Loss in New Zealand in 2009. A Report for Vision 2020 Australia in Support of the Vision 2020 New Zealand Trust
          <publisher-name>Access Economics Pty Limited</publisher-name>
<publisher-loc>Melbourne, Australia</publisher-loc>
<year>2010</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://blindfoundation.org.nz/learn/blindness/clear-focus">http://blindfoundation.org.nz/learn/blindness/clear-focus</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-01-10">(accessed on 10 January 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B50-ijerph-16-00856">
<label>50.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>National Health Committee</collab>
</person-group>
<source/>Age-Related Macular Degeneration, Tier 2 Assessment Consultation Submissions
          <publisher-name>National Health Committee</publisher-name>
<publisher-loc>Wellington, New Zealand</publisher-loc>
<year>2015</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://nhc.health.govt.nz">http://nhc.health.govt.nz</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-01-10">(accessed on 10 January 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B51-ijerph-16-00856">
<label>51.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>Blind Foundation</collab>
</person-group>
<article-title>Eye Diseases</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://blindfoundation.org.nz/eye-info/latest-statistics/">https://blindfoundation.org.nz/eye-info/latest-statistics/</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-01-29">(accessed on 29 January 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B52-ijerph-16-00856">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorsby</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Experimental degeneration of the retina</article-title>
<source/>Br. J. Ophthalmol.
          <year>1960</year>
<volume>44</volume>
<fpage>213</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1136/bjo.44.4.213</pub-id>
<pub-id pub-id-type="pmid">13832930</pub-id>
</element-citation>
</ref>
<ref id="B53-ijerph-16-00856">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorsby</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Oxidizing agents as potentiators of the retinotoxic action of sodium fluoride, sodium iodate and sodium iodoacetate</article-title>
<source/>Nature
          <year>1966</year>
<volume>210</volume>
<fpage>997</fpage>
<lpage>998</lpage>
<pub-id pub-id-type="doi">10.1038/210997a0</pub-id>
<pub-id pub-id-type="pmid">5914923</pub-id>
</element-citation>
</ref>
<ref id="B54-ijerph-16-00856">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orzalesi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Grignolo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calabria</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Experimental degeneration of the rabbit retina induced by sodium fluoride</article-title>
<source/>Exp. Eye Res.
          <year>1967</year>
<volume>6</volume>
<fpage>165</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-4835(67)80068-X</pub-id>
<pub-id pub-id-type="pmid">6024069</pub-id>
</element-citation>
</ref>
<ref id="B55-ijerph-16-00856">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orzalesi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Grignolo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calabria</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Castellazzo</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>A study on the fine structure and the rhodopsin cycle of the rabbit retina in experimental degeneration induced by diaminodiphenoxypentane</article-title>
<source/>Exp. Eye Res.
          <year>1967</year>
<volume>6</volume>
<fpage>376</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-4835(67)80012-5</pub-id>
<pub-id pub-id-type="pmid">6060549</pub-id>
</element-citation>
</ref>
<ref id="B56-ijerph-16-00856">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanysek</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Anton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hrachovina</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Moster</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Some metabolic disturbances of the retina due to the effect of natrium fluoride</article-title>
<source/>Ophthalmologica
          <year>1969</year>
<volume>158</volume>
<fpage>684</fpage>
<lpage>690</lpage>
<pub-id pub-id-type="pmid">5359765</pub-id>
</element-citation>
</ref>
<ref id="B57-ijerph-16-00856">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shukla</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>G.S.</given-names>
</name>
</person-group>
<article-title>Fluoride level in cataract lenses in an urban area of India</article-title>
<source/>Fluoride
          <year>1991</year>
<volume>24</volume>
<fpage>40</fpage>
<lpage>43</lpage>
</element-citation>
</ref>
<ref id="B58-ijerph-16-00856">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rapaport</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Les opacifications du cristallin mongolisme et cataracte sénile (Donées statisques récentes)</article-title>
<source/>Rev. Anthropol. (Paris)
          <year>1957</year>
<volume>2</volume>
<fpage>133</fpage>
<lpage>135</lpage>
</element-citation>
</ref>
<ref id="B59-ijerph-16-00856">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rapaport</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Contribution a l’étude etiologique du mongolisme: Rôle des inhibiteurs enzymatiques</article-title>
<source/>L’Encéphale
          <year>1957</year>
<volume>46</volume>
<fpage>468</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="pmid">13473746</pub-id>
</element-citation>
</ref>
<ref id="B60-ijerph-16-00856">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rapaport</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Oligophrénie mongolienne et ectodermoses congénitales</article-title>
<source/>Ann. Dermatol. Syphiligr.
          <year>1960</year>
<volume>87</volume>
<fpage>263</fpage>
<lpage>278</lpage>
</element-citation>
</ref>
<ref id="B61-ijerph-16-00856">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kas’ianenko</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Korneva</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Kovgan</surname>
<given-names>N.I.</given-names>
</name>
</person-group>
<article-title>Dissemination of senile cataract among the population of Poltava Province consuming water with various fluorine levels</article-title>
<source/>Oftalmol. Zh.
          <year>1984</year>
<volume>5</volume>
<fpage>302</fpage>
<lpage>304</lpage>
</element-citation>
</ref>
<ref id="B62-ijerph-16-00856">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aytuluner</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mensiz</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Heavy iridocorneal angle hyperpigmentation and glaucoma associated with fluorosis</article-title>
<source/>J. Toxicol. Cutaneous Ocular Toxicol.
          <year>2002</year>
<volume>21</volume>
<fpage>203</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1081/CUS-120014093</pub-id>
</element-citation>
</ref>
<ref id="B63-ijerph-16-00856">
<label>63.</label>
<element-citation publication-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Tomar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Fluoride intake increases oxidative burden of cataractogenesis in fluoride endemic areas in India, Abstract</article-title>
<source/>Proceedings of the XXXII Congress of the ESCRS
          <conf-loc>London, UK</conf-loc>
<conf-date>13–17 September 2014</conf-date>
</element-citation>
</ref>
<ref id="B64-ijerph-16-00856">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aytuluner</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mensiz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Candir</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Aydin</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cataractogenic effect of fluorosis in an animal model</article-title>
<source/>J. Toxicol. Cutaneous Ocular Toxicol.
          <year>2003</year>
<volume>22</volume>
<fpage>23</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1081/CUS-120019327</pub-id>
</element-citation>
</ref>
<ref id="B65-ijerph-16-00856">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tomar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Fluoride Induces Morphological and Biochemical Changes in Goat Eye Lens</article-title>
<source/>J. Environ. Anal. Toxicol.
          <year>2014</year>
<volume>4</volume>
<fpage>231</fpage>
<pub-id pub-id-type="doi">10.4172/2161-0525.1000231</pub-id>
</element-citation>
</ref>
<ref id="B66-ijerph-16-00856">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nordmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mandel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Archard</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Inhibition of sugar metabolism in the lens</article-title>
<source/>Br. J. Ophthal.
          <year>1954</year>
<volume>38</volume>
<fpage>673</fpage>
<pub-id pub-id-type="doi">10.1136/bjo.38.11.673</pub-id>
<pub-id pub-id-type="pmid">13208963</pub-id>
</element-citation>
</ref>
<ref id="B67-ijerph-16-00856">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashton</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Graymore</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Petlar</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Studies on developing retinal vessels</article-title>
<source/>Br. J. Ophthalmol.
          <year>1957</year>
<volume>41</volume>
<fpage>449</fpage>
<lpage>460</lpage>
<pub-id pub-id-type="doi">10.1136/bjo.41.8.449</pub-id>
<pub-id pub-id-type="pmid">13446355</pub-id>
</element-citation>
</ref>
<ref id="B68-ijerph-16-00856">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graymore</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>In vitro swelling of the kitten retina induced by sodium fluoride inhibition</article-title>
<source/>Br. J. Ophthalmol.
          <year>1959</year>
<volume>43</volume>
<fpage>40</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1136/bjo.43.1.40</pub-id>
<pub-id pub-id-type="pmid">13618529</pub-id>
</element-citation>
</ref>
<ref id="B69-ijerph-16-00856">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleifeld</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Hockwine</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ayberk</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>The effect of sodium fluoride on the metabolism of the lens</article-title>
<source/>Graefes Arch. Ophthalmol.
          <year>1956</year>
<volume>158</volume>
<fpage>39</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1007/BF00684762</pub-id>
<pub-id pub-id-type="pmid">13372473</pub-id>
</element-citation>
</ref>
<ref id="B70-ijerph-16-00856">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dickens</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Simer</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Observations on Tissue Glycolysis: The effect of fluoride and some other substances</article-title>
<source/>Biochem. J.
          <year>1929</year>
<volume>23</volume>
<fpage>936</fpage>
<lpage>958</lpage>
<pub-id pub-id-type="doi">10.1042/bj0230936</pub-id>
<pub-id pub-id-type="pmid">16744297</pub-id>
</element-citation>
</ref>
<ref id="B71-ijerph-16-00856">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomar</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Fluoride intake increases oxidative burden of cataractognesis in fluoride endemic areas in India</article-title>
<source/>J. Clin. Exp. Ophthalmol.
          <year>2014</year>
<volume>5</volume>
<fpage>119</fpage>
</element-citation>
</ref>
<ref id="B72-ijerph-16-00856">
<label>72.</label>
<element-citation publication-type="journal">
<article-title>Recommendations for using fluoride to prevent and control dental caries in the United States</article-title>
<source/>MMWR
          <year>2001</year>
<volume>50</volume>
<fpage>1</fpage>
<lpage>42</lpage>
</element-citation>
</ref>
<ref id="B73-ijerph-16-00856">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mehra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saikat</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Human exposure assessment of fluoride from tea (Camellia sinensis L.)</article-title>
<source/>Food Res. Int.
          <year>2013</year>
<volume>51</volume>
<fpage>564</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="doi">10.1016/j.foodres.2013.01.025</pub-id>
</element-citation>
</ref>
<ref id="B74-ijerph-16-00856">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waugh</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Limeback</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Godfrey</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Risk assessment of fluoride intake from tea in the republic of Ireland and its implications for public health and water fluoridation</article-title>
<source/>Int. J. Environ. Res. Public Health
          <year>2016</year>
<volume>13</volume>
<elocation-id>259</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijerph13030259</pub-id>
<pub-id pub-id-type="pmid">26927146</pub-id>
</element-citation>
</ref>
<ref id="B75-ijerph-16-00856">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waugh</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Godfrey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Limeback</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Black Tea Source, Production, and Consumption: Assessment of Health Risks of Fluoride Intake in New Zealand</article-title>
<source/>J. Environ. Public Health
          <year>2017</year>
<volume>2017</volume>
<fpage>5120504</fpage>
<pub-id pub-id-type="doi">10.1155/2017/5120504</pub-id>
<pub-id pub-id-type="pmid">28713433</pub-id>
</element-citation>
</ref>
<ref id="B76-ijerph-16-00856">
<label>76.</label>
<element-citation publication-type="journal">
<article-title>Scientific Opinion on Dietary Reference Values for fluoride</article-title>
<source/>EFSA J.
          <year>2013</year>
<volume>11</volume>
<fpage>3332</fpage>
<pub-id pub-id-type="doi">10.2903/j.efsa.2013.3332</pub-id>
</element-citation>
</ref>
<ref id="B77-ijerph-16-00856">
<label>77.</label>
<element-citation publication-type="web">
<article-title>Water Fluoridation for the Prevention of Dental Caries (Review). The Cochrane Library 2015, Issue 6</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.cochrane.org/CD010856/ORAL_water-fluoridation-prevent-tooth-decay">https://www.cochrane.org/CD010856/ORAL_water-fluoridation-prevent-tooth-decay</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-01-11">(accessed on 11 January 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B78-ijerph-16-00856">
<label>78.</label>
<element-citation publication-type="web">
<article-title>Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers Concerning the Safety of Fluorine Compounds in Oral Hygiene Products for Children Under the Age of 6 Years</article-title>
<month>6</month>
<year>2003</year>
<comment>SCCNFP/0653/03</comment>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_024.pdf">https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_024.pdf</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-01-11">(accessed on 11 January 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B79-ijerph-16-00856">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.F.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pant</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>The Nrf2 Signaling in Retinal Ganglion Cells under Oxidative Stress in Ocular Neurodegenerative Diseases</article-title>
<source/>Int. J. Biol. Sci.
          <year>2018</year>
<volume>14</volume>
<fpage>1090</fpage>
<lpage>1098</lpage>
<pub-id pub-id-type="doi">10.7150/ijbs.25996</pub-id>
<pub-id pub-id-type="pmid">29989056</pub-id>
</element-citation>
</ref>
<ref id="B80-ijerph-16-00856">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dröge</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Free radicals in the physiological control of cell function</article-title>
<source/>Physiol. Rev.
          <year>2002</year>
<volume>82</volume>
<fpage>47</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00018.2001</pub-id>
<pub-id pub-id-type="pmid">11773609</pub-id>
</element-citation>
</ref>
<ref id="B81-ijerph-16-00856">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grune</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sommerburg</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Siems</surname>
<given-names>W.G.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in anemia</article-title>
<source/>Clin. Nephrol.
          <year>2000</year>
<volume>53</volume>
<issue>Suppl. 1</issue>
<fpage>S18</fpage>
<lpage>S22</lpage>
<pub-id pub-id-type="pmid">10746801</pub-id>
</element-citation>
</ref>
<ref id="B82-ijerph-16-00856">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spector</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Oxidative stress-induced cataract: Mechanism of action</article-title>
<source/>FASEB J.
          <year>1995</year>
<volume>9</volume>
<fpage>1173</fpage>
<lpage>1182</lpage>
<pub-id pub-id-type="doi">10.1096/fasebj.9.12.7672510</pub-id>
<pub-id pub-id-type="pmid">7672510</pub-id>
</element-citation>
</ref>
<ref id="B83-ijerph-16-00856">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvarado</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Polansky</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Juster</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Age-related changes in human trabecular meshwork cellularity</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>1981</year>
<volume>21</volume>
<fpage>714</fpage>
<lpage>727</lpage>
<pub-id pub-id-type="pmid">7298275</pub-id>
</element-citation>
</ref>
<ref id="B84-ijerph-16-00856">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahn</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Giblin</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Glutathione in calf trabecular meshwork and its relation to aqueous humor outflow facility</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>1983</year>
<volume>24</volume>
<fpage>1283</fpage>
<lpage>1287</lpage>
<pub-id pub-id-type="pmid">6885312</pub-id>
</element-citation>
</ref>
<ref id="B85-ijerph-16-00856">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>Solar radiation and age-related macular degeneration</article-title>
<source/>Surv. Ophthalmol.
          <year>1988</year>
<volume>32</volume>
<fpage>252</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1016/0039-6257(88)90174-9</pub-id>
<pub-id pub-id-type="pmid">3279560</pub-id>
</element-citation>
</ref>
<ref id="B86-ijerph-16-00856">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kowluru</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Kern</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Engerman</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants</article-title>
<source/>Diabetes
          <year>1996</year>
<volume>45</volume>
<fpage>1233</fpage>
<lpage>1237</lpage>
<pub-id pub-id-type="doi">10.2337/diab.45.9.1233</pub-id>
<pub-id pub-id-type="pmid">8772728</pub-id>
</element-citation>
</ref>
<ref id="B87-ijerph-16-00856">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>G.S.</given-names>
</name>
</person-group>
<article-title>Free radical mediated photoreceptor damage in uveitis</article-title>
<source/>Prog. Retin. Eye Res.
          <year>2000</year>
<volume>19</volume>
<fpage>41</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1016/S1350-9462(99)00003-8</pub-id>
<pub-id pub-id-type="pmid">10614680</pub-id>
</element-citation>
</ref>
<ref id="B88-ijerph-16-00856">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hedge</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Varma</surname>
<given-names>S.D.</given-names>
</name>
</person-group>
<article-title>Prevention of cataract by pyruvate in experimentally diabetic mice</article-title>
<source/>Mol. Cell Biochem.
          <year>2005</year>
<volume>269</volume>
<fpage>115</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="pmid">15786723</pub-id>
</element-citation>
</ref>
<ref id="B89-ijerph-16-00856">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hegde</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Kovtun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Varma</surname>
<given-names>S.D.</given-names>
</name>
</person-group>
<article-title>Inhibition of glycolysis in the retina by oxidative stress: Prevention by pyruvate</article-title>
<source/>Mol. Cell. Biochem.
          <year>2010</year>
<volume>343</volume>
<fpage>101</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1007/s11010-010-0503-9</pub-id>
<pub-id pub-id-type="pmid">20559692</pub-id>
</element-citation>
</ref>
<ref id="B90-ijerph-16-00856">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berthoud</surname>
<given-names>V.M.</given-names>
</name>
<name>
<surname>Beyer</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>Oxidative stress, lens gap junctions, and cataracts</article-title>
<source/>Antioxid. Redox Signal.
          <year>2009</year>
<volume>11</volume>
<fpage>339</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2008.2119</pub-id>
<pub-id pub-id-type="pmid">18831679</pub-id>
</element-citation>
</ref>
<ref id="B91-ijerph-16-00856">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izzotti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bagnis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saccà</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>The role of oxidative stress in glaucoma</article-title>
<source/>Mutat. Res.
          <year>2006</year>
<volume>612</volume>
<fpage>105</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="doi">10.1016/j.mrrev.2005.11.001</pub-id>
<pub-id pub-id-type="pmid">16413223</pub-id>
</element-citation>
</ref>
<ref id="B92-ijerph-16-00856">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMonnies</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy</article-title>
<source/>J. Optom.
          <year>2017</year>
<volume>11</volume>
<fpage>3</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.optom.2017.06.002</pub-id>
<pub-id pub-id-type="pmid">28760643</pub-id>
</element-citation>
</ref>
<ref id="B93-ijerph-16-00856">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babizhayev</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Deyev</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Yermakova</surname>
<given-names>V.N.</given-names>
</name>
<name>
<surname>Brikman</surname>
<given-names>I.V.</given-names>
</name>
<name>
<surname>Bours</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes</article-title>
<source/>Drugs R&amp;D
          <year>2004</year>
<volume>5</volume>
<fpage>125</fpage>
<lpage>139</lpage>
</element-citation>
</ref>
<ref id="B94-ijerph-16-00856">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brennan</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Kantorow</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Mitochondrial function and redox control in the aging eye: Role of MsrA and other repair systems in cataract and macular degenerations</article-title>
<source/>Exp. Eye Res.
          <year>2009</year>
<volume>88</volume>
<fpage>195</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1016/j.exer.2008.05.018</pub-id>
<pub-id pub-id-type="pmid">18588875</pub-id>
</element-citation>
</ref>
<ref id="B95-ijerph-16-00856">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ottonello</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Foroni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Carta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Petrucco</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maraini</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Oxidative stress and age-related cataract</article-title>
<source/>Ophthalmologica.
          <year>2000</year>
<volume>214</volume>
<fpage>78</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1159/000027474</pub-id>
<pub-id pub-id-type="pmid">10657746</pub-id>
</element-citation>
</ref>
<ref id="B96-ijerph-16-00856">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beswick</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Conformational changes induced in bovine lens alpha-crystallin by carbamylation. Relevance to cataract</article-title>
<source/>Biochem. J.
          <year>1984</year>
<volume>223</volume>
<fpage>221</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1042/bj2230221</pub-id>
<pub-id pub-id-type="pmid">6497840</pub-id>
</element-citation>
</ref>
<ref id="B97-ijerph-16-00856">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ushio-Fukai</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Superoxide dismutases: Role in redox signaling, vascular function, and diseases</article-title>
<source/>Antioxid. Redox Signal.
          <year>2011</year>
<volume>15</volume>
<fpage>1583</fpage>
<lpage>1606</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2011.3999</pub-id>
<pub-id pub-id-type="pmid">21473702</pub-id>
</element-citation>
</ref>
<ref id="B98-ijerph-16-00856">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>V.N.</given-names>
</name>
</person-group>
<article-title>Glutathione and its function in the lens-an overview</article-title>
<source/>Exp. Eye Res.
          <year>1990</year>
<volume>50</volume>
<fpage>771</fpage>
<lpage>778</lpage>
<pub-id pub-id-type="doi">10.1016/0014-4835(90)90127-G</pub-id>
<pub-id pub-id-type="pmid">2197112</pub-id>
</element-citation>
</ref>
<ref id="B99-ijerph-16-00856">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhee</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Peroxiredoxin, a novel family of peroxidases</article-title>
<source/>IUBMB Life
          <year>2001</year>
<volume>52</volume>
<fpage>35</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1080/15216540252774748</pub-id>
<pub-id pub-id-type="pmid">11795591</pub-id>
</element-citation>
</ref>
<ref id="B100-ijerph-16-00856">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spector</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Kleiman</surname>
<given-names>N.J.</given-names>
</name>
</person-group>
<article-title>Microperoxidases catalytically degrade reactive oxygen species and may be anti-cataract agents</article-title>
<source/>Exp. Eye Res.
          <year>1997</year>
<volume>65</volume>
<fpage>457</fpage>
<lpage>470</lpage>
<pub-id pub-id-type="doi">10.1006/exer.1997.0336</pub-id>
<pub-id pub-id-type="pmid">9464180</pub-id>
</element-citation>
</ref>
<ref id="B101-ijerph-16-00856">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forman</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rinna</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Glutathione: Overview of its protective roles, measurement, and biosynthesis</article-title>
<source/>Mol. Aspects Med.
          <year>2008</year>
<volume>30</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/j.mam.2008.08.006</pub-id>
<pub-id pub-id-type="pmid">18796312</pub-id>
</element-citation>
</ref>
<ref id="B102-ijerph-16-00856">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarrett</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Boulton</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Consequences of oxidative stress in age-related macular degeneration</article-title>
<source/>Mol. Aspects Med.
          <year>2012</year>
<volume>33</volume>
<fpage>399</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="doi">10.1016/j.mam.2012.03.009</pub-id>
<pub-id pub-id-type="pmid">22510306</pub-id>
</element-citation>
</ref>
<ref id="B103-ijerph-16-00856">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maurya</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>Mohanty</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bhaduri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Role of anti-oxidant enzymes superoxide dismutase and catalase in the development of cataract: Study of serum levels in patients with senile and diabetic cataracts</article-title>
<source/>J. Indian Med. Assoc.
          <year>2006</year>
<volume>104</volume>
<fpage>396</fpage>
<lpage>397</lpage>
</element-citation>
</ref>
<ref id="B104-ijerph-16-00856">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozmen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ozmen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Erkin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Güner</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Habif</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bayindir</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Lens superoxide dismutase and catalase activities in diabetic cataract</article-title>
<source/>Clin. Biochem.
          <year>2002</year>
<volume>35</volume>
<fpage>69</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1016/S0009-9120(01)00284-3</pub-id>
<pub-id pub-id-type="pmid">11937081</pub-id>
</element-citation>
</ref>
<ref id="B105-ijerph-16-00856">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babizhayev</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Deyev</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Linberg</surname>
<given-names>L.F.</given-names>
</name>
</person-group>
<article-title>Lipid peroxidation as a possible cause of cataract</article-title>
<source/>Mech. Age Dev.
          <year>1988</year>
<volume>44</volume>
<fpage>68</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1016/0047-6374(88)90080-2</pub-id>
</element-citation>
</ref>
<ref id="B106-ijerph-16-00856">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obara</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>The oxidative stress in the cataract formation</article-title>
<source/>Nippon-Ganka-Gakkai-Zasshi
          <year>1995</year>
<volume>99</volume>
<fpage>1303</fpage>
<lpage>1341</lpage>
<pub-id pub-id-type="pmid">8571853</pub-id>
</element-citation>
</ref>
<ref id="B107-ijerph-16-00856">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yildirim</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ucgun</surname>
<given-names>N.I.</given-names>
</name>
<name>
<surname>Yildirim</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration</article-title>
<source/>Clinics
          <year>2011</year>
<volume>66</volume>
<fpage>743</fpage>
<lpage>746</lpage>
<pub-id pub-id-type="pmid">21789374</pub-id>
</element-citation>
</ref>
<ref id="B108-ijerph-16-00856">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>X.Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Changes in blood oxidative and antioxidant parameters in a group of Chinese patients with age-related macular degeneration</article-title>
<source/>J. Nutr. Health Aging
          <year>2012</year>
<volume>16</volume>
<fpage>201</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1007/s12603-011-0350-8</pub-id>
<pub-id pub-id-type="pmid">22456773</pub-id>
</element-citation>
</ref>
<ref id="B109-ijerph-16-00856">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Serum superoxide dismutase and malondialdehyde levels in a group of Chinese patients with age-related macular degeneration</article-title>
<source/>Aging Clin. Exp. Res.
          <year>2011</year>
<volume>23</volume>
<fpage>264</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1007/BF03324965</pub-id>
<pub-id pub-id-type="pmid">22067370</pub-id>
</element-citation>
</ref>
<ref id="B110-ijerph-16-00856">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anand</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>N.K.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prabhakar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Superoxide dismutase1 levels in North Indian population with age-related macular degeneration</article-title>
<source/>Oxid. Med. Cell. Longev.
          <year>2013</year>
<volume>2013</volume>
<fpage>365046</fpage>
<pub-id pub-id-type="doi">10.1155/2013/365046</pub-id>
<pub-id pub-id-type="pmid">24363822</pub-id>
</element-citation>
</ref>
<ref id="B111-ijerph-16-00856">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thangapandiyan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miltonprabu</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Epigallocatechin gallate supplementation protects against renal injury induced by fluoride intoxication in rats: Role of Nrf2/HO-1 signaling</article-title>
<source/>Toxicol. Rep.
          <year>2014</year>
<volume>1</volume>
<fpage>12</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxrep.2014.01.002</pub-id>
<pub-id pub-id-type="pmid">28962222</pub-id>
</element-citation>
</ref>
<ref id="B112-ijerph-16-00856">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q.K.</given-names>
</name>
<name>
<surname>Parnell</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Meydani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ordovas</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>C.Q.</given-names>
</name>
</person-group>
<article-title>Curcumin-supplemented diets increase superoxide dismutase activity and mean lifespan in Drosophila</article-title>
<source/>Age (Dordr.)
          <year>2012</year>
<volume>35</volume>
<fpage>1133</fpage>
<lpage>1142</lpage>
<pub-id pub-id-type="doi">10.1007/s11357-012-9438-2</pub-id>
<pub-id pub-id-type="pmid">22653297</pub-id>
</element-citation>
</ref>
<ref id="B113-ijerph-16-00856">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akinyemi</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Oboh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ogunsuyi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Abolaji</surname>
<given-names>A.O.</given-names>
</name>
<name>
<surname>Udofia</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Curcumin-supplemented diets improve antioxidant enzymes and alter acetylcholinesterase genes expression level in Drosophila melanogaster model</article-title>
<source/>Metab. Brain Dis.
          <year>2018</year>
<volume>33</volume>
<fpage>369</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="doi">10.1007/s11011-017-0100-7</pub-id>
<pub-id pub-id-type="pmid">28849357</pub-id>
</element-citation>
</ref>
<ref id="B114-ijerph-16-00856">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nabavi</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Nabavi</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Abolhasani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Moghaddam</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Eslami</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cytoprotective effects of curcumin on sodium fluoride-induced intoxication in rat erythrocytes</article-title>
<source/>Bull. Environ. Contam. Toxicol.
          <year>2012</year>
<volume>88</volume>
<fpage>486</fpage>
<lpage>490</lpage>
<pub-id pub-id-type="doi">10.1007/s00128-011-0495-5</pub-id>
<pub-id pub-id-type="pmid">22143374</pub-id>
</element-citation>
</ref>
<ref id="B115-ijerph-16-00856">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Y.W.</given-names>
</name>
</person-group>
<article-title>Tea and Risk of Age-Related Cataracts: A Cross-Sectional Study in Zhejiang Province, China</article-title>
<source/>J. Epidemiol.
          <year>2016</year>
<volume>26</volume>
<fpage>587</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="doi">10.2188/jea.JE20150223</pub-id>
<pub-id pub-id-type="pmid">27180932</pub-id>
</element-citation>
</ref>
<ref id="B116-ijerph-16-00856">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ozawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kurihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hirasawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ozeki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shiba</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ishida</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tsubota</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Retinal Ganglion Cell Loss in Superoxide Dismutase 1 Deficiency</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2011</year>
<volume>52</volume>
<fpage>4143</fpage>
<lpage>4150</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.10-6294</pub-id>
<pub-id pub-id-type="pmid">21421868</pub-id>
</element-citation>
</ref>
<ref id="B117-ijerph-16-00856">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Longo-Guess</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Rossmann</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Seburn</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Hurd</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Frankel</surname>
<given-names>W.N.</given-names>
</name>
<name>
<surname>Bronson</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Ackerman</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>The harlequin mouse mutation downregulates apoptosis-inducing factor</article-title>
<source/>Nature
          <year>2002</year>
<volume>419</volume>
<fpage>367</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="doi">10.1038/nature01034</pub-id>
<pub-id pub-id-type="pmid">12353028</pub-id>
</element-citation>
</ref>
<ref id="B118-ijerph-16-00856">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tezel</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences</article-title>
<source/>Prog. Retin. Eye Res.
          <year>2006</year>
<volume>25</volume>
<fpage>490</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="doi">10.1016/j.preteyeres.2006.07.003</pub-id>
<pub-id pub-id-type="pmid">16962364</pub-id>
</element-citation>
</ref>
<ref id="B119-ijerph-16-00856">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulz</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Lindenau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seyfried</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dichgans</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Glutathione, oxidative stress and neurodegeneration</article-title>
<source/>Eur. J. Biochem.
          <year>2000</year>
<volume>267</volume>
<fpage>4904</fpage>
<lpage>4911</lpage>
<pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.01595.x</pub-id>
<pub-id pub-id-type="pmid">10931172</pub-id>
</element-citation>
</ref>
<ref id="B120-ijerph-16-00856">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gherghel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Griffiths</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Hilton</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Cunliffe</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Hosking</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2005</year>
<volume>46</volume>
<fpage>877</fpage>
<lpage>883</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.04-0777</pub-id>
<pub-id pub-id-type="pmid">15728543</pub-id>
</element-citation>
</ref>
<ref id="B121-ijerph-16-00856">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spector</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Oxidation and cataract</article-title>
<source/>Ciba Found Symp.
          <year>1984</year>
<volume>106</volume>
<fpage>48</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="pmid">6568980</pub-id>
</element-citation>
</ref>
<ref id="B122-ijerph-16-00856">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Pogwizd</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Prabhu</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Inhibiting Na+/K+ ATPase can impair mitochondrial energetics and induce abnormal Ca2+ cycling and automaticity in guinea pig cardiomyocytes</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e93928</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0093928</pub-id>
<pub-id pub-id-type="pmid">24722410</pub-id>
</element-citation>
</ref>
<ref id="B123-ijerph-16-00856">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dasgupta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mukhopadhyay</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Role of membrane cholesterol and lipid peroxidation in regulating the Na+/K+-ATPase activity in schizophrenia</article-title>
<source/>Indian J. Psychiatry
          <year>2016</year>
<volume>58</volume>
<fpage>317</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="pmid">28066011</pub-id>
</element-citation>
</ref>
<ref id="B124-ijerph-16-00856">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Ouabain-stimulated trafficking regulation of the Na/K-ATPase and NHE3 in renal proximal tubule cells</article-title>
<source/>Mol. Cell. Biochem.
          <year>2012</year>
<volume>367</volume>
<fpage>175</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1007/s11010-012-1331-x</pub-id>
<pub-id pub-id-type="pmid">22618525</pub-id>
</element-citation>
</ref>
<ref id="B125-ijerph-16-00856">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delamere</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Tamiya</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Expression, regulation and function of Na,K-ATPase in the lens</article-title>
<source/>Prog. Retin. Eye Res.
          <year>2004</year>
<volume>23</volume>
<fpage>593</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="doi">10.1016/j.preteyeres.2004.06.003</pub-id>
<pub-id pub-id-type="pmid">15388076</pub-id>
</element-citation>
</ref>
<ref id="B126-ijerph-16-00856">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unakar</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Tsui</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Effect of pretreatment of germanium-1322 on NaC,KC-ATPase and galactose cataracts</article-title>
<source/>Curr. Eye Res.
          <year>1997</year>
<volume>16</volume>
<fpage>832</fpage>
<lpage>837</lpage>
<pub-id pub-id-type="doi">10.1076/ceyr.16.8.832.8980</pub-id>
<pub-id pub-id-type="pmid">9255513</pub-id>
</element-citation>
</ref>
<ref id="B127-ijerph-16-00856">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokoyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Giblin</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>V.N.</given-names>
</name>
</person-group>
<article-title>A physiological level of ascorbate inhibits galactose cataract in guinea pigs by decreasing polyol accumulation in the lens epithelium: A dehydroascorbate-linked mechanism</article-title>
<source/>Exp. Eye Res.
          <year>1994</year>
<volume>58</volume>
<fpage>207</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1006/exer.1994.1009</pub-id>
<pub-id pub-id-type="pmid">8157113</pub-id>
</element-citation>
</ref>
<ref id="B128-ijerph-16-00856">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Tsou</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>S.I.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Kirmani</surname>
<given-names>T.H.</given-names>
</name>
</person-group>
<article-title>Studies on cataractogenesis in humans and rats with Alloxan-induced diabetes</article-title>
<source/>Ophthalm. Res.
          <year>1985</year>
<volume>17</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1159/000265343</pub-id>
<pub-id pub-id-type="pmid">2984622</pub-id>
</element-citation>
</ref>
<ref id="B129-ijerph-16-00856">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizuno</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Chipault</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Lipid composition and(NaC C KC)-ATPase activity in rat lens during triparanol-induced cataract formation</article-title>
<source/>Biochim. Biophys. Acta
          <year>1981</year>
<volume>644</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/0005-2736(81)90052-3</pub-id>
<pub-id pub-id-type="pmid">6266459</pub-id>
</element-citation>
</ref>
<ref id="B130-ijerph-16-00856">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Reddig</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>Loss of Na+/K+-ATPase in Drosophila photoreceptors leads to blindness and age-dependent neurodegeneration</article-title>
<source/>Exp. Neurol.
          <year>2014</year>
<volume>261</volume>
<fpage>791</fpage>
<lpage>801</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2014.08.025</pub-id>
<pub-id pub-id-type="pmid">25205229</pub-id>
</element-citation>
</ref>
<ref id="B131-ijerph-16-00856">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated phase II enzymes through activation of PI3K/Akt</article-title>
<source/>Mol. Vis.
          <year>2013</year>
<volume>19</volume>
<fpage>1656</fpage>
<lpage>1666</lpage>
<pub-id pub-id-type="pmid">23901249</pub-id>
</element-citation>
</ref>
<ref id="B132-ijerph-16-00856">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rushworth</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Mackman</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ogborne</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>O’Connell</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C</article-title>
<source/>J. Immunol.
          <year>2005</year>
<volume>175</volume>
<fpage>4408</fpage>
<lpage>4415</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.175.7.4408</pub-id>
<pub-id pub-id-type="pmid">16177082</pub-id>
</element-citation>
</ref>
<ref id="B133-ijerph-16-00856">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pickering</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Linder</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Forman</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>K.J.</given-names>
</name>
</person-group>
<article-title>Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress</article-title>
<source/>J. Biol. Chem.
          <year>2012</year>
<volume>287</volume>
<fpage>10021</fpage>
<lpage>10031</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.277145</pub-id>
<pub-id pub-id-type="pmid">22308036</pub-id>
</element-citation>
</ref>
<ref id="B134-ijerph-16-00856">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.F.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>D.D.</given-names>
</name>
</person-group>
<article-title>Nrf2 as a target for prevention of age-related and diabetic cataracts by against oxidative stress</article-title>
<source/>Aging Cell.
          <year>2017</year>
<volume>16</volume>
<fpage>934</fpage>
<lpage>942</lpage>
<pub-id pub-id-type="doi">10.1111/acel.12645</pub-id>
<pub-id pub-id-type="pmid">28722304</pub-id>
</element-citation>
</ref>
<ref id="B135-ijerph-16-00856">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SERPINA3K protects against oxidative stress via modulating ROS generation/degradation and KEAP1-NRF2 pathway in the corneal epithelium</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2012</year>
<volume>53</volume>
<fpage>5033</fpage>
<lpage>5043</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.12-9729</pub-id>
<pub-id pub-id-type="pmid">22736614</pub-id>
</element-citation>
</ref>
<ref id="B136-ijerph-16-00856">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambros</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Plafker</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Oxidative Stress and the Nrf2 Anti-Oxidant Transcription Factor in Age-Related Macular Degeneration</article-title>
<source/>Adv. Exp. Med. Biol.
          <year>2016</year>
<volume>854</volume>
<fpage>67</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">26427395</pub-id>
</element-citation>
</ref>
<ref id="B137-ijerph-16-00856">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Serum Response Factor Protects Retinal Ganglion Cells Against High-Glucose Damage</article-title>
<source/>J. Mol. Neurosci.
          <year>2016</year>
<volume>59</volume>
<fpage>232</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1007/s12031-015-0708-1</pub-id>
<pub-id pub-id-type="pmid">26803311</pub-id>
</element-citation>
</ref>
<ref id="B138-ijerph-16-00856">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hartsock</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Duh</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion</article-title>
<source/>J. Neuroinflamm.
          <year>2015</year>
<volume>12</volume>
<fpage>239</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-015-0452-z</pub-id>
</element-citation>
</ref>
<ref id="B139-ijerph-16-00856">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sternberg</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Grossniklaus</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Age-Related Retinopathy in NRF2-Deficient Mice</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<elocation-id>e19456</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0019456</pub-id>
<pub-id pub-id-type="pmid">21559389</pub-id>
</element-citation>
</ref>
<ref id="B140-ijerph-16-00856">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jobin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bradham</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Juma</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Narula</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Sartor</surname>
<given-names>R.B.</given-names>
</name>
</person-group>
<article-title>Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity</article-title>
<source/>J. Immunol.
          <year>1999</year>
<volume>163</volume>
<fpage>3474</fpage>
<lpage>3483</lpage>
<pub-id pub-id-type="pmid">10477620</pub-id>
</element-citation>
</ref>
<ref id="B141-ijerph-16-00856">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baeuerle</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Henkle</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Function and activation of NF-κB in the immune system</article-title>
<source/>Annu. Rev. Immunol.
          <year>1994</year>
<volume>12</volume>
<fpage>141</fpage>
<pub-id pub-id-type="doi">10.1146/annurev.iy.12.040194.001041</pub-id>
<pub-id pub-id-type="pmid">8011280</pub-id>
</element-citation>
</ref>
<ref id="B142-ijerph-16-00856">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnes</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Karin</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Nuclear factor-κB, a pivotal transcription factor in chronic inflammatory diseases</article-title>
<source/>N. Engl. J. Med.
          <year>1997</year>
<volume>336</volume>
<fpage>1066</fpage>
<lpage>1071</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199704103361506</pub-id>
<pub-id pub-id-type="pmid">9091804</pub-id>
</element-citation>
</ref>
<ref id="B143-ijerph-16-00856">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pahl</surname>
<given-names>H.L.</given-names>
</name>
</person-group>
<article-title>Activators and target genes of Rel/NF-kappaB transcription factors</article-title>
<source/>Oncogene
          <year>1999</year>
<volume>18</volume>
<fpage>6853</fpage>
<lpage>6866</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1203239</pub-id>
<pub-id pub-id-type="pmid">10602461</pub-id>
</element-citation>
</ref>
<ref id="B144-ijerph-16-00856">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexander</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Carlsen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Blomhoff</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Corneal NF-κB activity is necessary for the retention of transparency in the cornea of UV-B-exposed transgenic reporter mice</article-title>
<source/>Exp. Eye Res.
          <year>2006</year>
<volume>82</volume>
<fpage>700</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1016/j.exer.2005.09.012</pub-id>
<pub-id pub-id-type="pmid">16289165</pub-id>
</element-citation>
</ref>
<ref id="B145-ijerph-16-00856">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>X.H.</given-names>
</name>
<name>
<surname>Ohgami</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shiratori</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Koyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kase</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Inhibition of nuclear factor-kappa B activation attenuates hydrogen peroxide-induced cytotoxicity in human lens epithelial cells</article-title>
<source/>Br. J. Ophthalmol.
          <year>2006</year>
<volume>91</volume>
<fpage>369</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="doi">10.1136/bjo.2006.107037</pub-id>
<pub-id pub-id-type="pmid">17020896</pub-id>
</element-citation>
</ref>
<ref id="B146-ijerph-16-00856">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kauppinen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Paterno</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Blasiak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Salminen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaarniranta</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Inflammation and its role in age-related macular degeneration</article-title>
<source/>Cell. Mol. Life Sci.
          <year>2016</year>
<volume>73</volume>
<fpage>1765</fpage>
<lpage>1786</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-016-2147-8</pub-id>
<pub-id pub-id-type="pmid">26852158</pub-id>
</element-citation>
</ref>
<ref id="B147-ijerph-16-00856">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lukiw</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bhattacharjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alexandrov</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dua</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>TREM2 (chr6p21.1) and CFH (chr1q32) regulation by NF-kB-sensitive miRNAs in age-related macular degeneration (AMD) and Alzheimer’s disease (AD)</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2013</year>
<volume>54</volume>
<fpage>3652</fpage>
</element-citation>
</ref>
<ref id="B148-ijerph-16-00856">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lupien</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Horner</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Calkins</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>NFkB signaling in retinal glia mediates progressive neural degeneration and vision decline in glaucoma</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2013</year>
<volume>54</volume>
<fpage>415</fpage>
<pub-id pub-id-type="pmid">23233256</pub-id>
</element-citation>
</ref>
<ref id="B149-ijerph-16-00856">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yazdankhah</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhutto</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hose</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Montezuma</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chattopadhyay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lutty</surname>
<given-names>G.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activating the AKT2-nuclear factor-κB-lipocalin-2 axis elicits an inflammatory response in age-related macular degeneration</article-title>
<source/>J. Pathol.
          <year>2017</year>
<volume>241</volume>
<fpage>583</fpage>
<lpage>588</lpage>
<pub-id pub-id-type="doi">10.1002/path.4870</pub-id>
<pub-id pub-id-type="pmid">28026019</pub-id>
</element-citation>
</ref>
<ref id="B150-ijerph-16-00856">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimm</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>M.K.A.</given-names>
</name>
<name>
<surname>Baeuerle</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Schulze-Osthoff</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Bcl-2 down-regulates the activity of transcription factor NF-kB induced upon apoptosis</article-title>
<source/>J. Cell. Biol.
          <year>1996</year>
<volume>134</volume>
<fpage>13</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.134.1.13</pub-id>
<pub-id pub-id-type="pmid">8698809</pub-id>
</element-citation>
</ref>
<ref id="B151-ijerph-16-00856">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seidl</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bidmon</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bajo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>LaCasse</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Lubec</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Evidence for apoptosis in the fetal Down syndrome brain</article-title>
<source/>J. Child Neurol.
          <year>2001</year>
<volume>16</volume>
<fpage>438</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="doi">10.1177/088307380101600610</pub-id>
<pub-id pub-id-type="pmid">11417611</pub-id>
</element-citation>
</ref>
<ref id="B152-ijerph-16-00856">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolvetang</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Sanij</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Busciglio</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hatzistavrou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Seth</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hertzog</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Kola</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway</article-title>
<source/>Hum. Mol. Genet.
          <year>2003</year>
<volume>12</volume>
<fpage>247</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddg015</pub-id>
<pub-id pub-id-type="pmid">12554679</pub-id>
</element-citation>
</ref>
<ref id="B153-ijerph-16-00856">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zampieri</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Biselli-Périco</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Bürger</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Silva Júnior</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Goloni-Bertollo</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Pavarino</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>Altered Expression of Immune-Related Genes in Children with Down Syndrome</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e107218</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0107218</pub-id>
<pub-id pub-id-type="pmid">25222269</pub-id>
</element-citation>
</ref>
<ref id="B154-ijerph-16-00856">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fredrik Jarskog</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gilmore</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Selinger</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Lieberman</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Cortical Bcl-2 Protein Expression and Apoptotic Regulation in Schizophrenia</article-title>
<source/>Biol. Psychiatry
          <year>2000</year>
<volume>48</volume>
<fpage>641</fpage>
<lpage>650</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-3223(00)00988-4</pub-id>
<pub-id pub-id-type="pmid">11032975</pub-id>
</element-citation>
</ref>
<ref id="B155-ijerph-16-00856">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cipollone</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chiarelli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Iezzi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fazia</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Cuccurullo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pini</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>De Cesare</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Torello</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tumini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cuccurullo</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes</article-title>
<source/>Int. J. Immunopathol. Pharmacol.
          <year>2005</year>
<volume>18</volume>
<fpage>625</fpage>
<lpage>635</lpage>
<pub-id pub-id-type="doi">10.1177/039463200501800403</pub-id>
<pub-id pub-id-type="pmid">16388709</pub-id>
</element-citation>
</ref>
<ref id="B156-ijerph-16-00856">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calnan</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Brunet</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The FoxO code</article-title>
<source/>Oncogene
          <year>2008</year>
<volume>27</volume>
<fpage>2276</fpage>
<lpage>2288</lpage>
<pub-id pub-id-type="doi">10.1038/onc.2008.21</pub-id>
<pub-id pub-id-type="pmid">18391970</pub-id>
</element-citation>
</ref>
<ref id="B157-ijerph-16-00856">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van der Horst</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Burgering</surname>
<given-names>B.M.</given-names>
</name>
</person-group>
<article-title>Stressing the role of FoxO proteins in lifespan and disease</article-title>
<source/>Nat. Rev. Mol. Cell. Biol.
          <year>2007</year>
<volume>8</volume>
<fpage>440</fpage>
<lpage>450</lpage>
<pub-id pub-id-type="doi">10.1038/nrm2190</pub-id>
<pub-id pub-id-type="pmid">17522590</pub-id>
</element-citation>
</ref>
<ref id="B158-ijerph-16-00856">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kops</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Dansen</surname>
<given-names>T.B.</given-names>
</name>
<name>
<surname>Polderman</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Saarloos</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Wirtz</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Coffer</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Bos</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Medema</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Burgering</surname>
<given-names>B.M.T.</given-names>
</name>
</person-group>
<article-title>Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress</article-title>
<source/>Nature
          <year>2002</year>
<volume>419</volume>
<fpage>316</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1038/nature01036</pub-id>
<pub-id pub-id-type="pmid">12239572</pub-id>
</element-citation>
</ref>
<ref id="B159-ijerph-16-00856">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nemoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Finkel</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway</article-title>
<source/>Science
          <year>2002</year>
<volume>295</volume>
<fpage>2450</fpage>
<lpage>2452</lpage>
<pub-id pub-id-type="doi">10.1126/science.1069004</pub-id>
<pub-id pub-id-type="pmid">11884717</pub-id>
</element-citation>
</ref>
<ref id="B160-ijerph-16-00856">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ghosh-Choudhury</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dey</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mariappan</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Kasinath</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Ghosh Choudhury</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>High Glucose Forces a Positive Feedback Loop Connecting Akt Kinase and FoxO1 Transcription Factor to Activate mTORC1 Kinase for Mesangial Cell Hypertrophy and Matrix Protein Expression</article-title>
<source/>J. Biol. Chem.
          <year>2014</year>
<volume>289</volume>
<fpage>32703</fpage>
<lpage>32716</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M114.605196</pub-id>
<pub-id pub-id-type="pmid">25288788</pub-id>
</element-citation>
</ref>
<ref id="B161-ijerph-16-00856">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Challa</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>FOXO Protein Expression is Down-Regulated With Aging in the Lens</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2010</year>
<volume>51</volume>
<fpage>4590</fpage>
</element-citation>
</ref>
<ref id="B162-ijerph-16-00856">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rose-John</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Winthrop</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Calabrese</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The role of IL-6 in host defence against infections: Immunobiology and clinical implications</article-title>
<source/>Nat. Rev. Rheumatol.
          <year>2017</year>
<volume>13</volume>
<fpage>399</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="doi">10.1038/nrrheum.2017.83</pub-id>
<pub-id pub-id-type="pmid">28615731</pub-id>
</element-citation>
</ref>
<ref id="B163-ijerph-16-00856">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dethlefsen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Højfeldt</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hojman</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The role of intratumoral and systemic IL-6 in breast cancer</article-title>
<source/>Breast Cancer Res. Treat.
          <year>2013</year>
<volume>138</volume>
<fpage>657</fpage>
<lpage>664</lpage>
<pub-id pub-id-type="doi">10.1007/s10549-013-2488-z</pub-id>
<pub-id pub-id-type="pmid">23532539</pub-id>
</element-citation>
</ref>
<ref id="B164-ijerph-16-00856">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabay</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Interleukin-6 and chronic inflammation</article-title>
<source/>Arthritis Res. Ther.
          <year>2006</year>
<volume>8</volume>
<issue>Suppl. 2</issue>
<fpage>S3</fpage>
<pub-id pub-id-type="doi">10.1186/ar1917</pub-id>
<pub-id pub-id-type="pmid">16899107</pub-id>
</element-citation>
</ref>
<ref id="B165-ijerph-16-00856">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Discrepant expression of cytokines in inflammation- and age-related cataract patients</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e109647</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0109647</pub-id>
<pub-id pub-id-type="pmid">25303043</pub-id>
</element-citation>
</ref>
<ref id="B166-ijerph-16-00856">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Potvin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stip</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sepehry</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bah</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kouassi</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review</article-title>
<source/>Biol. Psychiatry
          <year>2008</year>
<volume>63</volume>
<fpage>801</fpage>
<lpage>808</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2007.09.024</pub-id>
<pub-id pub-id-type="pmid">18005941</pub-id>
</element-citation>
</ref>
<ref id="B167-ijerph-16-00856">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>P.H.</given-names>
</name>
</person-group>
<article-title>Immune involvement in schizophrenia and autism: Etiology, pathology and animal models</article-title>
<source/>Behav. Brain Res.
          <year>2009</year>
<volume>204</volume>
<fpage>313</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2008.12.016</pub-id>
<pub-id pub-id-type="pmid">19136031</pub-id>
</element-citation>
</ref>
<ref id="B168-ijerph-16-00856">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohamed-Ali</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Goodrick</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rawesh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Miles</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Yudkin</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Coppack</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo</article-title>
<source/>J. Clin. Endocrinol. Metab.
          <year>1997</year>
<volume>82</volume>
<fpage>4196</fpage>
<lpage>4200</lpage>
<pub-id pub-id-type="pmid">9398739</pub-id>
</element-citation>
</ref>
<ref id="B169-ijerph-16-00856">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Straub</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Hense</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Andus</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Scholmerich</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Riegger</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Schunkert</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women</article-title>
<source/>J. Clin. Endocrinol. Metab.
          <year>2000</year>
<volume>85</volume>
<fpage>1340</fpage>
<lpage>1344</lpage>
<pub-id pub-id-type="doi">10.1210/jcem.85.3.6355</pub-id>
<pub-id pub-id-type="pmid">10720088</pub-id>
</element-citation>
</ref>
<ref id="B170-ijerph-16-00856">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Real</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Vayreda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Richart</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gutierrez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Broch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vendrell</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ricart</surname>
<given-names>W.J.</given-names>
</name>
</person-group>
<article-title>Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women</article-title>
<source/>J. Clin. Endocrinol. Metab.
          <year>2001</year>
<volume>86</volume>
<fpage>1154</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="doi">10.1210/jcem.86.3.7305</pub-id>
<pub-id pub-id-type="pmid">11238501</pub-id>
</element-citation>
</ref>
<ref id="B171-ijerph-16-00856">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kado</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nagase</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus</article-title>
<source/>Acta Diabetol.
          <year>1999</year>
<volume>36</volume>
<fpage>67</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1007/s005920050147</pub-id>
<pub-id pub-id-type="pmid">10436255</pub-id>
</element-citation>
</ref>
<ref id="B172-ijerph-16-00856">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pickup</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Mattock</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Chusney</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Burt</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X</article-title>
<source/>Diabetologia
          <year>1997</year>
<volume>40</volume>
<fpage>1286</fpage>
<lpage>1292</lpage>
<pub-id pub-id-type="doi">10.1007/s001250050822</pub-id>
<pub-id pub-id-type="pmid">9389420</pub-id>
</element-citation>
</ref>
<ref id="B173-ijerph-16-00856">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sumegová</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nagyová</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Waczulíková</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Žitňanová</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ďuračková</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Activity of Paraoxonase 1 and Lipid Profile in Healthy Children</article-title>
<source/>Physiol. Res.
          <year>2007</year>
<volume>56</volume>
<fpage>351</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="pmid">16792468</pub-id>
</element-citation>
</ref>
<ref id="B174-ijerph-16-00856">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozenberg</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Shiner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aviram</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties</article-title>
<source/>Free Rad. Biol. Med.
          <year>2008</year>
<volume>44</volume>
<fpage>1951</fpage>
<lpage>1959</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.02.012</pub-id>
<pub-id pub-id-type="pmid">18358245</pub-id>
</element-citation>
</ref>
<ref id="B175-ijerph-16-00856">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koren-Gluzer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aviram</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Meilin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release</article-title>
<source/>Atherosclerosis
          <year>2011</year>
<volume>219</volume>
<fpage>532</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2011.07.119</pub-id>
<pub-id pub-id-type="pmid">21906740</pub-id>
</element-citation>
</ref>
<ref id="B176-ijerph-16-00856">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baskol</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Karakucuk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Oner</surname>
<given-names>A.O.</given-names>
</name>
<name>
<surname>Baskol</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kocer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mirza</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Saraymen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ustdal</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration</article-title>
<source/>Ophthalmologica
          <year>2006</year>
<volume>220</volume>
<fpage>12</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1159/000089269</pub-id>
<pub-id pub-id-type="pmid">16374043</pub-id>
</element-citation>
</ref>
<ref id="B177-ijerph-16-00856">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ates</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Azizi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alp</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Kiziltunc</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Beydemir</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cinici</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kocer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Baykal</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in age-related macular degeneration</article-title>
<source/>Tohoku J. Exp. Med.
          <year>2009</year>
<volume>217</volume>
<fpage>17</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1620/tjem.217.17</pub-id>
<pub-id pub-id-type="pmid">19155603</pub-id>
</element-citation>
</ref>
<ref id="B178-ijerph-16-00856">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Javadzadeh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ghorbanihaghjo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bahreini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rashtchizadeh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Argani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Alizadeh</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein</article-title>
<source/>Retina
          <year>2012</year>
<volume>32</volume>
<fpage>658</fpage>
<lpage>666</lpage>
<pub-id pub-id-type="doi">10.1097/IAE.0b013e31822529b1</pub-id>
<pub-id pub-id-type="pmid">22030834</pub-id>
</element-citation>
</ref>
<ref id="B179-ijerph-16-00856">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashim</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zarina</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract</article-title>
<source/>Clin. Biochem.
          <year>2007</year>
<volume>40</volume>
<fpage>705</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1016/j.clinbiochem.2007.03.015</pub-id>
<pub-id pub-id-type="pmid">17466963</pub-id>
</element-citation>
</ref>
<ref id="B180-ijerph-16-00856">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butterfield</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Multifunctional roles of enolase in Alzheimer’s disease brain: Beyond altered glucose metabolism</article-title>
<source/>J. Neurochem.
          <year>2009</year>
<volume>111</volume>
<fpage>915</fpage>
<lpage>933</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06397.x</pub-id>
<pub-id pub-id-type="pmid">19780894</pub-id>
</element-citation>
</ref>
<ref id="B181-ijerph-16-00856">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warburg</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Christian</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Isolation and crystallization of enolase</article-title>
<source/>Biochem. Z.
          <year>1942</year>
<volume>310</volume>
<fpage>384</fpage>
<lpage>421</lpage>
</element-citation>
</ref>
<ref id="B182-ijerph-16-00856">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cimasoni</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The Inhibition of Enolase by Fluoride in vitro</article-title>
<source/>Caries Res.
          <year>1972</year>
<volume>6</volume>
<fpage>93</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1159/000259782</pub-id>
<pub-id pub-id-type="pmid">4502285</pub-id>
</element-citation>
</ref>
<ref id="B183-ijerph-16-00856">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brewer</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Lovelace</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Lebioda</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Fluoride inhibition of enolase: Crystal structure and thermodynamics</article-title>
<source/>Biochemistry
          <year>2006</year>
<volume>45</volume>
<fpage>793</fpage>
<lpage>800</lpage>
<pub-id pub-id-type="doi">10.1021/bi051558s</pub-id>
<pub-id pub-id-type="pmid">16411755</pub-id>
</element-citation>
</ref>
<ref id="B184-ijerph-16-00856">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pietkiewicz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gamian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Staniszewska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Danielewicz</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Inhibition of human muscle-specific enolase by methylglyoxal and irreversible formation of advanced glycation end products</article-title>
<source/>J. Enzyme Inhib. Med. Chem.
          <year>2009</year>
<volume>24</volume>
<fpage>356</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1080/14756360802187679</pub-id>
<pub-id pub-id-type="pmid">18830874</pub-id>
</element-citation>
</ref>
<ref id="B185-ijerph-16-00856">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chibber</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Molinatti</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Rosatto</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lambourne</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kohner</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: Revelance to diabetic retinopathy</article-title>
<source/>Diabetologia
          <year>1997</year>
<volume>40</volume>
<fpage>156</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1007/s001250050657</pub-id>
<pub-id pub-id-type="pmid">9049475</pub-id>
</element-citation>
</ref>
<ref id="B186-ijerph-16-00856">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duhaiman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Glycation of human lens proteins from diabetic and nondiabetic senile cataract patients</article-title>
<source/>Glycoconj. J.
          <year>1995</year>
<volume>12</volume>
<fpage>618</fpage>
<lpage>621</lpage>
<pub-id pub-id-type="doi">10.1007/BF00731255</pub-id>
<pub-id pub-id-type="pmid">8595250</pub-id>
</element-citation>
</ref>
<ref id="B187-ijerph-16-00856">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Z.Z.</given-names>
</name>
</person-group>
<article-title>Activation of the AGE/RAGE system in the brains of rats and in SH-SY5Y cells exposed to high level of fluoride might connect to oxidative stress</article-title>
<source/>Neurotoxicol. Teratol.
          <year>2015</year>
<volume>48</volume>
<fpage>49</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1016/j.ntt.2015.01.007</pub-id>
<pub-id pub-id-type="pmid">25666879</pub-id>
</element-citation>
</ref>
<ref id="B188-ijerph-16-00856">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wistow</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Lietman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Stapel</surname>
<given-names>S.O.</given-names>
</name>
<name>
<surname>De Jong</surname>
<given-names>W.W.</given-names>
</name>
<name>
<surname>Horwitz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Piatigorsky</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>τ-Crystallin/α-enolase: One gene encodes both an enzyme and a lens structural protein</article-title>
<source/>J. Cell Biol.
          <year>1988</year>
<volume>107</volume>
<fpage>2729</fpage>
<lpage>2736</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.107.6.2729</pub-id>
<pub-id pub-id-type="pmid">2462567</pub-id>
</element-citation>
</ref>
<ref id="B189-ijerph-16-00856">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yahara</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Yeast heat-shock protein of Mr 48,000 is an isoprotein of enolase</article-title>
<source/>Nature
          <year>1985</year>
<volume>315</volume>
<fpage>688</fpage>
<lpage>690</lpage>
<pub-id pub-id-type="doi">10.1038/315688a0</pub-id>
</element-citation>
</ref>
<ref id="B190-ijerph-16-00856">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aaronson</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Graven</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Tucci</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Farber</surname>
<given-names>H.W.</given-names>
</name>
</person-group>
<article-title>Non-neuronal enolase is an endothelial hypoxic stress protein</article-title>
<source/>J. Biol. Chem.
          <year>1995</year>
<volume>270</volume>
<fpage>27752</fpage>
<lpage>27757</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.270.46.27752</pub-id>
<pub-id pub-id-type="pmid">7499243</pub-id>
</element-citation>
</ref>
<ref id="B191-ijerph-16-00856">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Structural analysis of α-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene</article-title>
<source/>J. Biol. Chem.
          <year>2000</year>
<volume>275</volume>
<fpage>5958</fpage>
<lpage>5965</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.275.8.5958</pub-id>
<pub-id pub-id-type="pmid">10681589</pub-id>
</element-citation>
</ref>
<ref id="B192-ijerph-16-00856">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piatigorsky</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Gene Sharing, Lens Crystallins and Speculations on an Eye/Ear Evolutionary Relationship</article-title>
<source/>Integr. Comp. Biol.
          <year>2003</year>
<volume>43</volume>
<fpage>492</fpage>
<lpage>499</lpage>
<pub-id pub-id-type="doi">10.1093/icb/43.4.492</pub-id>
<pub-id pub-id-type="pmid">21680457</pub-id>
</element-citation>
</ref>
<ref id="B193-ijerph-16-00856">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zigler</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>βA3/A1-crystallin: More than a lens protein</article-title>
<source/>Prog. Retin. Eye Res.
          <year>2014</year>
<volume>44</volume>
<fpage>62</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1016/j.preteyeres.2014.11.002</pub-id>
<pub-id pub-id-type="pmid">25461968</pub-id>
</element-citation>
</ref>
<ref id="B194-ijerph-16-00856">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urbak</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vorum</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Heat shock proteins in the human eye</article-title>
<source/>Int. J. Proteom.
          <year>2011</year>
<volume>2010</volume>
<fpage>479571</fpage>
<pub-id pub-id-type="doi">10.1155/2010/479571</pub-id>
<pub-id pub-id-type="pmid">22084677</pub-id>
</element-citation>
</ref>
<ref id="B195-ijerph-16-00856">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ireland</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Katar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maisel</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Heat shock proteins of chicken lens</article-title>
<source/>J. Cell. Biochem.
          <year>2001</year>
<volume>82</volume>
<fpage>409</fpage>
<lpage>414</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.1168</pub-id>
<pub-id pub-id-type="pmid">11500917</pub-id>
</element-citation>
</ref>
<ref id="B196-ijerph-16-00856">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strunnikova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Baffi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Silk</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cousins</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Csaky</surname>
<given-names>K.G.</given-names>
</name>
</person-group>
<article-title>Regulated heat shock protein 27 expression in human retinal pigment epithelium</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2001</year>
<volume>42</volume>
<fpage>2130</fpage>
<lpage>2138</lpage>
<pub-id pub-id-type="pmid">11481282</pub-id>
</element-citation>
</ref>
<ref id="B197-ijerph-16-00856">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoehenwarter</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ackermann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pleissner</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zimny-Arndt</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Jungblut</surname>
<given-names>P.R.</given-names>
</name>
</person-group>
<article-title>Identification of proteins that modify cataract of mouse eye lens</article-title>
<source/>Proteomics
          <year>2008</year>
<volume>8</volume>
<fpage>5011</fpage>
<lpage>5024</lpage>
<pub-id pub-id-type="doi">10.1002/pmic.200800380</pub-id>
<pub-id pub-id-type="pmid">19003866</pub-id>
</element-citation>
</ref>
<ref id="B198-ijerph-16-00856">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salehi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gholaminia</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Panjtanpanah</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Association of HSP70-2 Gene 1267A/G Polymorphism with Cataract Incidence Among Guilan Population</article-title>
<source/>Iran South Med. J.
          <year>2017</year>
<volume>19</volume>
<fpage>931</fpage>
<lpage>939</lpage>
<pub-id pub-id-type="doi">10.18869/acadpub.ismj.19.6.931</pub-id>
</element-citation>
</ref>
<ref id="B199-ijerph-16-00856">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Genetic polymorphisms of HSP70 in age-related cataract</article-title>
<source/>Cell Stress Chaperones.
          <year>2013</year>
<volume>18</volume>
<fpage>703</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1007/s12192-013-0420-4</pub-id>
<pub-id pub-id-type="pmid">23666708</pub-id>
</element-citation>
</ref>
<ref id="B200-ijerph-16-00856">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayub</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Micheal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ajmal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shafique</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Benish Ali</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>den Hollander</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Qamar</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts</article-title>
<source/>Mol. Vis.
          <year>2010</year>
<volume>16</volume>
<fpage>18</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="pmid">20069064</pub-id>
</element-citation>
</ref>
<ref id="B201-ijerph-16-00856">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Talian</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Zelenka</surname>
<given-names>P.S.</given-names>
</name>
</person-group>
<article-title>Contrasting patterns of c-myc and N-myc expression in proliferating, quiescent, and differentiating cells of the embryonic chicken lens</article-title>
<source/>Development
          <year>1992</year>
<volume>115</volume>
<fpage>813</fpage>
<lpage>820</lpage>
<pub-id pub-id-type="pmid">1339339</pub-id>
</element-citation>
</ref>
<ref id="B202-ijerph-16-00856">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavalheiro</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Matos-Rodrigues</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>P.M.G.</given-names>
</name>
<name>
<surname>Martins</surname>
<given-names>R.A.P.</given-names>
</name>
</person-group>
<article-title>c-myc Regulates Cell Proliferation during Lens Development</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e87182</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0087182</pub-id>
<pub-id pub-id-type="pmid">24503550</pub-id>
</element-citation>
</ref>
<ref id="B203-ijerph-16-00856">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashery-Padan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Marquardt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gruss</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye</article-title>
<source/>Genes Dev.
          <year>2000</year>
<volume>14</volume>
<fpage>2701</fpage>
<lpage>2711</lpage>
<pub-id pub-id-type="doi">10.1101/gad.184000</pub-id>
<pub-id pub-id-type="pmid">11069887</pub-id>
</element-citation>
</ref>
<ref id="B204-ijerph-16-00856">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panneerselvam</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Raghunath</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perumal</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Differential expression of myocardial heat shock proteins in rats acutely exposed to fluoride</article-title>
<source/>Cell Stress Chaperones.
          <year>2017</year>
<volume>22</volume>
<fpage>743</fpage>
<lpage>750</lpage>
<pub-id pub-id-type="doi">10.1007/s12192-017-0801-1</pub-id>
<pub-id pub-id-type="pmid">28451878</pub-id>
</element-citation>
</ref>
<ref id="B205-ijerph-16-00856">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Fluoride exposure changed the structure and the expressions of HSP related genes in testes of pubertal rats</article-title>
<source/>Chemosphere
          <year>2017</year>
<volume>184</volume>
<fpage>1080</fpage>
<lpage>1088</lpage>
<pub-id pub-id-type="doi">10.1016/j.chemosphere.2017.06.030</pub-id>
<pub-id pub-id-type="pmid">28672688</pub-id>
</element-citation>
</ref>
<ref id="B206-ijerph-16-00856">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chattopadhyay</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Podder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Fluoride-induced histopathology and synthesis of stress protein in liver and kidney of mice</article-title>
<source/>Arch. Toxicol.
          <year>2011</year>
<volume>85</volume>
<fpage>327</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1007/s00204-010-0588-7</pub-id>
<pub-id pub-id-type="pmid">20859737</pub-id>
</element-citation>
</ref>
<ref id="B207-ijerph-16-00856">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Muhammad</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Selenium increases expression of HSP70 and antioxidant enzymes to lessen oxidative damage in Fincoal-type fluorosis</article-title>
<source/>J. Toxicol. Sci.
          <year>2009</year>
<volume>34</volume>
<fpage>399</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="doi">10.2131/jts.34.399</pub-id>
<pub-id pub-id-type="pmid">19652462</pub-id>
</element-citation>
</ref>
<ref id="B208-ijerph-16-00856">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waugh</surname>
<given-names>D.T.</given-names>
</name>
</person-group>
<article-title>Molecular Mechanisms of Fluoride inhibition of Na+, K+-ATPase activity: Implications for Public Health and Health Inequalities</article-title>
<source/>Int. J. Environ. Res. Public Health
          <year>2019</year>
<comment>in press</comment>
</element-citation>
</ref>
<ref id="B209-ijerph-16-00856">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opit</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Charnock</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>The effect of anions on (Na+ + K+)-activated. ATPase</article-title>
<source/>Biochim. Biophys. Acta
          <year>1966</year>
<volume>120</volume>
<fpage>159</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="doi">10.1016/0926-6585(66)90288-3</pub-id>
<pub-id pub-id-type="pmid">4225353</pub-id>
</element-citation>
</ref>
<ref id="B210-ijerph-16-00856">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kamei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Irreversible inactivation of (Na+-K+)-dependent ATPase and K+-dependent phosphatase by fluoride</article-title>
<source/>Biochim. Biophys. Acta
          <year>1968</year>
<volume>150</volume>
<fpage>162</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1016/0005-2736(68)90021-7</pub-id>
<pub-id pub-id-type="pmid">4296057</pub-id>
</element-citation>
</ref>
<ref id="B211-ijerph-16-00856">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millman</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Omachi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The Role of Oxidized Nicotinamide Adenine Dinucleotide in Fluoride Inhibition of Active Sodium Transport in Human Erythrocytes</article-title>
<source/>J. Gen. Physiol.
          <year>1972</year>
<volume>60</volume>
<fpage>337</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="doi">10.1085/jgp.60.3.337</pub-id>
<pub-id pub-id-type="pmid">4341351</pub-id>
</element-citation>
</ref>
<ref id="B212-ijerph-16-00856">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Fluoride and beryllium interact with the (Na + Kbdependent ATPase as analogs of phosphate</article-title>
<source/>J. Bioenergy Biomembr.
          <year>1986</year>
<volume>18</volume>
<fpage>521</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="doi">10.1007/BF00743148</pub-id>
</element-citation>
</ref>
<ref id="B213-ijerph-16-00856">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Hoover</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Inhibition of the Na/K-ATPase by fluoride. Parallels with its inhibition of the sarcoplasmic reticulum CaATPase</article-title>
<source/>J. Biol. Chem.
          <year>1992</year>
<volume>267</volume>
<fpage>16995</fpage>
<lpage>17000</lpage>
<pub-id pub-id-type="pmid">1324918</pub-id>
</element-citation>
</ref>
<ref id="B214-ijerph-16-00856">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Façanha</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>de Meis</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Inhibition of Maize Root H+-ATPase by Fluoride and Fluoroaluminate Complexes</article-title>
<source/>Plant Physiol.
          <year>1995</year>
<volume>108</volume>
<fpage>241</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1104/pp.108.1.241</pub-id>
<pub-id pub-id-type="pmid">12228469</pub-id>
</element-citation>
</ref>
<ref id="B215-ijerph-16-00856">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swann</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Inhibition of (Na+,K+)-ATPase by fluoride: Evidence for a membrane adaptation to ethanol</article-title>
<source/>Alcohol
          <year>1990</year>
<volume>7</volume>
<fpage>91</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1016/0741-8329(90)90067-M</pub-id>
<pub-id pub-id-type="pmid">2158328</pub-id>
</element-citation>
</ref>
<ref id="B216-ijerph-16-00856">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suketa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Taki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tanishita</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Effect of fluoride on the activities of the Na+/glucose cotransporter and Na+/K(+)-ATPase in brush border and basolateral membranes of rat kidney (in vitro and in vivo)</article-title>
<source/>Biol. Pharm. Bull.
          <year>1995</year>
<volume>18</volume>
<fpage>273</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="doi">10.1248/bpb.18.273</pub-id>
<pub-id pub-id-type="pmid">7742797</pub-id>
</element-citation>
</ref>
<ref id="B217-ijerph-16-00856">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iukhnovets</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Bachinskiĭ</surname>
<given-names>P.P.</given-names>
</name>
</person-group>
<article-title>Effect of fluoride and insulin on cation-dependent ATPase activity of the enterocytes during threonine absorption</article-title>
<source/>Vopr. Med. Khim.
          <year>1982</year>
<volume>28</volume>
<fpage>46</fpage>
<lpage>50</lpage>
</element-citation>
</ref>
<ref id="B218-ijerph-16-00856">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname>
<given-names>X.A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.R.</given-names>
</name>
</person-group>
<article-title>Effects of Fluoride on Growth and Thyroid Function in Young Pigs</article-title>
<source/>Fluoride
          <year>2006</year>
<volume>39</volume>
<fpage>95</fpage>
<lpage>100</lpage>
</element-citation>
</ref>
<ref id="B219-ijerph-16-00856">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkar</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pal</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Ameliorative effect of resveratrol against fluoride-induced alteration of thyroid function in male wistar rats</article-title>
<source/>Biol. Trace Elem. Res.
          <year>2014</year>
<volume>162</volume>
<fpage>278</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="doi">10.1007/s12011-014-0108-3</pub-id>
<pub-id pub-id-type="pmid">25164033</pub-id>
</element-citation>
</ref>
<ref id="B220-ijerph-16-00856">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkar</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pal</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Effects of sub-acute fluoride exposure on discrete regions of rat brain associated with thyroid dysfunction: A comparative study</article-title>
<source/>Int. J. Biomed. Res.
          <year>2015</year>
<volume>6</volume>
<fpage>647</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="doi">10.7439/ijbr.v6i9.2382</pub-id>
</element-citation>
</ref>
<ref id="B221-ijerph-16-00856">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arulkumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vijayan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Penislusshiyan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sathishkumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Angayarkanni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Palvannan</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Alteration of paraoxonase, arylesterase and lactonase activities in people around fluoride endemic area of Tamil Nadu, India</article-title>
<source/>Clin. Chim. Acta
          <year>2017</year>
<volume>471</volume>
<fpage>206</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1016/j.cca.2017.05.036</pub-id>
<pub-id pub-id-type="pmid">28579140</pub-id>
</element-citation>
</ref>
<ref id="B222-ijerph-16-00856">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shashi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meenakshi</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Inhibitory Effect of Fluoride on Na+,K+ ATPase Activity in Human Erythrocyte Membrane</article-title>
<source/>Biol. Trace Elem. Res.
          <year>2015</year>
<volume>168</volume>
<fpage>340</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="pmid">25957596</pub-id>
</element-citation>
</ref>
<ref id="B223-ijerph-16-00856">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallicchio</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Bach</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Advanced glycation end products inhibit Na+ K+ ATPase in proximal tubule epithelial cells: Role of cytosolic phospholipase A2alpha and phosphatidylinositol 4-phosphate 5-kinase gamma</article-title>
<source/>Biochim. Biophys. Acta
          <year>2010</year>
<volume>1803</volume>
<fpage>919</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamcr.2010.04.009</pub-id>
<pub-id pub-id-type="pmid">20435073</pub-id>
</element-citation>
</ref>
<ref id="B224-ijerph-16-00856">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thangapandiyan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miltonprabu</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Epigallocatechin gallate exacerbates fluoride-induced oxidative stress mediated testicular toxicity in rats through the activation of Nrf2 signaling pathway</article-title>
<source/>Asian Pacif. J. Reprod.
          <year>2015</year>
<volume>4</volume>
<fpage>272</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="doi">10.1016/j.apjr.2015.07.005</pub-id>
</element-citation>
</ref>
<ref id="B225-ijerph-16-00856">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janowiak</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Hayward</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>F.C.</given-names>
</name>
<name>
<surname>Volkman</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>O.W.</given-names>
</name>
</person-group>
<article-title>Gamma-glutamylcysteine synthetase-glutathione synthetase: Domain structure and identification of residues important in substrate and glutathione binding</article-title>
<source/>Biochemistry
          <year>2006</year>
<volume>45</volume>
<fpage>10461</fpage>
<lpage>10473</lpage>
<pub-id pub-id-type="doi">10.1021/bi052483v</pub-id>
<pub-id pub-id-type="pmid">16939198</pub-id>
</element-citation>
</ref>
<ref id="B226-ijerph-16-00856">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carnicer</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Bernardini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bellincampi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Noguera</surname>
<given-names>N.I.</given-names>
</name>
<name>
<surname>Nuccetelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ammatuna</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Breccia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lo-Coco</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Federici</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Role of gamma-glutamyl cysteine synthetase (gamma-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias</article-title>
<source/>Clin. Chim. Acta
          <year>2006</year>
<volume>365</volume>
<fpage>342</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1016/j.cca.2005.09.012</pub-id>
<pub-id pub-id-type="pmid">16239001</pub-id>
</element-citation>
</ref>
<ref id="B227-ijerph-16-00856">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patil</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bellner</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cullaro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gotlinger</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Schwartzman</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2008</year>
<volume>49</volume>
<fpage>3379</fpage>
<lpage>3386</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.07-1515</pub-id>
<pub-id pub-id-type="pmid">18441305</pub-id>
</element-citation>
</ref>
<ref id="B228-ijerph-16-00856">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nath</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Balla</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vercelotti</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Balla</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Levitt</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat</article-title>
<source/>J. Clin. Investig.
          <year>1992</year>
<volume>90</volume>
<fpage>267</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="doi">10.1172/JCI115847</pub-id>
<pub-id pub-id-type="pmid">1634613</pub-id>
</element-citation>
</ref>
<ref id="B229-ijerph-16-00856">
<label>229.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>A.M.K.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Heme Oxygenase-1: Function, Regulation, and Implication of a Novel Stress-inducible Protein in Oxidant-induced Lung Injury</article-title>
<source/>Am. J. Respir. Cell. Mol. Biol.
          <year>1996</year>
<volume>15</volume>
<fpage>9</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1165/ajrcmb.15.1.8679227</pub-id>
<pub-id pub-id-type="pmid">8679227</pub-id>
</element-citation>
</ref>
<ref id="B230-ijerph-16-00856">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seta</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bellner</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rezzani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Abraham</surname>
<given-names>N.G.</given-names>
</name>
<name>
<surname>Gronert</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Laniado-Schwartzman</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response</article-title>
<source/>Am. J. Pathol.
          <year>2006</year>
<volume>169</volume>
<fpage>1612</fpage>
<lpage>1623</lpage>
<pub-id pub-id-type="doi">10.2353/ajpath.2006.060555</pub-id>
<pub-id pub-id-type="pmid">17071585</pub-id>
</element-citation>
</ref>
<ref id="B231-ijerph-16-00856">
<label>231.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiwari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Trivedi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Godbole</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Simultaneous exposure of excess fluoride and calcium deficiency alters VDR, CaR, and calbindin D 9 k mRNA levels in rat duodenal mucosa</article-title>
<source/>Calcif. Tissue Int.
          <year>2004</year>
<volume>75</volume>
<fpage>313</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1007/s00223-004-0225-7</pub-id>
<pub-id pub-id-type="pmid">15549646</pub-id>
</element-citation>
</ref>
<ref id="B232-ijerph-16-00856">
<label>232.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Szeto</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Madara</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.C.</given-names>
</name>
</person-group>
<article-title>Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor</article-title>
<source/>Am. J. Physiol. Endocrinol. Metab.
          <year>2006</year>
<volume>291</volume>
<fpage>E315</fpage>
<lpage>E322</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00590.2005</pub-id>
<pub-id pub-id-type="pmid">16507601</pub-id>
</element-citation>
</ref>
<ref id="B233-ijerph-16-00856">
<label>233.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stachowska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Baśkiewicz-Masiuk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Machaliński</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rybickam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gutowska</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bober</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Grymula</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dziedziejko</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Chlubek</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Sodium fluoride enhancement of monocyte differentiation via nuclear factor κB mechanism</article-title>
<source/>Fluoride
          <year>2005</year>
<volume>38</volume>
<fpage>297</fpage>
<lpage>306</lpage>
</element-citation>
</ref>
<ref id="B234-ijerph-16-00856">
<label>234.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Comparative study of p38 MAPK signal transduction pathway of peripheral blood mononuclear cells from patients with coal-combustion-type fluorosis with and without high hair selenium levels</article-title>
<source/>Int. J. Hyg. Environ. Health
          <year>2010</year>
<volume>213</volume>
<fpage>381</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijheh.2010.06.002</pub-id>
<pub-id pub-id-type="pmid">20619728</pub-id>
</element-citation>
</ref>
<ref id="B235-ijerph-16-00856">
<label>235.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Regulation of LPS-induced mRNA expression of pro-inflammatory cytokines via alteration of NF-κB activity in mouse peritoneal macrophages exposed to fluoride</article-title>
<source/>Chemosphere
          <year>2016</year>
<volume>161</volume>
<fpage>89</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1016/j.chemosphere.2016.06.035</pub-id>
<pub-id pub-id-type="pmid">27421105</pub-id>
</element-citation>
</ref>
<ref id="B236-ijerph-16-00856">
<label>236.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Adcock</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>B.Y.</given-names>
</name>
<name>
<surname>Punchard</surname>
<given-names>N.A.</given-names>
</name>
</person-group>
<article-title>Modulation of LPS stimulated NF-kappaB mediated Nitric Oxide production by PKCε and JAK2 in RAW macrophages</article-title>
<source/>J. Inflamm. (Lond.)
          <year>2007</year>
<volume>4</volume>
<fpage>23</fpage>
<pub-id pub-id-type="doi">10.1186/1476-9255-4-23</pub-id>
<pub-id pub-id-type="pmid">18036230</pub-id>
</element-citation>
</ref>
<ref id="B237-ijerph-16-00856">
<label>237.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kuang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium fluoride induces renal inflammatory responses by activating NF-κB signaling pathway and reducing anti-inflammatory cytokine expression in mice</article-title>
<source/>Oncotarget
          <year>2017</year>
<volume>8</volume>
<fpage>80192</fpage>
<lpage>80207</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.19006</pub-id>
<pub-id pub-id-type="pmid">29113295</pub-id>
</element-citation>
</ref>
<ref id="B238-ijerph-16-00856">
<label>238.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Refsnes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Skuland</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Låg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schwarze</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Øvrevik</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Differential NF-κB and MAPK activation underlies fluoride- and TPA-mediated CXCL8 (IL-8) induction in lung epithelial cells</article-title>
<source/>J. Inflamm. Res.
          <year>2014</year>
<volume>7</volume>
<fpage>169</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.2147/JIR.S69646</pub-id>
<pub-id pub-id-type="pmid">25540590</pub-id>
</element-citation>
</ref>
<ref id="B239-ijerph-16-00856">
<label>239.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kuang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium fluoride induces apoptosis in mouse splenocytes by activating ROS-dependent NF-κB signalling</article-title>
<source/>Oncotarget
          <year>2017</year>
<volume>8</volume>
<fpage>114428</fpage>
<lpage>114441</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.22826</pub-id>
<pub-id pub-id-type="pmid">29383091</pub-id>
</element-citation>
</ref>
<ref id="B240-ijerph-16-00856">
<label>240.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Effects of fluoride on DNA damage, S-phase cell-cycle arrest and the expression of NF-kappaB in primary cultured rat hippocampal neurons</article-title>
<source/>Toxicol. Lett.
          <year>2008</year>
<volume>179</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2008.03.002</pub-id>
<pub-id pub-id-type="pmid">18485627</pub-id>
</element-citation>
</ref>
<ref id="B241-ijerph-16-00856">
<label>241.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.G.</given-names>
</name>
</person-group>
<article-title>Effect of fluoride on calcium ion concentration and expression of nuclear transcription factor kappa-B ρ65 in rat hippocampus</article-title>
<source/>Exp. Toxicol. Pathol.
          <year>2011</year>
<volume>63</volume>
<fpage>407</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="doi">10.1016/j.etp.2010.02.017</pub-id>
<pub-id pub-id-type="pmid">20304620</pub-id>
</element-citation>
</ref>
<ref id="B242-ijerph-16-00856">
<label>242.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Misra</surname>
<given-names>U.K.</given-names>
</name>
<name>
<surname>Gawdi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pizzo</surname>
<given-names>S.V.</given-names>
</name>
</person-group>
<article-title>Beryllium fluoride-induced cell proliferation: A process requiring P21(ras)-dependent activated signal transduction and NF-kappaB-dependent gene regulation</article-title>
<source/>J. Leukoc. Biol.
          <year>2002</year>
<volume>71</volume>
<fpage>487</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="pmid">11867686</pub-id>
</element-citation>
</ref>
<ref id="B243-ijerph-16-00856">
<label>243.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shanmugam</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Abdulla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yakulasamy</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Selvaraj</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mathan</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>A mechanism underlying the neurotoxicity induced by sodium fluoride and its reversal by epigallocatechin gallate in the rat hippocampus: Involvement of NrF2/Keap-1 signaling pathway</article-title>
<source/>J. Basic Appl. Zool.
          <year>2018</year>
<volume>79</volume>
<fpage>1</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1186/s41936-018-0020-z</pub-id>
</element-citation>
</ref>
<ref id="B244-ijerph-16-00856">
<label>244.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Fluoride-Induced Neuron Apoptosis and Expressions of Inflammatory Factors by Activating Microglia in Rat Brain</article-title>
<source/>Mol. Neurobiol.
          <year>2016</year>
<volume>53</volume>
<fpage>4449</fpage>
<lpage>4460</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-015-9380-2</pub-id>
<pub-id pub-id-type="pmid">26253724</pub-id>
</element-citation>
</ref>
<ref id="B245-ijerph-16-00856">
<label>245.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Effects of Different Levels of Calcium Intake on Brain Cell Apoptosis in Fluorosis Rat Offspring and Its Molecular Mechanism</article-title>
<source/>Biol. Trace Elem. Res.
          <year>2017</year>
<volume>176</volume>
<fpage>355</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="doi">10.1007/s12011-016-0850-9</pub-id>
<pub-id pub-id-type="pmid">27655243</pub-id>
</element-citation>
</ref>
<ref id="B246-ijerph-16-00856">
<label>246.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Effects of chronic fluorosis on CAMKIIα, C-FOS, BAX, and BCL-2 channel signalling in the Hippocampus of Rats</article-title>
<source/>Fluoride
          <year>2013</year>
<volume>46</volume>
<fpage>135</fpage>
<lpage>141</lpage>
</element-citation>
</ref>
<ref id="B247-ijerph-16-00856">
<label>247.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.S.</given-names>
</name>
</person-group>
<article-title>Expression of proto-oncogenes c-fos and c-jun in osteoblasts activated by excessive fluoride</article-title>
<source/>Zhonghua Yu Fang Yi Xue Za Zhi
          <year>2003</year>
<volume>37</volume>
<fpage>246</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="pmid">12930673</pub-id>
</element-citation>
</ref>
<ref id="B248-ijerph-16-00856">
<label>248.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The Effect of Chronic Fluorosis on Calcium Ions and CaMKIIα, and c-fos Expression in the Rat Hippocampus</article-title>
<source/>Biol. Trace Elem. Res.
          <year>2018</year>
<volume>182</volume>
<fpage>295</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1007/s12011-017-1098-8</pub-id>
<pub-id pub-id-type="pmid">28730575</pub-id>
</element-citation>
</ref>
<ref id="B249-ijerph-16-00856">
<label>249.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poche</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Nolte</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Udan</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Paik</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>DePinho</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Bartlett</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Dickinson</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Transcription factor FoxO1 is essential for enamel biomineralization</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e30357</elocation-id>
<pub-id pub-id-type="pmid">22291941</pub-id>
</element-citation>
</ref>
<ref id="B250-ijerph-16-00856">
<label>250.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Excessive fluoride reduces Foxo1 expression in dental epithelial cells of the rat incisor</article-title>
<source/>Eur. J. Oral Sci.
          <year>2014</year>
<volume>122</volume>
<fpage>317</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1111/eos.12148</pub-id>
<pub-id pub-id-type="pmid">25183529</pub-id>
</element-citation>
</ref>
<ref id="B251-ijerph-16-00856">
<label>251.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Foxo1 attenuates NaF-induced apoptosis of LS8 cells through the JNK and mitochondrial pathways</article-title>
<source/>Biol. Trace Elem. Res.
          <year>2017</year>
<volume>181</volume>
<fpage>104</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1007/s12011-017-1015-1</pub-id>
<pub-id pub-id-type="pmid">28429284</pub-id>
</element-citation>
</ref>
<ref id="B252-ijerph-16-00856">
<label>252.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>NaF Reduces KLK4 Gene Expression by Decreasing Foxo1 in LS8 Cells</article-title>
<source/>Biol. Trace Elem. Res.
          <year>2018</year>
<volume>186</volume>
<fpage>498</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="doi">10.1007/s12011-018-1325-y</pub-id>
<pub-id pub-id-type="pmid">29633120</pub-id>
</element-citation>
</ref>
<ref id="B253-ijerph-16-00856">
<label>253.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Screening of Environmental Response Genes Related To Dental Fluorosis</article-title>
<source/>Fluoride
          <year>2006</year>
<volume>39</volume>
<fpage>195</fpage>
<lpage>201</lpage>
</element-citation>
</ref>
<ref id="B254-ijerph-16-00856">
<label>254.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Loussararian</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Adelman</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koeffler</surname>
<given-names>H.P.</given-names>
</name>
</person-group>
<article-title>Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. Stimulation and regulation</article-title>
<source/>J. Clin. Investig.
          <year>1990</year>
<volume>85</volume>
<fpage>121</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="doi">10.1172/JCI114401</pub-id>
<pub-id pub-id-type="pmid">1688564</pub-id>
</element-citation>
</ref>
<ref id="B255-ijerph-16-00856">
<label>255.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Refsnes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Becher</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lag</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Skuland</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schwarze</surname>
<given-names>P.E.</given-names>
</name>
</person-group>
<article-title>Fluoride-induced interleukin-6 and interleukin-8 synthesis in human epithelial lung cells</article-title>
<source/>Hum. Exp. Toxicol.
          <year>1999</year>
<volume>18</volume>
<fpage>645</fpage>
<lpage>652</lpage>
<pub-id pub-id-type="doi">10.1191/096032799678839572</pub-id>
<pub-id pub-id-type="pmid">10602388</pub-id>
</element-citation>
</ref>
<ref id="B256-ijerph-16-00856">
<label>256.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Afolabi</surname>
<given-names>O.K.</given-names>
</name>
<name>
<surname>Oyewo</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Adekunle</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Adedosu</surname>
<given-names>O.T.</given-names>
</name>
<name>
<surname>Adedeji</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Oxidative indices correlate with dyslipidemia and pro-inflammatory cytokine levels in fluoride-exposed rats</article-title>
<source/>Arh. Hig. Rada Toksikol.
          <year>2013</year>
<volume>64</volume>
<fpage>521</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="doi">10.2478/10004-1254-64-2013-2351</pub-id>
<pub-id pub-id-type="pmid">24384758</pub-id>
</element-citation>
</ref>
<ref id="B257-ijerph-16-00856">
<label>257.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Inflammatory responses induced by fluoride and arsenic at toxic concentration in rabbit aorta</article-title>
<source/>Arch. Toxicol.
          <year>2012</year>
<volume>86</volume>
<fpage>849</fpage>
<lpage>856</lpage>
<pub-id pub-id-type="doi">10.1007/s00204-012-0803-9</pub-id>
<pub-id pub-id-type="pmid">22422340</pub-id>
</element-citation>
</ref>
<ref id="B258-ijerph-16-00856">
<label>258.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarze</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Låg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Becher</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Thrane</surname>
<given-names>E.V.</given-names>
</name>
<name>
<surname>Samuelsen</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Hetland</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Refsnes</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Role of signal transduction pathways in lung inflammatory responses</article-title>
<source/>Toxicol. Lett.
          <year>2000</year>
<volume>112–113</volume>
<fpage>165</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-4274(99)00280-5</pub-id>
</element-citation>
</ref>
<ref id="B259-ijerph-16-00856">
<label>259.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chouhan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lomash</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Flora</surname>
<given-names>S.J.S.</given-names>
</name>
</person-group>
<article-title>Fluoride-induced changes in haem biosynthesis pathway, neurological variables and tissue histopathology of rats</article-title>
<source/>J. Appl. Toxicol.
          <year>2010</year>
<volume>30</volume>
<fpage>63</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1002/jat.1474</pub-id>
<pub-id pub-id-type="pmid">19743388</pub-id>
</element-citation>
</ref>
<ref id="B260-ijerph-16-00856">
<label>260.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleiner</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Allmann</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>The effects of fluoridated water on rat urine and tissue cAMP levels</article-title>
<source/>Arch. Oral Biol.
          <year>1982</year>
<volume>27</volume>
<fpage>107</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1016/0003-9969(82)90129-7</pub-id>
<pub-id pub-id-type="pmid">6282241</pub-id>
</element-citation>
</ref>
<ref id="B261-ijerph-16-00856">
<label>261.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raina</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Baba</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Sultana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Hepatotoxicity Induced by Subchronic Exposure of Fluoride and Chlorpyrifos in Wistar Rats: Mitigating Effect of Ascorbic Acid</article-title>
<source/>Biol. Trace Elem. Res.
          <year>2015</year>
<volume>166</volume>
<fpage>157</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1007/s12011-015-0263-1</pub-id>
<pub-id pub-id-type="pmid">25669166</pub-id>
</element-citation>
</ref>
<ref id="B262-ijerph-16-00856">
<label>262.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baba</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Raina</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Sultana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Prawez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nisara</surname>
<given-names>N.A.</given-names>
</name>
</person-group>
<article-title>Toxic effects of fluoride and chlorpyrifos on antioxidant parameters in rats: Protective effects of vitamins C and E</article-title>
<source/>Fluoride
          <year>2013</year>
<volume>46</volume>
<fpage>73</fpage>
<lpage>79</lpage>
</element-citation>
</ref>
<ref id="B263-ijerph-16-00856">
<label>263.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chlubek</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Grucka-Mamczar</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Birkner</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Polaniak</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Starwiarska-Pieta</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Duliban</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Activity of pancreatic antioxidative enzymes and malondialdehyde concentrations in rats with hyperglycemia caused by fluoride intoxication</article-title>
<source/>J. Trace Elem. Med. Biol.
          <year>2003</year>
<volume>17</volume>
<fpage>57</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/S0946-672X(03)80047-0</pub-id>
</element-citation>
</ref>
<ref id="B264-ijerph-16-00856">
<label>264.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viglino</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rigo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stevanato</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ranieri</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>The binding of fluoride ion to bovine cuprozinc superoxide dismutase as studied by 19F magnetic relaxation</article-title>
<source/>J. Magn. Resonance
          <year>1969</year>
<volume>34</volume>
<fpage>265</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="doi">10.1016/0022-2364(79)90002-7</pub-id>
</element-citation>
</ref>
<ref id="B265-ijerph-16-00856">
<label>265.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dooley</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>T.F.</given-names>
</name>
<name>
<surname>Karas</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>McGuirl</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>R.D.</given-names>
<suffix>III</suffix>
</name>
<name>
<surname>Koenig</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Azide and fluoride binding to E. coli iron superoxide dismutase as studied by solvent proton magnetic relaxation dispersion</article-title>
<source/>J. Am. Chem. Soc.
          <year>1987</year>
<volume>109</volume>
<fpage>721</fpage>
<lpage>725</lpage>
</element-citation>
</ref>
<ref id="B266-ijerph-16-00856">
<label>266.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varol</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Icli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Aksoy</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bas</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Sutcu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ersoy</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Varol</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ozaydin</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Evaluation of total oxidative status and total antioxidant capacity in patients with endemic fluorosis</article-title>
<source/>Toxicol. Ind. Health
          <year>2013</year>
<volume>29</volume>
<fpage>175</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1177/0748233711428641</pub-id>
<pub-id pub-id-type="pmid">22155887</pub-id>
</element-citation>
</ref>
<ref id="B267-ijerph-16-00856">
<label>267.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalyanalakshmi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vijayabhaskar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dhananjaya Naidu</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Lipid peroxidation and antioxidant enzyme status of adult males with skeletal fluorosis in Andhra Pradesh, India</article-title>
<source/>Fluoride
          <year>2007</year>
<volume>40</volume>
<fpage>42</fpage>
<lpage>45</lpage>
</element-citation>
</ref>
<ref id="B268-ijerph-16-00856">
<label>268.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shanthakumari</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Srinivasalu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Antioxidant defense systems in red blood cell lysates of men with dental fluorosis living in Tamil Nadu, India</article-title>
<source/>Fluoride
          <year>2006</year>
<volume>39</volume>
<fpage>231</fpage>
<lpage>239</lpage>
</element-citation>
</ref>
<ref id="B269-ijerph-16-00856">
<label>269.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumari</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>P.R.</given-names>
</name>
</person-group>
<article-title>Red cell membrane alterations in human chronic fluoride toxicity</article-title>
<source/>Biochem. Int.
          <year>1991</year>
<volume>23</volume>
<fpage>639</fpage>
<lpage>648</lpage>
<pub-id pub-id-type="pmid">1831358</pub-id>
</element-citation>
</ref>
<ref id="B270-ijerph-16-00856">
<label>270.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shivarajashankara</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Shivashankara</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Gopalakrishna</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in children with endemic skeletal fluorosis</article-title>
<source/>Fluoride
          <year>2011</year>
<volume>34</volume>
<fpage>108</fpage>
<lpage>113</lpage>
</element-citation>
</ref>
<ref id="B271-ijerph-16-00856">
<label>271.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Khandare</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>P.Y.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Balakrishna</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Srivalli</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Antioxidant defense system and lipid peroxidation in patients with skeletal fluorosis and in fluoride-intoxicated rabbits</article-title>
<source/>Toxicol. Sci.
          <year>2003</year>
<volume>72</volume>
<fpage>363</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfg030</pub-id>
<pub-id pub-id-type="pmid">12660366</pub-id>
</element-citation>
</ref>
<ref id="B272-ijerph-16-00856">
<label>272.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gavriliuc</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Stepco</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lupan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sevcenco</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Spine</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Salivary Glutathione-Dependent Enzymes in Patients with Dental Fluorosis Treated by Complex Antioxidant Therapy</article-title>
<source/>Balk J. Stom
          <year>2012</year>
<volume>16</volume>
<fpage>79</fpage>
<lpage>83</lpage>
</element-citation>
</ref>
<ref id="B273-ijerph-16-00856">
<label>273.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anwar</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Frier</surname>
<given-names>B.M.</given-names>
</name>
</person-group>
<article-title>Type 1 diabetes mellitus and Down’s syndrome: Prevalence, management and diabetic complications</article-title>
<source/>Diabet. Med.
          <year>1998</year>
<volume>15</volume>
<fpage>160</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1096-9136(199802)15:2&lt;160::AID-DIA537&gt;3.0.CO;2-J</pub-id>
<pub-id pub-id-type="pmid">9507919</pub-id>
</element-citation>
</ref>
<ref id="B274-ijerph-16-00856">
<label>274.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergholdt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Eising</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nerup</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pociot</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Increased prevalence of Down’s syndrome in individuals with type 1 diabetes in Denmark: A nationwide population-based study</article-title>
<source/>Diabetologia
          <year>2006</year>
<volume>49</volume>
<fpage>1179</fpage>
<lpage>1182</lpage>
<pub-id pub-id-type="doi">10.1007/s00125-006-0231-6</pub-id>
<pub-id pub-id-type="pmid">16575558</pub-id>
</element-citation>
</ref>
<ref id="B275-ijerph-16-00856">
<label>275.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasher</surname>
<given-names>V.P.</given-names>
</name>
</person-group>
<article-title>Prevalence of psychiatric disorders in adults with Down’s syndrome</article-title>
<source/>Eur. J. Psychiatry
          <year>1995</year>
<volume>9</volume>
<fpage>77</fpage>
<lpage>82</lpage>
</element-citation>
</ref>
<ref id="B276-ijerph-16-00856">
<label>276.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ekstein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Glick</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Weill</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Down’s syndrome and attention-deficit/hyperactivity disorder (ADHD)</article-title>
<source/>J. Child Neurol.
          <year>2011</year>
<volume>26</volume>
<fpage>1290</fpage>
<lpage>1295</lpage>
<pub-id pub-id-type="doi">10.1177/0883073811405201</pub-id>
<pub-id pub-id-type="pmid">21628698</pub-id>
</element-citation>
</ref>
<ref id="B277-ijerph-16-00856">
<label>277.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vicari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pontillo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Armando</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Neurodevelopmental and psychiatric issues in Down’s syndrome: Assessment and intervention</article-title>
<source/>Psychiatr. Genet.
          <year>2013</year>
<volume>23</volume>
<fpage>95</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1097/YPG.0b013e32835fe426</pub-id>
<pub-id pub-id-type="pmid">23492931</pub-id>
</element-citation>
</ref>
<ref id="B278-ijerph-16-00856">
<label>278.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dykens</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fife</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fitzpatrick</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Psychiatric disorders in adolescents and young adults with Down’s syndrome and other intellectual disabilities</article-title>
<source/>J. Neurodev. Disord.
          <year>2015</year>
<volume>7</volume>
<fpage>9</fpage>
<pub-id pub-id-type="doi">10.1186/s11689-015-9101-1</pub-id>
<pub-id pub-id-type="pmid">25810793</pub-id>
</element-citation>
</ref>
<ref id="B279-ijerph-16-00856">
<label>279.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tassé</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Navas Macho</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Havercamp</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Allain</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Manickam</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Psychiatric Conditions Prevalent Among Adults with Down’s syndrome</article-title>
<source/>J. Pol. Pract. Intellect. Disabil.
          <year>2016</year>
<volume>13</volume>
<fpage>173</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1111/jppi.12156</pub-id>
</element-citation>
</ref>
<ref id="B280-ijerph-16-00856">
<label>280.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oxelgren</surname>
<given-names>U.W.</given-names>
</name>
<name>
<surname>Myrelid</surname>
<given-names>Å.</given-names>
</name>
<name>
<surname>Annerén</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ekstam</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Göransson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Holmbom</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Isaksson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Åberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fernell</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Prevalence of autism and attention-deficit-hyperactivity disorder in Down’s syndrome: A population-based study</article-title>
<source/>Dev. Med. Child Neurol.
          <year>2017</year>
<volume>59</volume>
<fpage>276</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1111/dmcn.13217</pub-id>
<pub-id pub-id-type="pmid">27503703</pub-id>
</element-citation>
</ref>
<ref id="B281-ijerph-16-00856">
<label>281.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohen</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Diabetes mellitus and schizophrenia: Historical perspective</article-title>
<source/>Br. J. Psychiatry Suppl.
          <year>2004</year>
<volume>47</volume>
<fpage>S64</fpage>
<lpage>S66</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.184.47.s64</pub-id>
<pub-id pub-id-type="pmid">15056595</pub-id>
</element-citation>
</ref>
<ref id="B282-ijerph-16-00856">
<label>282.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dixon</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Weiden</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Delahanty</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Postrado</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lucksted</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lehman</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Prevalence and correlates of diabetes in national schizophrenia samples</article-title>
<source/>Schizophr. Bull.
          <year>2000</year>
<volume>26</volume>
<fpage>903</fpage>
<lpage>912</lpage>
<pub-id pub-id-type="doi">10.1093/oxfordjournals.schbul.a033504</pub-id>
<pub-id pub-id-type="pmid">11087022</pub-id>
</element-citation>
</ref>
<ref id="B283-ijerph-16-00856">
<label>283.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Hert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>van Winkel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Van Eyck</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hanssens</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wampers</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Scheen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Peuskens</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: A cross-sectional study</article-title>
<source/>Clin. Pract. Epidemol. Ment. Health
          <year>2006</year>
<volume>2</volume>
<fpage>14</fpage>
<pub-id pub-id-type="doi">10.1186/1745-0179-2-14</pub-id>
<pub-id pub-id-type="pmid">16803620</pub-id>
</element-citation>
</ref>
<ref id="B284-ijerph-16-00856">
<label>284.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatemi</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Stary</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Halt</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Realmuto</surname>
<given-names>G.R.</given-names>
</name>
</person-group>
<article-title>Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum</article-title>
<source/>J. Autism. Dev. Disord.
          <year>2001</year>
<volume>31</volume>
<fpage>529</fpage>
<lpage>535</lpage>
<pub-id pub-id-type="doi">10.1023/A:1013234708757</pub-id>
<pub-id pub-id-type="pmid">11814262</pub-id>
</element-citation>
</ref>
<ref id="B285-ijerph-16-00856">
<label>285.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatemi</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Halt</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Stary</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Realmuto</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Jalali-Mousavi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Reduction in anti-apoptotic protein Bcl-2 in autistic cerebellum</article-title>
<source/>Neuroreport
          <year>2001</year>
<volume>12</volume>
<fpage>929</fpage>
<lpage>933</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-200104170-00013</pub-id>
<pub-id pub-id-type="pmid">11303762</pub-id>
</element-citation>
</ref>
<ref id="B286-ijerph-16-00856">
<label>286.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araghi-Niknam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fatemi</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects</article-title>
<source/>Cell. Mol. Neurobiol.
          <year>2003</year>
<volume>23</volume>
<fpage>945</fpage>
<lpage>952</lpage>
<pub-id pub-id-type="doi">10.1023/B:CEMN.0000005322.27203.73</pub-id>
<pub-id pub-id-type="pmid">14964781</pub-id>
</element-citation>
</ref>
<ref id="B287-ijerph-16-00856">
<label>287.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mal’tseva</surname>
<given-names>V.A.</given-names>
</name>
</person-group>
<article-title>Eye damage in workers with fluorine intoxication</article-title>
<source/>Vestn. Oftalmol.
          <year>1973</year>
<volume>2</volume>
<fpage>71</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">4754087</pub-id>
</element-citation>
</ref>
<ref id="B288-ijerph-16-00856">
<label>288.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karczewicz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Baranowska-George</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Palacz</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Tokarz-Sawinska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Krzystolik</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lubinski</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kosmider</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Evaluation of the visual system in peoplehaving extended contact with fluorine</article-title>
<source/>Klin. Oczna
          <year>1989</year>
<volume>91</volume>
<fpage>9</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">2811194</pub-id>
</element-citation>
</ref>
<ref id="B289-ijerph-16-00856">
<label>289.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>I.Y.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>LaCroix</surname>
<given-names>A.Z.</given-names>
</name>
</person-group>
<article-title>The association of age-related macular degeneration and lens opacities in the aged</article-title>
<source/>Am. J. Public Health
          <year>1989</year>
<volume>79</volume>
<fpage>765</fpage>
<lpage>769</lpage>
<pub-id pub-id-type="doi">10.2105/AJPH.79.6.765</pub-id>
<pub-id pub-id-type="pmid">2729473</pub-id>
</element-citation>
</ref>
<ref id="B290-ijerph-16-00856">
<label>290.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Pulmonary function changes and increased Th-2 cytokine expression and nuclear factor kB activation in the lung after sensitization and allergen challenge in brown Norway rats</article-title>
<source/>Immunol. Lett.
          <year>2000</year>
<volume>73</volume>
<fpage>57</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-2478(00)00200-5</pub-id>
<pub-id pub-id-type="pmid">10963812</pub-id>
</element-citation>
</ref>
<ref id="B291-ijerph-16-00856">
<label>291.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caramori</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Casolari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Adcock</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Role of Transcription Factors in the Pathogenesis of Asthma and COPD</article-title>
<source/>Cell Commun. Adhes.
          <year>2013</year>
<volume>20</volume>
<fpage>21</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">23472830</pub-id>
</element-citation>
</ref>
<ref id="B292-ijerph-16-00856">
<label>292.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caramori</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Adcock</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD</article-title>
<source/>Curr. Opin. Investig. Drugs
          <year>2004</year>
<volume>5</volume>
<fpage>1141</fpage>
<lpage>1147</lpage>
<pub-id pub-id-type="pmid">15573863</pub-id>
</element-citation>
</ref>
<ref id="B293-ijerph-16-00856">
<label>293.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edwards</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Bartlett</surname>
<given-names>N.W.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Birrell</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Belvisi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease</article-title>
<source/>Pharmacol. Ther.
          <year>2009</year>
<volume>121</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/j.pharmthera.2008.09.003</pub-id>
<pub-id pub-id-type="pmid">18950657</pub-id>
</element-citation>
</ref>
<ref id="B294-ijerph-16-00856">
<label>294.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>No</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Rhee</surname>
<given-names>S.H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modulation of age-related NF-kappaB activation by dietary zingerone via MAPK pathway</article-title>
<source/>Exp. Gerontol.
          <year>2010</year>
<volume>45</volume>
<fpage>419</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="doi">10.1016/j.exger.2010.03.005</pub-id>
<pub-id pub-id-type="pmid">20211236</pub-id>
</element-citation>
</ref>
<ref id="B295-ijerph-16-00856">
<label>295.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naik</surname>
<given-names>U.S.</given-names>
</name>
<name>
<surname>Gangadharan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Abbagani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nagalla</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dasari</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Manna</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>A study of nuclear transcription factor-kappa B in childhood autism</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<elocation-id>e19488</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0019488</pub-id>
<pub-id pub-id-type="pmid">21573053</pub-id>
</element-citation>
</ref>
<ref id="B296-ijerph-16-00856">
<label>296.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Suckling</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Powis</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Aberrant NF-kappaB expression in autism spectrum condition: A mechanism for neuroinflammation</article-title>
<source/>Front. Psychiatry.
          <year>2011</year>
<volume>2</volume>
<fpage>27</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2011.00027</pub-id>
<pub-id pub-id-type="pmid">21629840</pub-id>
</element-citation>
</ref>
<ref id="B297-ijerph-16-00856">
<label>297.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Salam</surname>
<given-names>O.M.E.</given-names>
</name>
<name>
<surname>Youness</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Mohammed</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Elhamed</surname>
<given-names>W.A.A.</given-names>
</name>
</person-group>
<article-title>Nuclear Factor-Kappa B and Other Oxidative Stress Biomarkers in Serum of Autistic Children</article-title>
<source/>Open J. Mol. Integr. Physiol.
          <year>2015</year>
<volume>5</volume>
<fpage>18</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.4236/ojmip.2015.51002</pub-id>
</element-citation>
</ref>
<ref id="B298-ijerph-16-00856">
<label>298.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghanizadeh</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Nuclear factor kappa B may increase insight into the management of neuroinflammation and excitotoxicity in autism</article-title>
<source/>Expert Opin. Ther. Targets
          <year>2011</year>
<volume>15</volume>
<fpage>781</fpage>
<lpage>783</lpage>
<pub-id pub-id-type="doi">10.1517/14728222.2011.571212</pub-id>
<pub-id pub-id-type="pmid">21554160</pub-id>
</element-citation>
</ref>
<ref id="B299-ijerph-16-00856">
<label>299.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Regulation of set gene expression by NF- κB</article-title>
<source/>Mol. Neurobiol.
          <year>2016</year>
<volume>54</volume>
<fpage>4477</fpage>
<lpage>4485</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-016-9967-2</pub-id>
<pub-id pub-id-type="pmid">27351675</pub-id>
</element-citation>
</ref>
<ref id="B300-ijerph-16-00856">
<label>300.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lukiw</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Bazan</surname>
<given-names>N.G.</given-names>
</name>
</person-group>
<article-title>Strong nuclear factor-κB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer’s disease superior temporal lobe neocortex</article-title>
<source/>J. Neurosci. Res.
          <year>1998</year>
<volume>53</volume>
<fpage>583</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19980901)53:5&lt;583::AID-JNR8&gt;3.0.CO;2-5</pub-id>
<pub-id pub-id-type="pmid">9726429</pub-id>
</element-citation>
</ref>
<ref id="B301-ijerph-16-00856">
<label>301.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boissiere</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hunot</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Faucheux</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Duyckaerts</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hauw</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Agid</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>Nuclear translocation of NF-κB in cholinergic neurons of patients with Alzheimer’s disease</article-title>
<source/>Neuroreport
          <year>1997</year>
<volume>8</volume>
<fpage>2849</fpage>
<lpage>2852</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-199709080-00009</pub-id>
<pub-id pub-id-type="pmid">9376517</pub-id>
</element-citation>
</ref>
<ref id="B302-ijerph-16-00856">
<label>302.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akiyama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>McGeer</surname>
<given-names>P.L.</given-names>
</name>
</person-group>
<article-title>Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer’s disease and amyotrophic lateral sclerosis</article-title>
<source/>Brain Res.
          <year>1994</year>
<volume>639</volume>
<fpage>171</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(94)91779-5</pub-id>
<pub-id pub-id-type="pmid">7514086</pub-id>
</element-citation>
</ref>
<ref id="B303-ijerph-16-00856">
<label>303.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunot</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brugg</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ricard</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>Muriel</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Ruberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Faucheux</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Agid</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1997</year>
<volume>94</volume>
<fpage>7531</fpage>
<lpage>7536</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.94.14.7531</pub-id>
<pub-id pub-id-type="pmid">9207126</pub-id>
</element-citation>
</ref>
<ref id="B304-ijerph-16-00856">
<label>304.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Block</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism</article-title>
<source/>Prog. Neurobiol.
          <year>2005</year>
<volume>76</volume>
<fpage>77</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2005.06.004</pub-id>
<pub-id pub-id-type="pmid">16081203</pub-id>
</element-citation>
</ref>
<ref id="B305-ijerph-16-00856">
<label>305.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonetti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Stegagno</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cannella</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rizzuto</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Moretto</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Raine</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>Activation of NF-κB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology</article-title>
<source/>Am. J. Pathol.
          <year>1999</year>
<volume>155</volume>
<fpage>1433</fpage>
<lpage>1438</lpage>
<pub-id pub-id-type="doi">10.1016/S0002-9440(10)65456-9</pub-id>
<pub-id pub-id-type="pmid">10550297</pub-id>
</element-citation>
</ref>
<ref id="B306-ijerph-16-00856">
<label>306.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glass</surname>
<given-names>C.K.</given-names>
</name>
<name>
<surname>Saijo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Winner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Marchetto</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Gage</surname>
<given-names>F.H.</given-names>
</name>
</person-group>
<article-title>Mechanisms underlying inflammation in neurodegeneration</article-title>
<source/>Cell
          <year>2010</year>
<volume>140</volume>
<fpage>918</fpage>
<lpage>934</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.02.016</pub-id>
<pub-id pub-id-type="pmid">20303880</pub-id>
</element-citation>
</ref>
<ref id="B307-ijerph-16-00856">
<label>307.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Mandelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>O.J.</given-names>
</name>
<name>
<surname>Pae</surname>
<given-names>C.U.</given-names>
</name>
<name>
<surname>Serretti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nimgaonkar</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Paik</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Jun</surname>
<given-names>T.Y.</given-names>
</name>
</person-group>
<article-title>Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia</article-title>
<source/>Eur. Arch. Psychiatry Clin. Neurosci.
          <year>2008</year>
<volume>258</volume>
<fpage>239</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1007/s00406-007-0791-6</pub-id>
<pub-id pub-id-type="pmid">18299791</pub-id>
</element-citation>
</ref>
<ref id="B308-ijerph-16-00856">
<label>308.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kowalczyk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Owczarek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suchanek</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Paul-Samojedny</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fila-Danilow</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Borkowska</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kucia</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kowalski</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Heat shock protein 70 gene polymorphisms are associated with paranoid schizophrenia in the Polish population</article-title>
<source/>Cell Stress Chaperones
          <year>2014</year>
<volume>19</volume>
<fpage>205</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1007/s12192-013-0446-7</pub-id>
<pub-id pub-id-type="pmid">23893339</pub-id>
</element-citation>
</ref>
<ref id="B309-ijerph-16-00856">
<label>309.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Ansary</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Al-Ayadhi</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Neuroinflammation in autism spectrum disorders</article-title>
<source/>J. Neuroinflamm.
          <year>2012</year>
<volume>9</volume>
<fpage>265</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-9-265</pub-id>
</element-citation>
</ref>
<ref id="B310-ijerph-16-00856">
<label>310.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aron</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Busson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Polla</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Dusser</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lockhart</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Swierczewski</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Favatier</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Analysis of hsp70 gene polymorphism in allergic asthma</article-title>
<source/>Allergy
          <year>1999</year>
<volume>54</volume>
<fpage>165</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1034/j.1398-9995.1999.00859.x</pub-id>
<pub-id pub-id-type="pmid">10221440</pub-id>
</element-citation>
</ref>
<ref id="B311-ijerph-16-00856">
<label>311.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhenyu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Laiyu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wancheng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shao-xi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fei</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Increased heat shock protein 70 levels in induced sputum and plasma correlate with severity of asthma patients</article-title>
<source/>Cell Stress Chaperones
          <year>2011</year>
<volume>16</volume>
<fpage>663</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="doi">10.1007/s12192-011-0278-2</pub-id>
<pub-id pub-id-type="pmid">21643870</pub-id>
</element-citation>
</ref>
<ref id="B312-ijerph-16-00856">
<label>312.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schett</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Redlich</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Bizan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Groger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tohidast-Akrad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kiener</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Smolen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs</article-title>
<source/>J. Clin. Investig.
          <year>1998</year>
<volume>102</volume>
<fpage>302</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="pmid">9664071</pub-id>
</element-citation>
</ref>
<ref id="B313-ijerph-16-00856">
<label>313.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Release of heat shock protein 70 and the effects of extracellular heat shock protein 70 on the production of IL-10 in fibroblast-like synoviocytes</article-title>
<source/>Cell Stress Chaperones
          <year>2008</year>
<volume>13</volume>
<fpage>365</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1007/s12192-008-0036-2</pub-id>
<pub-id pub-id-type="pmid">18392950</pub-id>
</element-citation>
</ref>
<ref id="B314-ijerph-16-00856">
<label>314.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Najafizadeh</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Ghazizadeh</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Nargesi</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Mahdavi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Abtahi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mirmiranpour</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nakhjavani</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Analysis of serum heat shock protein 70 (HSPA1A) concentrations for diagnosis and disease activity monitoring in patients with rheumatoid arthritis</article-title>
<source/>Cell Stress Chaperones
          <year>2015</year>
<volume>20</volume>
<fpage>537</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="doi">10.1007/s12192-015-0578-z</pub-id>
<pub-id pub-id-type="pmid">25739548</pub-id>
</element-citation>
</ref>
<ref id="B315-ijerph-16-00856">
<label>315.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.W.</given-names>
</name>
</person-group>
<article-title>Downregulation of heat shock protein 70 protects rheumatoid arthritis fibroblast-like synoviocytes from nitric oxide-induced apoptosis</article-title>
<source/>Arthritis Res. Ther.
          <year>2009</year>
<volume>11</volume>
<fpage>R130</fpage>
<pub-id pub-id-type="doi">10.1186/ar2797</pub-id>
<pub-id pub-id-type="pmid">19709444</pub-id>
</element-citation>
</ref>
<ref id="B316-ijerph-16-00856">
<label>316.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ucisik-Akkaya</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Gorodezky</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Alaez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dorak</surname>
<given-names>M.T.</given-names>
</name>
</person-group>
<article-title>HLA complex-linked heat shock protein genes and childhood acute lymphoblastic leukemia susceptibility</article-title>
<source/>Cell Stress Chaperones
          <year>2010</year>
<volume>15</volume>
<fpage>475</fpage>
<lpage>485</lpage>
<pub-id pub-id-type="doi">10.1007/s12192-009-0161-6</pub-id>
<pub-id pub-id-type="pmid">20012387</pub-id>
</element-citation>
</ref>
<ref id="B317-ijerph-16-00856">
<label>317.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciocca</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Tandon</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Fuqua</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Welch</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>McGuire</surname>
<given-names>W.L.</given-names>
</name>
</person-group>
<article-title>Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: Prognostic implications</article-title>
<source/>J. Natl. Cancer Inst.
          <year>1993</year>
<volume>85</volume>
<fpage>570</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="doi">10.1093/jnci/85.7.570</pub-id>
<pub-id pub-id-type="pmid">8455204</pub-id>
</element-citation>
</ref>
<ref id="B318-ijerph-16-00856">
<label>318.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>M.Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y.M.</given-names>
</name>
</person-group>
<article-title>Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer</article-title>
<source/>J. Gastroenterol. Hepatol.
          <year>2003</year>
<volume>18</volume>
<fpage>690</fpage>
<lpage>700</lpage>
<pub-id pub-id-type="doi">10.1046/j.1440-1746.2003.03011.x</pub-id>
<pub-id pub-id-type="pmid">12753152</pub-id>
</element-citation>
</ref>
<ref id="B319-ijerph-16-00856">
<label>319.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Expressions of HSP70 and HSP27 in hepatocellular carcinoma</article-title>
<source/>J. Korean Med. Sci.
          <year>2005</year>
<volume>20</volume>
<fpage>829</fpage>
<lpage>834</lpage>
<pub-id pub-id-type="doi">10.3346/jkms.2005.20.5.829</pub-id>
<pub-id pub-id-type="pmid">16224158</pub-id>
</element-citation>
</ref>
<ref id="B320-ijerph-16-00856">
<label>320.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luk</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Siu</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>B.Y.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>I.O.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>M.Y.</given-names>
</name>
<name>
<surname>Che</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>S.T.</given-names>
</name>
</person-group>
<article-title>Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values</article-title>
<source/>Proteomics
          <year>2006</year>
<volume>6</volume>
<fpage>1049</fpage>
<lpage>1105</lpage>
<pub-id pub-id-type="doi">10.1002/pmic.200500306</pub-id>
<pub-id pub-id-type="pmid">16400691</pub-id>
</element-citation>
</ref>
<ref id="B321-ijerph-16-00856">
<label>321.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alaiya</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Oppermann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Langridge</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Roblick</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Egevad</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brindstedt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hellström</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Linder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bergman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jörnvall</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry</article-title>
<source/>Cell Mol. Life Sci.
          <year>2001</year>
<volume>58</volume>
<fpage>307</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1007/PL00000858</pub-id>
<pub-id pub-id-type="pmid">11289312</pub-id>
</element-citation>
</ref>
<ref id="B322-ijerph-16-00856">
<label>322.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Khaleque</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Theriault</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Calderwood</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo</article-title>
<source/>Cell Stress Chaperones
          <year>2005</year>
<volume>10</volume>
<fpage>46</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1379/CSC-44R.1</pub-id>
<pub-id pub-id-type="pmid">15832947</pub-id>
</element-citation>
</ref>
<ref id="B323-ijerph-16-00856">
<label>323.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Heat shock protein 70 chaperoned alpha-fetoprotein in human hepatocellular carcinoma cell line BEL-7402</article-title>
<source/>World J. Gastroenterol.
          <year>2005</year>
<volume>11</volume>
<fpage>5561</fpage>
<lpage>5564</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v11.i35.5561</pub-id>
<pub-id pub-id-type="pmid">16222756</pub-id>
</element-citation>
</ref>
<ref id="B324-ijerph-16-00856">
<label>324.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hellman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Alaiya</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Schedvins</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hellstrom</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Auer</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Protein expression patterns in primary carcinoma of the vagina</article-title>
<source/>Br. J. Cancer
          <year>2004</year>
<volume>91</volume>
<fpage>319</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjc.6601944</pub-id>
<pub-id pub-id-type="pmid">15199389</pub-id>
</element-citation>
</ref>
<ref id="B325-ijerph-16-00856">
<label>325.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yaglom</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Gabai</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>M.Y.</given-names>
</name>
</person-group>
<article-title>Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis</article-title>
<source/>Oncogene
          <year>2011</year>
<volume>30</volume>
<fpage>2836</fpage>
<lpage>2845</lpage>
<pub-id pub-id-type="doi">10.1038/onc.2011.5</pub-id>
<pub-id pub-id-type="pmid">21297664</pub-id>
</element-citation>
</ref>
<ref id="B326-ijerph-16-00856">
<label>326.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tetu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Brisson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Landry</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huot</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma: An immunohistochemical study</article-title>
<source/>Breast Cancer Res. Treat.
          <year>1995</year>
<volume>36</volume>
<fpage>93</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1007/BF00690189</pub-id>
<pub-id pub-id-type="pmid">7579511</pub-id>
</element-citation>
</ref>
<ref id="B327-ijerph-16-00856">
<label>327.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>B.C.</given-names>
</name>
</person-group>
<article-title>Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability</article-title>
<source/>BMC Cancer
          <year>2008</year>
<volume>8</volume>
<elocation-id>286</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2407-8-286</pub-id>
<pub-id pub-id-type="pmid">18834540</pub-id>
</element-citation>
</ref>
<ref id="B328-ijerph-16-00856">
<label>328.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geisler</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Tammela</surname>
<given-names>J.E.J.E.</given-names>
</name>
<name>
<surname>Manahan</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Geisler</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>G.A.G.A.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wiemann</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>HSP27 in patients with ovarian carcinoma: Still an independent prognostic indicator at 60 months follow-up</article-title>
<source/>Eur. J. Gynaecol. Oncol.
          <year>2004</year>
<volume>25</volume>
<fpage>165</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="pmid">15032273</pub-id>
</element-citation>
</ref>
<ref id="B329-ijerph-16-00856">
<label>329.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giaginis</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Daskalopoulou</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Vgenopoulou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sfiniadakis</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kouraklis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Theocharis</surname>
<given-names>S.E.</given-names>
</name>
</person-group>
<article-title>Heat shock protein-27, -60 and -90 expression in gastric cancer: Association with clinicopathological variables and patient survival</article-title>
<source/>BMC Gastroenterol.
          <year>2009</year>
<volume>9</volume>
<elocation-id>14</elocation-id>
<pub-id pub-id-type="pmid">19203381</pub-id>
</element-citation>
</ref>
<ref id="B330-ijerph-16-00856">
<label>330.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foster</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Dodson</surname>
<given-names>A.R.A.R.</given-names>
</name>
<name>
<surname>Ambroisine</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Attard</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>De-Bono</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Scardino</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Reuter</surname>
<given-names>V.E.V.E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement</article-title>
<source/>Br. J. Cancer
          <year>2009</year>
<volume>101</volume>
<fpage>1137</fpage>
<lpage>1144</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjc.6605227</pub-id>
<pub-id pub-id-type="pmid">19707199</pub-id>
</element-citation>
</ref>
<ref id="B331-ijerph-16-00856">
<label>331.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Clinical significance of HSP27 expression in colorectal cancer</article-title>
<source/>Mol. Med. Rep.
          <year>2010</year>
<volume>3</volume>
<fpage>953</fpage>
<lpage>958</lpage>
<pub-id pub-id-type="pmid">21472339</pub-id>
</element-citation>
</ref>
<ref id="B332-ijerph-16-00856">
<label>332.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tweedle</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Khattak</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Nedjadi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Kalirai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dodson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Azadeh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Terlizzo</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer</article-title>
<source/>Gut
          <year>2010</year>
<volume>59</volume>
<fpage>1501</fpage>
<lpage>1510</lpage>
<pub-id pub-id-type="doi">10.1136/gut.2009.196626</pub-id>
<pub-id pub-id-type="pmid">20947885</pub-id>
</element-citation>
</ref>
<ref id="B333-ijerph-16-00856">
<label>333.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ioachin</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Immunohistochemical tumour markers in endometrial carcinoma</article-title>
<source/>Eur. J. Gynaecol. Oncol.
          <year>2005</year>
<volume>26</volume>
<fpage>363</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="pmid">16122180</pub-id>
</element-citation>
</ref>
<ref id="B334-ijerph-16-00856">
<label>334.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Storm</surname>
<given-names>F.K.</given-names>
</name>
<name>
<surname>Mahvi</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Gilchrist</surname>
<given-names>K.W.</given-names>
</name>
</person-group>
<article-title>Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers</article-title>
<source/>Urology
          <year>1993</year>
<volume>42</volume>
<fpage>379</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1016/0090-4295(93)90361-D</pub-id>
<pub-id pub-id-type="pmid">8212437</pub-id>
</element-citation>
</ref>
<ref id="B335-ijerph-16-00856">
<label>335.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciocca</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Calderwood</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications</article-title>
<source/>Cell Stress Chaperones.
          <year>2005</year>
<volume>10</volume>
<fpage>86</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1379/CSC-99r.1</pub-id>
<pub-id pub-id-type="pmid">16038406</pub-id>
</element-citation>
</ref>
<ref id="B336-ijerph-16-00856">
<label>336.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavernier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Duval</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cornillon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Flandrin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Guyotat</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Prognostic value of CXCRCR4, adhesion molecules and heat shock proteins (HSP) in acute myelogenous leukemia</article-title>
<source/>Blood (ASH Ann. Meet. Abstr.)
          <year>2007</year>
<volume>110</volume>
<fpage>2848</fpage>
</element-citation>
</ref>
<ref id="B337-ijerph-16-00856">
<label>337.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexiou</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Karamoutsios</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lallas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ragos</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Goussia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kyritsis</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Voulgaris</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vartholomatos</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Expression of heat shock proteins in brain tumors</article-title>
<source/>Turk. Neurosurg.
          <year>2014</year>
<volume>24</volume>
<fpage>745</fpage>
<lpage>749</lpage>
<pub-id pub-id-type="doi">10.5137/1019-5149.JTN.9852-13.0</pub-id>
<pub-id pub-id-type="pmid">25269047</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<table-wrap id="ijerph-16-00856-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijerph-16-00856-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Summary of molecular mechanisms by which fluoride contributes to eye diseases.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Factor</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Effect of F</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Contribution to Degenerative Eye Diseases </th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Enolase</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Loss of enolase induces cataractogenesis. τ-Crystallin, heat shock proteins, hypoxic stress proteins and c-Myc binding proteins possess enolase activity. These proteins are essential for lens function repair and protection. </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Heat Shock Proteins</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="left" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Hsp 40</td>
<td align="center" colspan="1" rowspan="1" valign="middle">↓</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Hsp 40 has been found to protect the lens from stress induced denaturation. </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Hsp 27</td>
<td align="center" colspan="1" rowspan="1" valign="middle">↑</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Hsp27 expression associated with AMD and cataracts. </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hsp 70</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hsp70 expression associated with increased risk of cataracts and glaucoma</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">FoxO proteins</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">FoxO proteins regulate antioxidant enzymes. Down regulation of FoxO1 and FoxO3a expression contributes to degenerative eye disorders such as cataract formation.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Na+, K+-ATPase</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Inhibition of Na+, K+-ATPase leads to enhanced ROS production and oxidative stress. Loss of Na+, K+-ATPase associated with cataractogenesis and age-dependent degeneration in photoreceptors, suggesting a link between loss of Na+, K+-ATPase and AMD. Loss of Na+, K+-ATPase linked to hypertension. Hypertension is a risk factor for cataracts, AMD and glaucoma. </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PON1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PON1 is an antioxidant and reduces oxidative stress. Low PON1 activity associated with AMD and cataracts.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">IL-6</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">IL-6 has been shown to be a key player in chronic low-grade systemic inflammation. Associated with cataracts, AMD and glaucoma.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Nrf2</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Inhibition of dysregulation of Nrf2 pathway contributes to a state of chronic systemic inflammation with a diminished capacity to compensate for conditions of increased oxidative stress. Loss of Nrf2 is associated with AMD.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NF-kB</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NF-kB plays a critical role in the expression of inflammatory cytokines. Expression of NF-kB linked to AMD, cataracts and glaucoma. </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">BCL-2</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Has anti-inflammatory properties, reduced expression associated with pathological states and degenerative eye diseases. </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Antioxidants</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Impaired antioxidant activity leads to oxidative stress. Oxidative stress strongly associated with AMD, cataracts and glaucoma.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p><xref ref-type="table" rid="ijerph-16-00856-t001">Table 1</xref> summarises key molecular pathways by which F contributes to eye diseases. Hsp: Heat shock protein; FoxO: Foxhead box ‘Other’ proteins; PON1: Paraoxonase 1; N2f2: Nuclear factor erythroid-2-related factor 2 Nuclear factor; IL6: Interleukin 6; NF-Kb: Nuclear Factor kappa-light-chain-enhancer of activated B cells; BCL-2: B-cell lymphoma 2.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>